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1 Summary 
This work deals with the synthesis of copper complexes as models for the enzyme 
galactose oxidase. The latter were tested in the catalytic aerobic oxidation of primary 
alcohols. 
 
The first models for the active site of galactose oxidase are the libraries of 81 
decapeptide–copper complexes represented in Figure  1-1.  
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
Cu
NH2PEG amino TentaGel resin Cu
N N
H2O O
O
Tyr 272
S
Cys 228
NHHN
His 496 His 581
Tyr 495
 
library 1:
library 2:
Xn = His, Tyr, mod-Cys 
Xn = His, Tyr, TOAC 
Figure  1-1: Active site of GOase and libraries of peptide–copper complexes 
designed to mimic the active site of the enzyme. 
 
The decapeptides contain four variable positions occupied in a combinatorial fashion 
by histidine, tyrosine or the unnatural amino acids TOAC 41 or mod-Cys 42. Histidine 
and tyrosine were chosen because of their presence at the active site of the enzyme, 
while TOAC and mod-Cys should mimic the Tyr 272–Cys 228 conjugate and act as a 
redox centre. 
N
O
CO2HH2N
H3C CH3
H3C CH3
 
S
OH
t-But-Bu
CO2HH2N  
TOAC, 41 mod-Cys, 42 
 
The modified cysteine mod-Cys was synthesised with Boc- and Cbz-protected amino 
function (47 and 53), while the N-Fmoc-protected mod-Cys could not be obtained. 
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S
OMOM
t-But-Bu
CO2HNH
Boc
 
S
OMOM
t-But-Bu
CO2HNH
Cbz
 
47 53 
 
The two mod-Cys containing decapeptides 82 and 83 were synthesised on 
amino TentaGel resin in order to show that it was possible to incorporate the N-Boc 
protected mod-Cys building block 47 in a peptide sequence. 
 
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
82 83 
 
The two decapeptides were incubated in a copper(II) salt solution and the resulting 
peptide–copper complexes were used as catalysts in the aerobic oxidation of 
3-methoxybenzyl alcohol. A turnover number of 40 was observed after 24 hours with 
the copper complex of peptide 82 in neat alcohol and potassium hydroxide as a 
base. 
 
The 81-mer library including TOAC (Figure  1-1, library 2) was synthesised following 
the split-mix protocol and the IRORI-“directed synthesis” system. The decapeptides 
were synthesised on amino TentaGel resin. After acetylation of the N-terminus, the 
solid-supported peptide-ligands were incubated in a copper(II) acetate solution.  The 
observation of the resulting resin beads under the microscope revealed a particular 
colour for each peptide sequence. These different colours demonstrate the affinity of 
the copper ion for the functional groups of the peptide-ligands. 
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Figure  1-2: Microscope view of the solid-supported peptide–copper complexes. 
 
The peptide-ligands were screened for activity in the copper-catalysed aerobic 
oxidation of primary alcohols. 3-Methoxybenzyl alcohol was used as a test substrate 
since the formation of the corresponding aldehyde can be followed by 
UV-spectroscopy. 
 
peptide–ligand, Cu(OAc)2, air 
 
OH
OMe  
MeCN / H2O (1:1), r.t. 
H O
OMe  
absorption at λ = 310 nm
39            40 
Scheme  1-1: Assay for the screening of the library of peptide–ligands. 
 
The screening allowed to distinguish between the members of the library and 
revealed some particularly interesting peptide sequences (Figure  1-3). A turnover 
frequency of 10–4 s–1 was obtained with the peptide ligand containing 2 tyrosine 
residues at the X1 and X2 positions and two TOAC residues at the X3 and X4 
positions. 
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0
1
2
3
4
5
6
YYT'T'
YHT'T'
T'YT'T'
T'T'YT'
T'T'HT'
T'HT'T'
YHT'Y YT'YT'
YT'T'T'
HYT'T' HHT'T'
HT'T'Y
T'HT'H
T'T'T'T'
 
Figure  1-3: Screening of the 81-mer library of decapeptides 99. From left to right are 
all the members of the library in the order given in the experimental 
section with compound 99-01 to the left and compound 99-81 to the right. 
As an example, YYT’T’ corresponds to the peptide-ligands where X1 = Tyr, 
X2 = Tyr, X3 = TOAC and X4 = TOAC. 
 
HO
O
NH
O
HN
O
NH
O
HN
O
NH
O
O
H
N
O
N
H
H
N
O
O
N
H
N
N
N
H
N
O
O
H3C
NO
HN N H3C CH3
H3C
H3C CH3
H3C
H3C
H3C
 
101 
peptide-ligand
% yield of 
aldehyde after 
24 hours 
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One of the peptide-ligands was synthesised on cleavable resin and subsequently 
cleaved from the resin. The activity of this peptide-ligand 101 proved to be higher 
than its solid-supported counterpart since 14.3 µmol of aldehyde were formed with 
the soluble copper complex and 7.29 µmol were formed with the solid-supported 
copper complex after 24 hours. 
 
In another part of this work, the low molecular weight ligand 66 was synthesised on 
solid support. The in situ formed copper complex proved to be active in the catalytic 
aerobic oxidation of benzyl alcohol and 3-methoxybenzyl alcohol. A turnover 
frequency of 3·10–3 s–1 was achieved with this solid-supported ligand. 
 
t-Bu
t-Bu
OH
N
S
O
O
HN
66 
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2 Introduction 
Aldehydes constitute a group of very interesting compounds in organic chemistry. 
They occur as natural flavouring constituents in a wide variety of foods, often in 
relatively small, but occasionally in very large concentrations, and are therefore 
widely used as food additives.[1] Aldehydes also belong to the most frequently used 
intermediates in organic synthesis since they are relatively reactive compounds. The 
controlled oxidation of primary alcohols is a common way for the preparation of 
aldehydes. Traditionally, the oxidation of primary alcohols to aldehydes is performed 
with stoichiometric amounts of inorganic oxidants, notably chromium(VI)[2] (e.g. 
pyridinium chlorochromate in the Corey oxidation)[3] or with activated 
dimethylsulfoxide[4] (e.g. dimethylsulfoxide and dicyclohexylcarbodiimide in the 
Pfitzner-Moffatt oxidation,[5] or dimethylsulfoxide and oxalylchloride in the Swern 
oxidation).[6] More recently, catalysts containing heavy metals such as palladium[7] or 
ruthenium[8] have been developed. But these oxidising agents and catalysts are 
hazardous, toxic, relatively expensive or generate a lot of waste. Therefore, from 
both economical and environmental points of view, there is a demand for more 
effective methods that employ clean oxidants. Particularly, the use of dioxygen as a 
stoichiometric oxidant together with a cheap metal catalyst appears very attractive. A 
few synthetic catalysts using copper and molecular oxygen or air have been reported 
so far, notably by Sheldon,[9] Semmelhack[10] and Markó.[11, 12] 
Copper is an abundant metal on earth and is found in various metalloproteins,[13] 
especially in enzymes involved in the binding of molecular oxygen.[14] An interesting 
example is found in the enzyme galactose oxidase (GOase) which catalyses the 
selective oxidation of primary alcohols to aldehydes, coupled with the reduction of 
dioxygen to hydrogen peroxide (Figure  2-1).[15] 
 
O
OH
HO
OH
OH
O
OH
HO
OH
O
GOase
+  O2 +  H2O2OH OH
 
Figure  2-1: Oxidation of galactose by galactose oxidase.[15] 
 
In the last fifteen years, various groups have been working on the synthesis of 
models for the enzyme galactose oxidase. Biomimetic low molecular weight copper 
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complexes have so far been synthesised by various groups, notably by Stack,[16, 17] 
Wieghardt[18] and Chaudhuri.[19, 20] However these complexes have a narrow range of 
substrates, often limited to activated alcohols and their turnover frequency remains 
low. Therefore, improvements with respect to catalytic activity still remain an 
attractive goal. Moreover, structural models for GOase are still of valuable interest. 
Spectroscopic data of structural models can give information about the active site of 
the enzyme itself. 
Combinatorial chemistry has been widely used in the field of pharmaceutical 
chemistry.[21] More recently, its use for the discovery of new catalysts has also 
attracted increasing interest.[22] Peptide chemistry has been the main field of 
application of combinatorial synthesis. With the development of solid-phase peptide 
synthesis by Merrifield,[23] the design of the tea-bag system by Houghten[24] and the 
introduction of the split-mix method by Furka,[25] the automatic combinatorial 
synthesis of large varieties of peptides has become possible. 
Towards the synthesis of structural models for natural proteins, peptides are obvious 
attractive candidates. This work deals with the combinatorial synthesis of a library of 
resin-supported peptide–copper complexes. These compounds were synthesised by 
the split-mix strategy and designed to mimic the active site of the enzyme GOase. 
The peptide–copper complexes were finally screened for activity in the catalytic 
aerobic oxidation of primary alcohols. 
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3 Background 
3.1 Combinatorial chemistry and solid-phase peptide synthesis 
The basic principle of combinatorial chemistry is to prepare a large number of 
different compounds at the same time, instead of synthesising compounds in a 
conventional one-at-a-time manner.[26] Various compounds are generated 
simultaneously under identical reaction conditions in a systematic manner, so that 
ideally the products of all possible combinations of a given set of starting materials 
(termed building blocks) will be obtained at once. The collection of these finally 
synthesised compounds is referred to as a combinatorial library. The library is then 
screened for the property in question and the active compounds are identified. In a 
multistep combinatorial synthesis, the total number of all synthesised compounds 
within the combinatorial library is determined by N = bx where b is an equal number 
of building blocks used in each reaction (1, 2, …, x) and x is the number of reaction 
steps in which a new building block is introduced. If the number of building blocks for 
each reaction step varies (e.g. a, b and c in a three-step synthesis), then N = a·b·c. 
Thus a large compound library will be obtained rapidly from only a few building 
blocks. 
The principles used in combinatorial chemistry have their origin in the field of peptide 
chemistry. Solid-phase peptide synthesis was first presented by Merrifield in 1963.[23] 
Moreover, the development of the tea-bag system by Houghten in 1985[24] opened 
new possibilities for the parallel synthesis of peptides. Combinatorial synthesis of 
peptides was made possible by the split-mix method developed by Furka in 1988.[25] 
Since the early 1990’s, combinatorial chemistry has attracted the attention of 
companies as a means of reducing the time and high costs associated with the 
traditional and serial synthesis of compounds. At first combinatorial chemistry has 
been mainly used in the field of drug discovery,[21, 26] but more recently its principles 
have been applied increasingly in the search for new materials and catalysts.[22, 27, 28] 
In principle, combinatorial synthesis can be performed both in solution and on solid 
phase.[26] However, due to easy work-ups by simple filtrations, the possibility to 
increase the yields of the reaction by employing excess of reagents and the 
possibility of automation, the majority of compound libraries have been synthesised 
on solid supports such as resin beads. In the following, only the case of solid-phase 
combinatorial libraries will be considered. 
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3.1.1 Split-mix synthesis 
The split-mix synthesis (also termed split-pool synthesis or divide, couple and 
recombined synthesis)[29-31] was first introduced by Furka and co-workers in 1988.[25] 
During the synthesis of a library by the split-mix method, the number of reaction 
vessels used is always inferior to the number of compounds synthesised (Figure 
 3-1).[26] In the first step, the resin is split equally in separate reaction vessels and 
each portion is reacted with a single building block (A1, A2 or A3). After the first step 
has been carried out, the resin-bound compounds from all reaction vessels are 
pooled together in one vessel where the common steps such as resin washing and 
deprotection are performed. For the second step, the resin is again split in separate 
reaction vessels and each portion is reacted with a second building block (B1, B2 or 
B3). The number of reaction vessels corresponds to the number of building blocks 
used in the step. In this way, the second solid-phase reaction provides compounds 
that incorporate all of the possible combinations of the two sets of building blocks. 
These split and mix operation are repeated until completion of the desired library. In 
the case of 3 building blocks used for each coupling step, a total of 27 different 
compounds are formed using only 9 individual reactions (Figure  3-1). Through this 
process, each resin bead in a library ends up with (ideally) just one single compound 
bound to it. The name of “one-bead-one-compound” for this type of libraries was 
introduced by Lebl.[30, 31] 
 
The split-mix protocol is normally carried out on resin beads. Due to the statistical 
distribution of the solid support at each splitting step, the synthesis will lead to over- 
and under-representation within the library. In order to ensure that 95 % of all 
possible compound members of the library are included with a probability greater 
than 99 %, the split-mix synthesis should be carried out with an approximately 
threefold amount of resin beads.[32] 
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Figure  3-1: Split-mix synthesis to prepare combinatorial libraries. (Spheres represent 
resin beads and A, B, C represent the set of building blocks.)[26] 
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3.1.2 Identification of the active compounds 
One of the problems arising from the split-mix synthesis of libraries is the 
identification or analysis of the hits. Numerous analytical systems have been 
developed for the quality control of combinatorial libraries comprising resin-bound 
compound mixture.[33] While automatic microsequencing procedures (Edman 
degradation)[34] allow the structural elucidation of peptides and oligonucleotides, 
mass spectroscopic methods are the method of choice for the analysis of 
low-molecular weight organic compounds. The sensitivity of modern mass 
spectrometry allows the structural determination of compounds in the high 
femtomolar range.[35] Especially, electrospray mass spectrometry (ES/MS) or 
matrix-assisted laser desorption ionisation time-of-flight mass spectrometry 
(MALDI-TOF/MS) techniques are used for compound analysis from small resin 
samples or single beads. Recent progress has also been made in the field of IR[36] 
and NMR[37] spectroscopy for the analysis of small quantities of compounds. 
In addition to direct methods for the structural analysis of compound libraries, there 
are also indirect methods, which are particularly advantageous when working with 
larger compound libraries made by the split-mix synthesis method. The 
deconvolution strategy enables the identification of active compounds of a library by 
synthesis and screening of several sub-libraries.[26] 
An alternative strategy, termed “encoding” or “tagging”, is the labelling of the 
compounds during the split-mix synthesis.[21, 38] The labelling can be chemical or 
non-chemical. In the chemical encoding strategy,[39]  resin linkers containing two 
orthogonally protected functional groups are used to allow the concurrent synthesis 
of both the compound of interest and the encoding compound (so-called tags) on the 
bead, which upon cleavage are sequenced or otherwise decoded to determine the 
structure of the compound of interest (Figure  3-2). 
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Figure  3-2: Encoded combinatorial library by sequenceable chemical tags (left) or by 
non-sequenceable chemical tags (right). Tn represents the tags. 
 
The use of “tea-bags”, associated with the radiofrequency encoding system, allows to 
obtain pure compounds, even when synthesised by the split-mix method. In the 
so-called tea-bag method, originated in 1984 by Houghten and co-workers,[24] the 
split-mix protocol occurs in 15 ¯ 22 mm polypropylene mesh packets with µm-sized 
pores known as tea-bags, filled with resin beads for solid-phase synthesis. This 
method offers the advantage that a greater quantity of each compound of the library 
is available at once (up to 500 µmol), which is sufficient for a complete biological and 
structural characterisation. Based on the concept of the tea bags, the Kan™ reactors 
developed by IRORI are rigid containers with mesh side walls (Figure  3-3). These 
micro-reactors are available in various sizes (MiniKans, MicroKans, and MacroKans) 
and can be filled with resins, manually or automatically. Up to 30 mg of resin can be 
filled in a MicroKan and up to 300 mg in a MacroKan, leaving enough space available 
for the resin to swell and still remain loose within the Kan. The Kans can be closed 
and opened, thus allowing the removal of samples during the synthesis. The 
synthesis takes place by allowing the reagents to flow through the outer mesh walls 
of the Kan. Syntheses are performed using normal laboratory glassware and 
apparatus for heating, cooling, mixing, etc. 
 
resin
bead
T1T2
T3
compoundcompoundresin
bead
T1
T2
T3
compoundcompound
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Figure  3-3: IRORI MacroKan containing up to 30 mg resin and a Rf tag. 
 
More recently, Nicolaou and Xiao,[40] as well as Moran,[41] developed a 
radiofrequency encoding system. This system consists of a glass-encased 
semiconductor memory microchip (Rf tag) capable of receiving, storing and emitting 
radiofrequency signals. The use of these Rf tags together with the IRORI MicroKans 
(designed especially to accommodate a Rf tag) is of great value in split-mix 
protocols. Indeed, a specific radiofrequency signal is recorded on the memory 
microchip, and the capsules are radio-scanned between the steps of the solid-phase 
synthesis. Ultimately, the device can be scanned to identify the compound bound to 
the resin beads. 
 
3.1.3 Solid-phase peptide synthesis 
3.1.3.1 General procedure 
Solid-phase peptide synthesis (SPPS) was first introduced by Merrifield and has 
become the method of choice for the synthesis of peptides and small proteins.[23] 
The general approach to SPPS is outlined in Figure  3-4.[42] Typically, an N-protected 
α-amino acid is attached to an insoluble (solid) support via a linker. The N-protecting 
group (PG1) is then removed and the next N-protected α-amino acid is coupled to the 
first amino acid as either a pre-activated species (symmetrical anhydride, active 
ester) or in situ in the presence of an activator. The cleavage/coupling cycle is 
repeated until the desired sequence of amino acids is obtained. The peptide is then 
cleaved from the linker and obtained as a free acid or amide, depending on the 
chemical nature of the linker. Ideally, the cleavage reagent also removes the amino 
acid side chain protecting goups (PG2), which are stable under the conditions of the 
peptide coupling. These steps may be carried out as either a batch process, where 
the support is filtered between each step, or as a continuous flow process, where the 
support is always solvated during reagent exchange. 
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Figure  3-4: Generalised approach to solid-phase peptide synthesis. (PG1 and PG2 are 
two orthogonal protecting groups).[42] 
 
3.1.3.2 Insoluble support 
The solid support that has been most widely used in SPPS is polystyrene, 
cross-linked with divinylbenzene.[43, 44] The degree of cross-linking influences the 
ability of the resin to swell in organic solvents such as dichloromethane or DMF. The 
optimum resin for swelling and stability is 1 % cross-linked. Resins with a 
cross-linking of 0.5 % were found to be too fragile, while those with a cross-linking of 
2 % or more do not swell sufficiently in dichloromethane or DMF. Based on the 
concept that the insoluble support and peptide chain should be of comparable 
polarities, other polymer supports were also used, e.g. polyacrylamide, 
polydimethylacrylamide, polyacrylylpyrrolidine. Moreover, controlled pore glass, 
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cellulose and polypropylene membranes have been demonstrated to be adequate 
supports. 
 
3.1.3.3 Anchors, spacers and linkers 
To allow the attachment of the first amino acid, the solid support has to be 
functionalised. For example, the Merrifield resin[42] is a chloromethylated 
styrene-divinylbenzene copolymer (Figure  3-5). 
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Figure  3-5: Synthesis of Merrifield resin by chloromethylation of a styrene–
divinylbenzene copolymer.[42] 
 
Nowadays, resins with numerous kinds of functionalities are available.[26] To the resin 
a linker can be bound, and if needed, also a spacer. The “spacer” is located between 
the resin carrier and the linker and, when present, should reduce factors such as 
steric hindrance of reactions brought about by the bulk of the resin or to modify 
features such as the hydrophilicity/hydrophobicity of the local environment. A 
common spacer is polyethylene glycol (PEG). The “linker” is a bifunctional molecule 
which, on the one hand can be bound irreversibly to the resin and, on the other hand, 
offers a reversible binding site for the peptide. An “anchor” is defined as a 
resin-immobilised functional group which forms a cleavable connection to the first 
building block used in the synthesis. Therefore a linker becomes an anchor after its 
immobilisation on the resin. 
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Depending on the chemical structure of the anchor and the chemistry of its 
attachment to the resin, the product can be cleaved at the end of the synthesis either 
with acid, base or a nucleophilic cleavage reagent, hydrogenolysis, enzymatic, 
palladium-catalysed or photochemical, oxidative and reductive cleavage methods.[26, 
43] 
When planning a synthesis, the type of linker or anchor has to be chosen carefully so 
that the peptide will stay bound to the resin until the end of the synthesis. The 
conditions of cleavage of the peptide from the resin have to be orthogonal to the 
temporary protecting groups used during the peptide synthesis. 
 
3.1.3.4 Temporary N-protecting groups and side chain protecting groups  
The most commonly used strategies in SPPS are the Boc/Cbz and Fmoc/t-Bu 
strategies[43] (Figure  3-6). In the Boc/Cbz strategy, the amino acids are N-protected 
with tert-butyloxycarbonyl (Boc) and the side chains are protected with 
benzyloxycarbonyl (Cbz), while in the Fmoc/t-Bu strategy, the amino acids are 
N-protected with 9-fluorenylmethoxycarbonyl (Fmoc) and the side chains are 
protected with tert-butyloxycarbonyl (t-Bu). The Boc protecting group is orthogonal to 
the Cbz protecting group since Boc is cleaved with TFA and Cbz requires stronger 
acidic conditions to be cleaved (HF). The Fmoc protecting group is also orthogonal to 
t-Bu since Fmoc is cleaved with secondary amines, such as piperidine, while t-Bu is 
removed under acidic conditions. 
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Figure  3-6: Protecting group strategies in SPPS. 
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In order to choose between these strategies, it is essential to use an anchor that 
remains stable under the conditions used for the removal of the amine protecting 
group. Usually, an anchor cleavable under the same conditions as the side chain 
protecting groups will be used. For example, a peptide is cleaved from Merrifield 
resin in strong acidic conditions (HF).[45] This resin was first used for the synthesis of 
peptides using N-Boc-protected amino acids since the anchor is stable to TFA. 
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Figure  3-7: Peptide synthesis on Merrifield resin and cleavage with HF.[45] 
 
The Wang linker is cleaved under milder conditions than Merrifield resin since it is 
cleaved with TFA.[46] This makes this linker compatible with the Fmoc/t-Bu strategy. 
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Figure  3-8: Peptide synthesis on Wang resin and cleavage with TFA.[46] 
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3.1.3.5 Coupling agents and formation of the peptide bond 
For peptide bond formation, the carboxylic acid group of the N-protected amino acid 
to be coupled has to be converted into an activated species. However, 
over-activation should be avoided because of the risk of racemisation of the amino 
acid. For example, the use of acid chlorides as activated species often leads to 
racemisation. One of the simplest methods of peptide bond formation is the treatment 
of the free amino group with symmetrical anhydrides. The use of 
dicyclohexylcarbodiimide (DCC) for the formation of symmetrical anhydrides has 
been a long recognised and well-established coupling procedure in SPPS.[47] The 
anhydride can be prepared and latter coupled to the free amine peptide chain. 
Another alternative is the direct addition of the carbodiimide (DCC or DIC) and 
N-protected amino acid to the resin. However, this procedure can lead to 
racemisation of the amino acid, which can be suppressed by the addition of auxiliary 
nucleophiles such as 1-hydroxybenzotriazole (HOBt).[48] Activated esters formed from 
N-hydroxysuccinimide[49] or HOBt have been used. More recently, other activating 
agents have been introduced, the most famous being BOP,[50] PyBOP,[51] HBTU,[52] 
TSTU,[53] TBTU[54] or CDI.[55] These coupling agents are added with the N-protected 
amino acid to the resin and the activated ester is formed in situ. 
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Figure  3-9: Examples of coupling agents used in solid-phase peptide synthesis. (The 
complete names are written in the abbreviation part.) 
 
3.1.3.6 Monitoring 
Despite the use of highly efficient coupling techniques, acylation reactions cannot be 
assumed to proceed with 100 % conversion. So the completion of couplings must be 
monitored. Monitoring techniques may be qualitative or quantitative. There are 
several well established qualitative monitoring methods, such as ninhydrin (Kaiser 
Test),[57] picric acid[58] or 2,4,6-trinitrobenzenesulfonic acid (TNBS),[59] based on 
reaction with free amino groups to produce a chromophoric compound. 
The NF31 test, described by De Clerq and co-workers,[60] makes use of the 
para-nitrophenyl ester 1 (NF31) synthesised from disperse red. This colour test is 
performed by suspending the resin beads in a solution of 1 in acetonitrile. After 
heating for 10 minutes and washing, the beads containing free amino functions 
appear as red spheres while completely coupled beads (containing no free amino 
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groups) remain colourless. This visual detection is a sensitive method and is 
especially valuable for the detection of sterically hindered amines. 
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Figure  3-10: Resin beads after treatment with NF31 (left: negative test; right: positive 
test). 
 
SPPS using Fmoc as the N-protecting group offers a unique opportunity to monitor 
N-amino group deprotection. Indeed, a dibenzofulvene–piperidine adduct is formed 
during deprotection by piperidine.[43, 61] This chromophoric adduct has a UV 
absorption maximum at 301 nm. This absorption property permits reasonably 
accurate determination of deprotection efficiency. 
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Figure  3-11: Deprotection of Fmoc amino acids by piperidine.[43, 61] 
  
3.2 Galactose oxidase 
Galactose oxidase (Goase or GO, EC 1.1.3.9) is a fungal enzyme that can be found 
in Dactylium dendroides, Gibberella fujikuroi or Fusarium graminearum.[15, 62-64] It 
belongs, together with glyoxal oxidase, to the family of radical-copper oxidases and it 
catalyses the aerobic oxidation of D-galactose and a wide range of primary alcohols 
(ranging from small molecules to polysaccharides) to the corresponding aldehydes, 
coupled with the reduction of dioxygen to hydrogen peroxide (Figure  3-12). Taking 
into account the low specificity of GOase for organic substrates, its biological function 
is probably to serve as a generator of hydrogen peroxide rather than as a source of 
aldehydes.[63] The specificity for oxidants is also broad: in the absence of dioxygen, 
several one-electron redox agents can act as electron acceptors.[63] 
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Figure  3-12: Oxidation of primary alcohols by galactose oxidase. 
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GOase consists of a single polypeptide with a molecular mass of 68.5 kDa. A 
breakthrough in the study of the enzyme came in 1991 when its crystal structure at 
1.7 Å was determined by Knowles and co-workers.[65] The crystal structure reveals 
the presence of three distinct domains in the folded polypeptide: the N-terminal 
domain (residues 1 to 155) that may have the function of targeting and positioning 
the substrate, the catalytic domain (residues 155 to 552) and the C-terminal domain 
(residues 553 to 639).[15] The active site is a distorted square pyramidal copper 
complex. The equatorial positions of the complex are occupied by two histidines 
(His 496 and His 581), one tyrosine (Tyr 272) and a molecule of solvent. The axial 
position is occupied by a tyrosine (Tyr 495) (Figure  3-13).[65] 
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Figure  3-13: Active site of galactose oxidase. 
 
GOase is unusual among metalloenzymes since it catalyses a two-electron redox 
reaction at a mononuclear copper centre. This is made possible by the action of an 
organic cofactor. The equatorial tyrosine (Tyr 272) is covalently bound at the position 
ortho to its phenolic hydroxyl group to the sulphur atom of the adjacent Cys 228, 
resulting in a Tyr-Cys cross-link. This built-in cofactor serves as a one-electron redox 
centre since the phenol moiety can be oxidised to a phenoxyl radical during the 
course of the redox cycle. The interconversion between Cu(I) and Cu(II) has also 
been demonstrated by X-ray absorption spectroscopy.[66] So GOase can exist in 
three distinct, stable oxidation states. These can be assigned as highest oxidation 
state [Cu(II) and tyrosyl radical], intermediate oxidation state [Cu(II) and tyrosine in 
equilibrium with Cu(I) and tyrosyl radical] and lowest oxidation state [Cu(I) and 
tyrosine] (Figure  3-14).[64] The highest oxidation state is the catalytically active form 
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of the enzyme. This active oxidised form is EPR-silent, indicating that the cupric ion 
is antiferromagnetically coupled to the tyrosyl radical. 
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Figure  3-14: Redox interconversion of galactose oxidase species. 
 
Moreover, the Tyr-Cys moiety is π-stacked to a tryptophan residue (Trp 290) (Figure 
 3-13). The interaction between Tyr-Cys and tryptophan side chains is believed to 
have a significant stabilising effect on the Tyr-Cys redox couple, even though there is 
no evidence for delocalisation of the radical over the indole moiety. The role of the 
tryptophan is probably to protect the cofactor from the solvent.[15] Another interesting 
feature of the active site is the direct backbone link between axial Tyr 495 and 
equatorial His 496. 
 
3.2.1 A radical mechanism 
Already before the availability of the X-ray structure of the enzyme, Whittaker 
detected the tyrosyl radical and proposed a radical mechanism for the turnover of 
GOase.[67] Taking advantage of the structural data from X-ray crystallography and 
kinetic evidence with radical-probing substrates, Branchaud and co-workers 
proposed a more detailed mechanism.[68] Then Whittaker refined the mechanistic 
scheme of Branchaud and proposed that Tyr 495 could act as a base to deprotonate 
the alcohol substrate.[69] Although there are some minor differences in the proposed 
mechanisms, the central feature of them all is that enzymatic catalysis was proposed 
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to proceed by a stepwise radical mechanism with a substrate-derived ketyl radical as 
a key intermediate. 
Figure  3-15 shows the mechanism that has been generally accepted. First, the 
substrate binds to the equatorial copper position (occupied by water or acetate in the 
crystal structures) to give copper complex B. Then a proton transfer from the alcohol 
to the axial tyrosinate (Tyr 495) leads to compound C. Next, in a step known from 
isotope substitution experiments to be at least partially rate-limiting and probably the 
major rate-limiting step, a hydrogen atom is transferred from the substrate to the 
equatorial modified tyrosyl radical (Tyr 272), giving D. The resulting substrate derived 
ketyl radical is then oxidised through electron transfer to the copper centre yielding 
Cu(I) and  the aldehyde product (E). Cu(I) and tyrosine are, finally, reoxidised by 
molecular oxygen through complex F, regenerating Cu(II) and tyrosyl radical, and 
giving hydrogen peroxide as a product. The hydrogen peroxide, which is a poor 
ligand, is replaced by a molecule of substrate and complex B is formed again. 
 
Further studies from the groups of Branchaud,[64] Whittaker[70] and Himo[71] have 
confirmed the proposed mechanism and gave more insight into the enzyme’s 
oxidation process. 
Branchaud and co-workers used β-haloethanol to trap the enzyme in a catalytically 
inactive one-electron reduced form.[64] Himo and co-workers used density functional 
methods and molecular mechanics to study the catalytic mechanism of GOase.[71] 
Their calculations strongly support the experimentally proposed mechanism, with one 
exception. They proposed that prior to the initiating proton transfer step the radical is 
located at the axial tyrosine (Tyr 495) and not at the equatorial thioether-substituted 
Tyr 272. The transfer of the proton and the one of the radical to Tyr 272 probably 
happens simultaneously. In 2001, Whittaker reported kinetic studies on a 
homologous series of benzyl alcohol derivatives.[70] These results support a 
mechanism in which initial proton abstraction from a coordinated substrate activates 
the alcohol towards inner sphere electron transfer to the Cu(II) metal centre in an 
unfavourable redox equilibrium, forming an alkoxy radical which undergoes hydrogen 
atom abstraction by the Tyr-Cys phenoxyl free radical ligand to form the product 
aldehyde. In another report, Whittaker concludes that the hydrogen atom transfer 
must be the first step, but that the substrate oxidation is a single-barrier process 
without resolved kinetic intermediates.[15]   
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Figure  3-15: Proposed mechanism for the aerobic oxidation of primary alcohols by 
galactose oxidase.  
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3.2.2 Structural models for studying the reactivity of GOase 
Model complexes of the active site of galactose oxidase have been synthesised by 
various groups with the aim of providing insight into the mechanism of the enzyme. 
One of the interesting features of the enzyme is the existence of the thioether linkage 
between Tyr 272 and Cys 228. A question that has been asked is why galactose 
oxidase employs such modified amino acid residues instead of simple tyrosine. The 
redox potential of galactose oxidase is estimated to be 400–500 mV versus NHE,[67] 
which is significantly lower than that of free tyrosine in solution (930 mV) or tyrosine 
in enzymatic systems (760–1000 mV).[72] Such a negative shift of the redox potential 
can be attributed to both the electron-donating nature and the radical-stabilising 
effect by electron spin delocalisation into the methylthio group, so-called 
electron-sharing conjugative effect. Synthetic models from Fukuzumi[73-75], 
Whittaker[76, 77] and Tolman[78] have brought detailed insight into the electronic effects 
of the thioether group of the cofactor on the physicochemical properties and the 
reactivity of the Cu(II)–phenoxyl radical species. Furthermore, the π-π-stacking 
interaction of the cofactor with the tryptophan (Trp 290) side chain seems to play a 
crucial role in the catalytic cycle, even if its role is not yet really defined. With the goal 
of clarifying the role of the tryptophan, Halcrow has synthesised structural models of 
GOase containing aromatic moieties able to show π-π interaction with the phenolate 
moiety.[79, 80] In this section, a few examples of ligands and copper complexes 
synthesised to provide insight into the mechanism of GOase are given. 
 
Fukuzumi, Itoh and co-workers have examined the physicochemical properties of the 
ligands 2 and 3, together with cresol as a reference.[73, 75] 1H NMR data of these 
compounds reveal the electron-donating nature of the thioether substituent. 
Moreover, the thioether substituent causes a negative shift of the redox potential 
(1106 mV for ligand 2 and 955 mV for ligand 3 compared to 1474 mV for 
para-cresol). Analysis of the radical species of compounds 2 and 3 by UV 
spectroscopy, cyclic voltammetry and ESR revealed behaviour of the ligands very 
similar to the behaviour of the oxidised form of GOase. 
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The first copper(II) complex model for the active site of the enzyme was reported by 
Whittaker and co-workers in 1993.[76] This model 4 consists of the ligand 2 and 
N,N,N’,N’’,N’’-pentamethyldiethylenetriamine complexed with a copper(II) ion. The 
copper complex has a square pyramidal structure. However, the sulphur atom of the 
methylthio group coordinates to the copper ion from the axial position, making the 
coordination geometry different from that of GOase where there is no coordinative 
interaction between the sulphur atom and Cu(II). Treatment of 4 with refluxing 
acetonitrile gave an ortho–ortho coupled dimer of 2, indicating an inner-sphere 
electron transfer from the phenolate to Cu(II) to generate a phenoxyl radical and 
Cu(I) (Scheme  3-1). 
 
CH3CN 
 
CH3
O
S
CH3
Cu
N
N
N
+
 
reflux 
CH3
O
S
CH3
Cu
N
N
N
OH
S
CH3
H3C
+
4  5 
Scheme  3-1: Refluxing Whittaker’s copper(II) complex in acetonitrile gives a dimer.[76] 
 
Later, Whittaker and co-workers have synthesised ligand 6 in order to mimic the 
N2O2 donor set of GOase.[77] A copper(II) complex of this ligand was obtained in a 
dimeric form containing a Cu(II)2O2 core as a linker group. The dimeric complex 
could be converted into the monomer by adding an external ligand such as pyridine. 
The copper monomer showed an ESR spectrum typical for a distorted square 
pyramidal structure. Studies by cyclic voltammetry of the copper monomer showed 
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irreversible oxidation waves at 434 mV and 781 mV versus NHE due to the 
one-electron oxidation of the phenolate group. 
Similar observations were made by Fukuzumi and co-workers with ligands 7 and 8. 
The dimeric complex is formed and can be converted to the monomeric copper(II) 
complex. The ESR spectrum of the monomeric complex is typical for a square 
pyramidal geometry.[73] In cyclic voltammetry, ligand 7 gave a reversible wave at 
688 mV versus NHE while ligand 8 which does not contain any thioether group did 
not show any reversible wave. 
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CH3
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CuPy
Py
N
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+
[Cu(II)2(7-)2]2+  Cu(II)(7-)(Py)+ 
Scheme  3-2: Fukuzumi’s dimeric and monomeric copper complexes of ligand 7.[75] 
 
Tolman and co-workers reported a copper(II) complex with a 1,4,7-triazacyclononane 
derived ligand.[78] Complex 9 was isolated with an alcohol molecule coordinated to it. 
Bulk electrolysis of the benzyl alcohol adduct (398 mV versus NHE in acetonitrile) 
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produced benzaldehyde in 46 % yield. It is interesting to note that there is a hydrogen 
bonding interaction between one of the benzylic protons of the bound substrate and 
the phenolate oxygen of the "cofactor". 
 
N
N
N
t-Bu
t-Bu
O O
H H
Cu
9 
 
In order to demonstrate the role of the ortho-thioether substituent as well as the role 
of the π-π interaction present at the active site of GOase, Halcrow and co-workers 
synthesised the compounds 3,4-benzo-8,9-(3’-hydroxybenzo)-bicyclo[4,4,1]-undeca-
3,8-dien-11-one 10 and 3,4-benzo-8,9-(3’-hydroxy-4-methylsulfanylbenzo)-bicyclo-
[4,4,1]-undeca-3,8-dien-11-one 11, as well as their ethylene acetals (12 and 13).[79]  
Crystallographic, UV–vis and NMR studies showed that the two ketones adopt 
boat/chair conformations, while the acetals exhibit chair/chair conformations with 
layered aryl rings. Analyses by cyclic voltammetry showed that the methylsulfanyl 
substituent and the π-π interaction both lower the oxidation potential of the phenol 
ring in these compounds. A difference of 0.29 V between the oxidation potential of 
compound 10 and compound 12 and a difference of 0.15 V between the oxidation 
potential of compound 11 and compound 13 imply that the π-π interaction contributes 
to the thermodynamic stability of the oxidised species. Compound 13 exhibits an 
oxidation potential 0.46 V lower than that of 10. This mirrors almost exactly the 
thermodynamic stabilisation of the GOase Tyr-Cys phenoxyl radical, which contains 
an ortho-thioether substituent and an overlying π-π interaction. 
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3.3 Copper catalysed oxidation of alcohols and active models for 
galactose oxidase 
Groups from both the industrial and the academic research have been working more 
and more on the development of green oxidation catalysts. Their main goals are the 
reduction of waste and the reduction of costs of production. In the field of alcohol 
oxidation, we have seen the apparition of new metal catalysts that use molecular 
dioxygen as a stoichiometric oxidant.[9, 12] These are particularly attractive since the 
only byproduct is water or hydrogen peroxide. Besides palladium[7] and ruthenium,[8] 
copper has also been used as a metal for the aerobic oxidation of alcohols.[17] 
 
3.3.1 Catalytic oxidation with TEMPO 
One of the most frequently applied methods for the catalytic oxidation of alcohols 
using the stable free radical 2,2’,6,6’-tetramethylpiperidine-N-oxyl (TEMPO, 14) does 
not employ oxygen as a stoichiometric oxidant but sodium hypochlorite (NaOCl) or 
bleach (Scheme  3-3).[81] In this reaction, the corresponding oxoammonium salt 15 is 
the active oxidant (obtained by in situ oxidation of 14 by NaOCl or NaOBr). Oxidation 
of the alcohol affords the corresponding carbonyl compound and the reduced form of 
TEMPO, the hydroxylamine 16. The latter is then re-oxidised by NaOCl or NaOBr to 
generate the oxoammonium salt 15. In the generally applied procedure,[82] sodium 
bromide (10 mol%) is used as a cocatalyst, since the re-oxidation step is more 
favourable with NaOBr and the sodium bromide produced is readily re-oxidised by 
NaOCl (Figure  3-16). 
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H3C CH3
CH3H3C
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1.00 mol% TEMPO 14, 
10.0 mol% NaBr 
 
HR1
R2 OH  
 
+ NaOCl 
CH2Cl2, pH 8.6, 0 °C 
 
O
R1
R2  
 
+ NaCl + H2O
R1, R2 = aryl, alkyl  75–95 %  
Scheme  3-3: Catalytic oxidation of alcohols with TEMPO and sodium hypochlorite as 
a stoichiometric oxidant.[82] 
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15
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Figure  3-16: TEMPO-catalysed bleach-oxidation of alcohols using bromide as a 
cocatalyst.[83] 
 
A shortcoming of this method is that it is not waste free since one equivalent of NaCl 
is produced per molecule of alcohol oxidised. 
Alternatively, the use of TEMPO in combination with copper salts and oxygen as a 
primary oxidant was first reported by Semmelhack in 1984.[10] At room temperature, 
allylic and benzylic alcohols are oxidised by molecular oxygen using a catalytic 
mixture of cuprous chloride and nitroxyl radical 14 in DMF. In this experiment, 
10 mol% of CuCl and 10 mol% of TEMPO 14 or its 4-hydroxy analogue 16 are used 
to convert benzyl alcohol to benzaldehyde in 2 hours with bubbling of dioxygen 
through the solution. Aliphatic alcohols do not give complete conversion under these 
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conditions. A first catalytic cycle was proposed by Semmelhack for this reaction 
where copper(II) oxidises the nitroxyl radical 14 to the oxoammonium 15. The 
oxoammonium 15 is the species able to perform the oxidation of alcohols, giving the 
corresponding aldehydes, together with the hydroxyl compound 16. The hydroxyl 
compound 16 and the oxoammonium 15 react stoichiometrically to give the starting 
material TEMPO 14. Further, the copper(I) species is re-oxidised to copper(II) by 
molecular dioxygen. 
 
10.0 mol% TEMPO 14, 
10.0 mol% CuCl  
R-CH2-OH 
DMF, 2 h, O2 
 
R-CHO 
R = aryl, vinyl  90–100 % 
Scheme  3-4: Catalytic aerobic oxidation of alcohols with TEMPO and CuCl.[10] 
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Figure  3-17: Catalytic cycle for the aerobic oxidation of primary alcohols with TEMPO 
according to Semmelhack.[10] 
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In 2003, Sheldon and co-workers reported Hammett correlation studies and primary 
kinetic isotope effect studies for this CuCl-TEMPO catalysed aerobic oxidation of 
benzylic alcohols.[84] These results are inconsistent with a mechanism where the 
active species is the oxoammonium cation 15. Instead, Sheldon proposed a 
copper-mediated dehydrogenation mechanism in which the active copper(II) species 
is generated via a one-electron oxidation of copper(I) by TEMPO 14 (Figure  3-18). 
Alkoxy replacement, followed by coordination of a second molecule of TEMPO and 
intramolecular β-hydrogen abstraction afford the desired carbonyl compound, Cu(I) 
and TEMPOH 16 (Figure  3-19). Finally TEMPO 14 is regenerated by rapid air 
oxidation of TEMPOH 16. This mechanism is analogous to the one formulated for the 
enzyme galactose oxidase.  
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Figure  3-18: Mechanism postulated by Sheldon for the CuCl-TEMPO catalysed 
aerobic oxidation of activated alcohols.[84] 
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Figure  3-19: Intramolecular transfer of β-hydrogen, followed by oxidative 
elimination.[84] 
 
Recently, Sheldon and co-workers reported a mild catalytic oxidation where primary 
alcohols are selectively converted to aldehydes.[9] In this novel procedure, 
CuBr2(2,2’-bipyridine) catalyses the aerobic oxidation of primary alcohols in 
acetonitrile : water (2 : 1) in the presence of TEMPO and a base as a cocatalyst. 
Typically, the reaction is performed at room temperature with 5 mol% of CuBr2, 
5 mol% of 2,2’-bipyridine, 5 mol% of TEMPO and 5 mol% of potassium tert-butylate. 
Under these conditions, various benzylic, allylic and aliphatic alcohols have been 
converted into their corresponding aldehydes. The oxidation of benzyl alcohol 
proceeded with a turnover frequency of 14 h–1 which is an excellent result for a room 
temperature oxidation reaction involving a copper catalyst. Secondary alcohols were 
unreactive under these conditions. In this reaction, TEMPO may act as a hydrogen 
acceptor during the catalytic cycle as in the CuCl-TEMPO catalysed oxidation 
(Figure  3-19). In the case of activated alcohols (benzylic and allylic), the oxidation is 
faster than in the case of aliphatic ones, indicating that hydrogen abstraction from the 
α-carbon atom by TEMPO is the rate-determining step of the reaction. The poor 
reactivity of secondary alcohols could be explained in terms of steric hindrance. In 
addition, in the case of primary alcohols, the second β-hydrogen atom is bonded to 
the oxygen atom of TEMPOH, stabilising the radical intermediate (Figure  3-20). 
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5.00 mol% CuBr2, 5.00 mol% bipyridine , 
5.00 mol% TEMPO 14, 5.00 mol% t-BuOK  
 
 
R-CH2-OH 
CH3CN/H2O (2:1), air 
 
R-CHO 
R = aryl, vinyl, alkyl   
 
alcohol time [h] conversion [%]
benzyl alcohol 2.5 100 
geraniol 5 100 
octan-1-ol 24 61 
octan-2-ol 5 no reaction 
 
Scheme  3-5: Catalytic aerobic oxidation of alcohols with TEMPO and [CuBr2(2,2’-
bipyridine)] according to Sheldon.[9] 
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Figure  3-20: Stabilisation of the radical species by the second β-hydrogen of primary 
alcohols.[9] 
 
3.3.2 Oxidation with azo compounds 
The catalytic aerobic oxidation of alcohols with copper chloride, phenanthroline and 
an azo compound such as diethylazodicarboxylate (DEAD) or its tert-butyl analogue 
(DBAD) was reported by Markó and co-workers for the first time in 1996.[11] With 
5 mol% of CuCl, 5 mol% of phenanthroline, 5 mol% of DBAD or its reduced form 
DBADH2, 25 mol% of K2CO3 and dioxygen or air in fluorobenzene at 80 °C, primary 
allylic and benzylic alcohols, as well as secondary aliphatic, allylic and benzylic 
alcohols can be oxidised to the corresponding aldehyde or ketone in 80 % to 100 % 
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yield in 1 to 2 hours.[85] However primary aliphatic alcohols are unreactive under 
these conditions. Later, Markò improved the reaction conditions which led to a 
catalytic system that quantitatively oxidises a large variety of primary alcohols to the 
corresponding aldehydes.[12] The addition of a heterocyclic amine is necessary to 
promote the oxidation of primary aliphatic alcohols to aldehydes, with 
N-methylimidazole giving the best results (Scheme  3-6). 
 
5.00 mol% CuCl/phen, 5.00 mol% DBAD 
5.00 mol% t-BuOK, 7.00 mol% NMI 
 
 
R-CH2-OH
C6H5F, O2, 70–80 °C, 100 min 
 
R-CHO 
 
R yield [%]
C9H19 95 
N  
93 
95 
 
Scheme  3-6: Copper-catalysed aerobic oxidation of primary alcohols according to 
Markó.[12] 
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Figure  3-21: Proposed intermediate for the copper-catalysed aerobic oxidation of 
alcohols according to Markó.[12] 
 
So far this protocol is the only copper-containing system that catalyses the aerobic 
oxidation of all classes of alcohols, including primary aliphatic alcohols. No 
over-oxidation to carboxylic acids has been observed. However, this system still 
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suffers from two major drawbacks: the oxidation has to be carried out at 
temperatures above 70 °C and the product obtained needs to be purified by column 
chromatography. Easy isolation of the product and recycling of the catalyst have to 
be taken into consideration for the synthesis of future generations of catalysts. 
 
3.3.3 Structural and active models of galactose oxidase 
Stack and co-workers described the salen type–copper(II) species with a binaphthyl 
backbone 17-22.[16, 86] Copper complexes 17 and 21 show catalytic activity, while 
copper complexes 18, 19, 20 and 22 do not show any catalytic activity. This implies 
that a 3,5-disubstitution on the salicylate ring is necessary for the catalytic activity. 
The copper complex 17 catalyses the oxidation of neat benzylic and allylic alcohols 
under 1 atmosphere of dioxygen at room temperature (Scheme  3-7). Due to the 
phenol moieties substituted with a thioether, this ligand is a structural model of 
GOase. With as little as 0.01 mol% of the salen type–copper(II) catalyst and 2 mol% 
of a base, neat benzyl alcohol was converted to benzaldehyde in 20 hours, resulting 
in a turnover of 1300. Moreover, the copper-complex with a thioether linkage 17 is 
more active than the copper-complex with two tert-butyl substituents 21. 
The rate determining step of this system was suggested to involve abstraction of the 
benzylic hydrogen, resulting in a ketyl radical. Then an inner sphere one-electron 
transfer from the ketyl radical to the copper(II) results in copper(I), phenol and the 
carbonyl compound (Figure  3-23). The copper complex is then reoxidised by 
dioxygen which is reduced to hydrogen peroxide. This mechanism is analogous to 
the one observed in the enzyme galactose oxidase. 
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SPh t-Bu 17 
Si-Pr t-Bu 18 
H t-Bu 19 
SPh H 20 
t-Bu t-Bu 21 
N N
O
O
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t-BuSPh
PhS
CuII
 
H H 22 
Figure  3-22: Salen-type copper(II) complexes by Stack.[86] 
 
17 or 21, 
base 
R3 R4
OH
 
1 atm O2, 295 K, 20 h 
R3 R4
O
 
 
R3 R4 complex base TON 
   [mol %] [mol %]  
Ph H 17 0.01 2.00 1300 
Ph H 21 0.01 2.00 200 
Ph CH3 17 0.05 0.30 60 
Ph CH3 21 0.05 0.30 30 
Scheme  3-7: Copper-catalysed aerobic oxidation of primary alcohols with Stack’s 
copper(II) complexes 17 and 21.[16]  
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Figure  3-23: Salen type–copper(II) catalysed aerobic oxidation of benzyl alcohol 
according to Stack.[16] 
 
Wieghardt, Chaudhuri and co-workers have synthesised the 2,4-di-tert-butylphenol 
derivative  ligands 23 and 24.[19, 87] 
 
S
OH
t-Bu
t-Bu t-Bu
OH
t-Bu N
HOH
t-Bu
t-Bu t-Bu
OH
t-Bu
 
23 24 
Figure  3-24: 2,4-Di-tert-butylphenol derived ligands by Wieghardt and Chaudhuri.[19, 
87] 
 
The copper(II) complexes of ligands 23 and 24 are structural and active models of 
GOase. In 1998, Wieghardt and Chaudhuri reported the formation of the dinuclear 
copper(II) phenoxyl complex 25 by reaction of 2,2’-thiobis(2,4-di-tert-butylphenol) 
ligand 23 with 1 equivalent of copper(I) chloride and 2 equivalents of triethylamine in 
THF and under a stream of dioxygen (Scheme  3-8).[87] 
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1.00 eq Cu(I)Cl, 
2.00 eq NEt3 
S
OH
t-Bu
t-Bu t-Bu
OH
t-Bu
 
THF, O2 
S O
t-Bu
t-Bu
O
t-Bu
t-Bu
SO
t-Bu
t-Bu
O
t-Bu
t-Bu
CuII CuII Cl2
23  25 
Scheme  3-8: Formation of dinuclear copper(II) phenoxyl complex 25.[87] 
 
0.1 Mol% of the dinuclear copper(II) complex 25 generated in situ converted ethanol 
and benzyl alcohol to their aldehyde, and secondary alcohols to dimeric 1,2-glycols 
with moderate yields. During the catalytic cycle, hydrogen peroxide is formed by the 
reduction of dioxygen (Scheme  3-9, Scheme  3-10). 
 
0.20 mol% Cu(I)Cl, 0.20 mol% 23,
0.40 mol% NEt3 
 
 
R-CH2-OH 
THF, air, 12 h 
 
R-CHO 
R = Ph, CH3 TON 300 60 % 
Scheme  3-9: Aerobic oxidation of primary alcohols with complex 25 generated in 
situ. 
  
0.20 mol% Cu(I)Cl, 0.20 mol% 23,
0.40 mol% NEt3 
 
 
R1 R2
OH
 THF, air, 12 h 
 
HO OH
R1 R1
R2R2
 
R = Ph, CH3 TON 300 60 % 
Scheme  3-10: Aerobic oxidation of secondary alcohols with complex 25 generated in 
situ. 
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In 1999, the same group reported the mononuclear copper complex 26 that catalyses 
the oxidation of primary alcohols (including ethanol, but not methanol) with dioxygen 
to aldehydes and hydrogen peroxide.[19] The complex was obtained by condensation 
of the ligand 3,5-di-tert-butylcatechol 24 with ammonia and a copper salt. In its active 
form, the complex contains a tyrosyl radical and a copper(II), similarly to the active 
centre of GOase. A solution of benzyl alcohol or ethanol in THF containing the 
complex 26 was stirred in open air at room temperature for 20 hours and gave about 
55 % of the corresponding aldehyde, together with hydrogen peroxide. The oxidation 
can also be carried out in pure alcohol. Kinetic studies have shown the active form to 
be the mononuclear copper species 26 and kinetic isotope effect studies showed that 
the α-hydrogen abstraction is the rate determining step of the reaction. With this 
system, ethanol was oxidised with a turnover frequency  of 0.5 s–1. Secondary 
alcohols are no substrates for catalyst 26. 
 
t-Bu
t-Bu
O
N
O
t-Bu
t-Bu
CuII
NEt3
26 
 
0.02 mol% 26  
R-CH2-OH 
THF, air, 20 h 
R-CHO 
R = Ph, CH3  55 % 
Scheme  3-11: Aerobic oxidation of primary alcohols with complex 26.[19] 
 
A third system reported by Wieghardt and Chaudhuri is the copper(II) complex 28 of 
ligand 27 which effectively catalyses the aerobic oxidation of primary alcohols, 
including methanol, with formation of the corresponding aldehydes and hydrogen 
peroxide at ambient temperature.[20] Secondary alcohols are no substrates for this 
system. Ligand 27 was complexed with copper and zinc ions. Up to 5000 turnovers in 
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50 hours have been achieved in the air oxidation of ethanol by the copper complex, 
which corresponds to a turnover frequency of 0.03 s–1. In contrast, the zinc analogue 
is less efficient, and the catalyst stability is inferior (170 turnovers in 24 hours, which 
corresponds to a turnover frequency of 0.002 s–1). This is the first copper system able 
to catalyse the aerobic oxidation of methanol. Triethylamine becomes an inhibitor in 
the oxidation of ethanol when it is used in more than four equivalents because it 
binds more effectively to the copper complex than the alcohol substrate.  
 
NH HN
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t-Bu
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t-Bu N N
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27 28 
Figure  3-25: Ligand 27 and the active species 28 in the aerobic oxidation of primary 
alcohols. 
 
0.01 mol% 28, 
2 eq NEt3   
CH3-CH2-OH 
CH2Cl2, 1 bar air, 50 h 
 
CH3-CHO 
 TOF 0.03 s–1  
Scheme  3-12: Aerobic oxidation of ethanol with complex 28.[20]  
 
Some cyclic voltammetric, EPR and kinetic studies were performed on the complex 
and, as a result, a mechanistic scheme was proposed for this aerobic oxidation 
(Figure  3-26). In the first step, a rapid equilibrium between the catalyst and one 
molecule of alcohol is established to give the five-coordinated copper complex A. 
The hydrogen abstraction that follows is most probably the rate determining step, 
resulting in the formation of a common ketyl radical anion. The resulting intermediate 
B is proposed to undergo a rapid intramolecular one-electron transfer with formation 
of a bound aldehyde, which is a poor ligand and dissociates. The ultimate electron 
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acceptor in this step is the o-diiminoquinone unit of the doubly protonated ligand. 
Mechanistically, it is conceivable that the copper(II) ion is the electron acceptor, 
which is thereby reduced to copper(I), and then intramolecularly re-oxidised to 
copper(II) to form intermediate C. The reduced catalysts react with dioxygen, 
resulting in hydrogen peroxide and the active catalyst 28. This reoxidation step most 
probably is also divided into two successive one-electron-transfer steps, where a 
coordinated superoxide copper(II) intermediate is formed. 
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Figure  3-26: Proposed mechanism for the catalytic oxidation of primary alcohols by 
dioxygen according to Wieghardt and Chaudhuri.[20] 
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Thomas and co-workers reported the tripodal ligand 29 as a structural and functional 
model of GOase.[88] Their strategy was based on the differentiation of the two 
phenolic arms. One of the tert-butyl phenolic arms bears an electron-withdrawing 
nitro group and the other an electron-donating methoxy group. 
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The monomeric copper(II) complex of ligand 29 was obtained. A square pyramidal 
geometry was identified by X-ray crystallography. It involves a [N2O2] coordination 
sphere around the copper(II) centre with an acetate molecule in equatorial position. 
The two different phenolic arms control the geometry of the complex. Indeed, the 
electron-donating effect of the methoxy group relative to the nitro group makes the 
deprotonation of the hydroxyl group harder. As a consequence, the weak 
Cu(II)…OH(Ar) bond occupies the more labile position, that is the axial position. 
Oxidation of benzyl alcohol to benzaldehyde by the monomeric copper(II) complex 
was observed in the presence of dioxygen and of a catalytic amount of potassium 
hydroxide. After 2 days, 220 turnovers were achieved. Again, use of PhCD2OH 
indicated that the rate-limiting step during oxidation of alcohol is the C–H bond 
cleavage as for GOase. The use of the electrochemically oxidised form of the 
complex led to the oxidation of benzyl alcohol with a higher rate (220 turnovers in 2 
hours). Unactivated primary alcohols were also oxidased to their corresponding 
aldehydes, but at a slower rate (80 turnovers in one day for the oxidation of ethanol). 
Secondary alcohols were not oxidised. 
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30, KOH 
R-CH2-OH 
O2, 1 d 
R-CHO 
 
R = Ph TON 300  
R = CH3 TON 80   
Scheme  3-13: Aerobic oxidation of ethanol with complex 28.  
 
The sulfonamide ligand 31 was synthesised by Bulat and screened for catalytic 
activity in the aerobic oxidation of benzyl alcohol.[89] Complex 32 was obtained by 
incubation of ligand 31 with copper(I) chloride and potassium hydroxide in 
acetonitrile. After addition of methanol and re-crystallisation from methanol, the 
complex was analysed by crystallography. The X-ray analysis of complex 32 reveals 
a square planar copper centre. In addition to the tridentate ligand, a methanol 
molecule is coordinated to the copper ion.  
 
Cu(I)Cl, KOH 
t-Bu
t-Bu
OH
N N S
O
O
CH3
 
CH3CN, CH3OH 
t-Bu
t-Bu
O
N N S
O
OCu
O
H3C
H
II CH3
31  32 
Scheme  3-14: Complexation of ligand 31 with copper.[89] 
 
Copper complex 32 mediates the catalytic aerobic oxidation of benzyl alcohol with a 
turnover number of up to 34. 
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0.50 mol% 31, 0.50 Cu(I)Cl 
5.00 mol% KOH 
OH
 CH3CN, O2, 3 h 
OH
 
33  34 
 TON up to 34 17 % 
Scheme  3-15: Aerobic oxidation of benzyl alcohol with complex 32.[89]  
 
The activity of the catalyst ceases after 3 hours. The appearance of a brown 
precipitate was observed in the reaction flask. This precipitation corresponds to the 
time when the oxidation starts to slow down. The brown solid has been attributed to 
copper oxide. Scheme  3-16 shows a plausible pathway leading to the deactivation of 
the catalyst by formation of a dinuclear copper(II)-trans-µ-peroxo complex. 
 
CuIIL CuII
O OH
L Cu
IIL
O O
CuII L
OH- H2O
+ CuO
 
Scheme  3-16: Generation of an unstable dinuclear copper(II)-trans-µ-peroxo compex. 
 
3.4 Peptide libraries as sources of active catalysts 
In 1996, Jacobsen and co-workers reported the synthesis of combinatorial libraries 
for the discovery of metal–ligand complexes.[90] The stability and activity of metal 
complexes are dependent on numerous variables, such as the coordination geometry 
required by the metal and the steric and electronic characteristics of the ligand. 
Therefore, combinatorial chemistry provides a powerful approach for the discovery of 
new coordination compounds. In their approach, Jacobsen and co-workers have 
synthesised ligand libraries with four variable components: two amino acids AA1 and 
AA2, a turn element and various capping ends (Figure  3-27). The library, consisting 
of 12 000 different ligands, was synthesised on amino TentaGel resin, using the 
standard split-mix technique. The peptide-ligands were encoded with photocleavable 
tags. The potential for members of this library to form coordination complexes was 
evaluated by exposing samples of the beads to homogeneous solutions of metal 
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ions: Ni(II), Fe(III), Cu(II), Pt(IV), Pt(II), Sn(IV), followed by treatment with a stain 
reagent and observation of the colour of the beads with a microscope. The structure 
of the ligands on the beads was analysed. 
 
N
H
O
H
N AA1
5 turn element
AA2end cap  
N
H
O
N
H
O
HN
N
NTrt
4
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HN
O
H
N
O
H3C
NTrt
N
 
Figure  3-27: Combinatorial library for the discovery of novel coordination complexes 
and an example of a structure that binds Ni(II).[90] 
 
The synthesis and sceening of peptide libraries in order to discover active catalysts 
has been used by Berkessel and Hérault.[27] In 1999, they reported the synthesis of a 
625-member library of undecapeptides and its screening for hydrolase activity 
(Figure  3-28). The library was synthesised on amino TentaGel resin following the 
split-mix strategy. The ligands were complexed with Lewis acidic transition metals 
(Cu2+, Zn2+, Fe3+, Co3+, Eu3+, Ce4+ or Zr4+). For the screening of the activity of the 
peptide–ligands, the 3-hydroxyindolyl derivatives 35 or 36 were used. Indeed, when 
the ester functions are hydrolysed, the resulting indoxyl derivative 37 is oxidised in 
the aerated solution to afford the turquoise and insoluble indigo dye 38. 
 
PEG Phe X GlyGlyGly Gly Gly GlyX X X
X = L-Arg, L-His, L-Tyr, L-Trp or L-Ser  
Figure  3-28: General structure of the undecapeptide library.[27] 
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38
3735 R = COCH3
36 R = PO32- indigo  
Figure  3-29: Test substrates for the screening of the library for hydrolysis activity.[27] 
 
The on-bead screening of the library with the test substrates 35 and 36 in the 
presence of a variety of transition metal ions enabled the identification of members of 
this library that, in combination with Zr4+, mediate phosphate hydrolysis. 
 
GlyGlyGly Gly Gly GlySerH2N His Arg His Phe CO2H  
GlyGlyGly Gly Gly GlySerH2N Ser Ser His Phe CO2H
GlyGlyGly Gly Gly GlySerH2N Arg His His Phe CO2H  
Figure  3-30: Active sequences found by screening of the undecapeptide library with 
Zr4+ and 36. 
 
As model for the enzyme GOase, the 16-member library described in Figure  3-31 
was synthesised by Bulat with the Xn positions occupied by histidine or tyrosine.[89] 
The 16 decapeptides were incubated in a copper salt solution and screened for 
activity. 
 
NH2PEG = amino TentaGel 
(loading 0.22 mmol/g) 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
  Xn  = Tyr, His 
Figure  3-31: Library of decapeptides as a model for the active site of GOase.[89] 
 
3-Methoxybenzyl alcohol was used as a test substrate to screen the copper(II)–
peptide library for catalytic activity. The oxidation product of 3-methoxybenzyl 
alcohol, 3-methoxybenzaldehyde, absorbs UV-light at λ = 310 nm. 3-Methoxybenzyl 
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alcohol does not absorb at this wavelength. The library was screened under various 
reaction conditions: varying the buffer solution and the oxidants (potassium 
hexacyanoferrate(III), ammonium cerium(IV)nitrate). The copper–peptide complexes 
were inactive under these conditions. In a last experiment where the TEMPO radical 
was added in stoichiometric amount to the copper–peptide library, 
3-methoxybenzaldehyde was formed (Figure  3-17). The best results were obtained 
for the peptide–ligands where X1, X2, X3, X4 = Tyr, Tyr, Tyr, Tyr and X1, X2, X3, X4 = 
Tyr, His, Tyr, Tyr. However the yield of 3-methoxybenzaldehyde after 22 hours was 
only 0.4 % for the best peptide sequence (X1, X2, X3, X4 = Tyr, Tyr, Tyr, Tyr). 
 
0.10 mol% Cu(II)–peptide complex,
0.10 mol% TEMPO 
 
OH
OMe  H2O/THF (3:1), buffer, O2, 22 h 
H O
OMe  
39  40 
 0.1–0.4 % 
TON 1–4 
λ = 310 nm 
Scheme  3-17: Aerobic oxidation of 3-methoxybenzyl alcohol with copper(II)–peptide 
complexes.[89] 
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4 Concept 
The following work deals with the synthesis of mimics for the enzyme GOase. This 
choice comes from the interest in developing new environmentally friendly catalysts 
for the oxidation of primary alcohols to aldehydes. Moreover, structural models for 
GOase are still needed to get information about the enzyme itself. In a first approach, 
peptide–copper complexes will be synthesised as models for GOase. In a second 
approach, a solid-supported low molecular weight copper complex will be 
synthesised as a model for the enzyme. 
 
4.1 Peptidic model for galactose oxidase 
The active site of GOase is a copper ion coordinated by four amino acids.[15] As a 
consequence, peptides complexed to a copper ion appear to be good structural 
models for the active site of the enzyme. 
The 16-membered peptide library 1 (Figure  4-1) was reported by Bulat.[89] The 
peptide–copper complexes have shown catalytic activity only when the radical 
TEMPO was added in the reaction mixture. The work of Whittaker and Fukuzumi has 
shown that the Tyr–Cys cross-link is necessary for the catalytic activity of the 
enzyme.[75] Moreover, Stack reported that copper complexes with phenol ligands 
possessing a thioether substituent in ortho position to the hydroxyl function are more 
efficient in catalysis than the equivalent copper–phenol complexes without thioether 
substituent.[16] 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
Cu
NH2PEG amino TentaGel resin 
Cu
N N
H2O O
O
Tyr 272
S
Cys 228
NHHN
His 496 His 581
Tyr 495
 
library 1:
library 2:
library 3:
Xn = His, Tyr[89] 
Xn = His, Tyr, TOAC 
Xn = His, Tyr, mod-Cys 
Figure  4-1: Active site of GOase and libraries of peptide–copper complexes 
designed to mimic the active site of the enzyme. 
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Taking these results into account, a third amino acid, in addition to histidine and 
tyrosine, should be added to the variable positions of the peptide library 1 in order to 
find active catalysts in the library. TOAC 41, which is a radical containing amino acid 
derivative of TEMPO, has been chosen. It is known from the work of Semmelhack 
that TEMPO, in combination with a copper ion, mediates the aerobic oxidation of 
alcohols.[91] This result, in addition to the work of Bulat, makes TOAC 41 a good 
candidate as a mimic for the Tyr–Cys cross-link. 
Another amino acid has been designed to mimic the Tyr–Cys cross-link found at the 
active site of GOase. The modified cysteine (mod-Cys, 42) possesses a phenol 
moiety with a thioether linkage in ortho position to the hydroxyl function. The second 
ortho position, as well as the para position, are occupied by tert-butyl substituents. 
Indeed, Stack and co-workers have shown that in GOase models, a complete 
ortho,para-substitution of the phenolate ring is necessary to prevent radical-ligand 
coupling.[86] 
S
O
O
NH
O
N
H
CuII
Tyr 272
Cys 228  
Figure  4-2: Tyr–Cys cross-link at the active site of GOase. 
 
N
O
CO2HH2N
H3C CH3
H3C CH3
 
S
OH
t-But-Bu
CO2HH2N  
TOAC, 41 mod-Cys, 42 
Figure  4-3: Amino acids as models for the Tyr–Cys cross-link found at the active 
site of GOase. 
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The 81-member peptide libraries 2 and 3 (Figure  4-1) have been designed to mimic 
the enzyme GOase. The four Xn positions are occupied by the functional amino 
acids, histidine, tyrosine and TOAC 41 or mod-Cys 42. The first amino acid linked to 
the resin is phenylalanine. It is intented to prevent the formation of diketopiperazine 
when attaching the next amino acid.[58] Glycines have been included to provide the 
desired shape to the peptide and the sequence D-Pro-Gly has been introduced to 
make a turn in the peptide–ligand so that it could complex around a copper ion.[92] 
Finally, the last amino acid will be acetylated to avoid complexation at the terminal 
amino group. 
Modeling studies, using MacroModel, of Ac-NH-His1-Gly-Tyr-Gly-D-Pro-Gly-His2-
TOAC-Gly-Phe-COOMe with copper(II) showed a His1–copper distance of 
2.3 ± 0.2 Å, a Tyr–copper distance of 5.5 ± 2.7 Å to minimal 2.8 Å, a His2–copper 
distance of 2.5 ± 0.3 Å and a TOAC–copper distance of 2.6 ± 0.3 Å. The 
corresponding distances in the enzyme are 1.94 Å for Tyr-Cys–copper, 2.11 Å and 
2.15 Å for His–copper and 2.69 Å for the axial Tyr–copper. This model shows that the 
peptide-ligands should be able to bind a copper ion. In the model, the tyrosine is 
more distant from the copper ion than the other amino acid residues, indicating a 
preference for an axial position. 
 
Figure  4-4: Calculated model of the copper complex of the peptide-ligand Ac-NH-
His1-Gly-Tyr-Gly-D-Pro-Gly-His2-TOAC-Gly-Phe-COOMe (Monte-Carlo 
calculation method, gas phase, MMFFs force field). 
 
Cu 
His 
His 
TOAC 
Tyr
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The split-mix method, in association with the IRORI “directed synthesis” system, is 
the method of choice for the synthesis of small size libraries. As a solid support, 
amino TentaGel was chosen because of its swelling properties. Indeed, this 
polystyrene resin with polyethylene glycol spacer swells in DMF, necessary for 
peptide synthesis, as well as in water, which is necessary for the catalysis. The 
libraries will be synthesised in IRORI MikroKans. These Kans can contain up to 
30 mg of resin, which is a reasonable quantity that allows screening for catalytic 
activity. The well-established Fmoc/PyBOP strategy will be used for peptide 
synthesis. 
For peptide synthesis, the hydroxyl function of tyrosine as well as the amine function 
of histidine must be protected in order to avoid side reactions at these groups. The 
protecting groups tert-butyl and trityl were chosen for the protection of tyrosine and 
histidine, respectively, because of their stability under the conditions of the peptide 
synthesis. They can be removed under acidic conditions after the acetylation step. 
 
The amino functions of the two unnatural amino acids should be protected with Fmoc 
in order to allow quantification of the peptide couplings. The radical containing 
Fmoc-TOAC-OH 43 is known from the litarature and will be synthesised according to 
the synthesis described by Dulog and co-workers.[93] 
 
N
O
CO2H
H3C CH3
Fmoc-HN
H3C CH3
43 
 
As shown by the work of Bulat, the hydroxyl function of the Fmoc-mod-Cys-OH 
amino acid 44 needs to be protected. Indeed, it proved impossible to incorporate 44 
into a peptide chain because of the formation of the lactone 45 (Scheme  4-1).[89] 
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2.5 eq PyBOP, 3 % NMM 
 S
OH
t-But-Bu
CO2HFmoc-HN  
CH2Cl2 
t-But-Bu
S
O
O
NH
Fmoc  
44 27 % 45 
Scheme  4-1: Lactonisation of the amino acid 44 under peptide coupling conditions.[89] 
 
The protecting groups methoxymethyl (MOM) and allyl have been chosen for the 
protection of the phenolic function since they are both stable under basic conditions 
(see later). 
 
Two strategies were planned for the synthesis of the enantiomerically pure 
Fmoc-mod-Cys(PG)-OH (Figure  4-5 and Figure  4-6). Both strategies are convergent 
syntheses and start from an enantiomerically pure amino acid. If racemisation is 
avoided, the synthesis should lead to an enantiomerically pure product. 
 
In the first strategy, L-cystine is used as a starting material (Figure  4-5). Its coupling 
with the MOM-protected bromo-phenol 48 by bromine/lithium exchange and 
electrophilic substitution should give the Boc-mod-Cys(MOM)-OH 47. The Boc 
protecting group has been chosen for the protection of the amino function since it is 
stable under the basic conditions necessary for the coupling of compounds 48 and 
49. The carboxylic acid function of the cystine derivative should be protected by 
methylation to avoid deprotonation by the organolithium. The organolithium could 
then react either at the carbonyl function of 49 to form an alcohol or at the disulfide to 
form compound 47. The MOM-protected bromo-phenol 48 would be obtained from 
the commercially available 2,4-di-tert-butylphenol 51 by bromination and protection of 
the hydroxyl function with the MOM protecting group. The bromination in ortho 
position to the hydroxyl function is favoured due to the directing effect of the OH 
group and the steric constraints of the 2 tert-butyl groups. Finally, the target 
compound 46 would be obtained by removal of the Boc protecting group of the amino 
acid 47, followed by Fmoc protection of the free amino function. The removal of the 
Boc should be possible without affecting the MOM protecting group. Indeed, while 
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MOM is cleaved under aqueous acidic conditions (HCl), Boc should be cleaved 
under anhydrous acidic conditions (TFA). Therefore, treatment of the amino acid 47 
with TFA in dry dichloromethane should lead to the removal of the Boc without 
cleavage of the MOM protecting group. 
 
 
t-Bu t-Bu
OMOM
S
CO2HNH
t-Bu t-Bu
OMOM
Br
t-Bu t-Bu
OH
Br
t-Bu t-Bu
OH
BocHN CO2Me
S S
MeO2C NHBoc
+
t-Bu t-Bu
OMOM
S
CO2HNH
Fmoc
BocHN CO2H
S S
HO2C NHBoc
Boc
46
47
48 49
52
5051
 
Figure  4-5: Retro-synthesis of the N-Fmoc-protected mod-Cys amino acid. Strategy 
using L-cystine as an enantiomerically pure starting material. 
 
In the second strategy, L-serine is used as a starting material (Figure  4-6). Serine 
lactones are widely used as intermediates in the enantioselective synthesis of 
β-substituted alanines, giving rise to many unnatural amino acids and other chiral 
building blocks.[94] Vederas and co-workers opened serine lactones with various 
nucleophiles, including amines, thiols, halogens, and a variety of organometallic 
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reagents.[95] The ring opening of the lactone 57 or 58 by the thiol 55 or 56 in basic 
conditions would lead to the N-protected O-protected mod-Cys 47, 53 and 54. 
Starting from the N-protected-L-serine 59 or 60, the N-protected-L-serine-β-lactone 
57 and 58 could be formed by a Mitsunobu reaction.[95, 96] To avoid polymerisation 
during the synthesis of the serine lactone 57 and 58, as well as for the reaction of the 
thiol 55 or 56 with the lactone 57 or 58, the amine function of the serine must be 
protected. Since the ring opening of the lactone will be carried out under basic 
conditions, the amine function has to be protected with a base-stable protecting 
group. The acid-labile Boc protecting group was chosen. The Cbz protecting group 
was also candidate because it is cleavable by catalytic hydrogenation. 
The thiols 55 and 56 can be synthesised from 2,4-di-tert-butylphenol 51. In a first 
step, the unprotected thiol 64 can be synthesised from 2,4-di-tert-butylphenol 51 
according to the procedure described by Pastor using sulphur monochloride.[97] Then 
the hydroxyl function of compound 64 needs to be protected. The thiyl function is 
more reactive than the hydroxyl function. Thus the strategy consists in protecting the 
thiol by formation of the disulfide 63, followed by protecting the hydroxyl function and 
reducing the disulfide back to the thiol.  The thiol 64 could be oxidised to the disulfide 
63 by iodine or bromine. Protection of the hydroxyl function by MOM or allyl could be 
performed in the standard conditions using MOMCl or allyl chloride. The reduction of 
the disulfides 61 and 62 to the thiols 55 and 56 could be carried out with sodium 
borohydride. 
Finally, the coupling of the lactone 57 or 58 with the thiol 55 or 56 should be possible 
after deprotonation of the thiol. The last step of the synthesis should be the selective 
cleavage of the N-protecting group and protection of the free amino function by 
Fmoc, to give the Fmoc-mod-Cys-OH. 
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R1 = MOM, R2 = Boc, 47
R1 = MOM, R2 = Cbz, 53
R1 = CH2-CH=CH2, R2 = Boc, 54
R1 = MOM, 55
R1 = CH2-CH=CH2, 56
R2 = Boc, 57
R2 = Cbz, 58
R2 = Boc, 59
R2 = Cbz, 60
R1 = MOM, 61
R1 = CH2-CH=CH2, 62
63
64 51  
Figure  4-6: Retro-synthesis of the N-Fmoc-protected mod-Cys amino acid. Strategy 
using L-serine as an enantiomerically pure starting material. 
 
After the synthesis of the library, the peptide-ligand should be complexed with 
copper. Finally, the peptide–copper complexes should be screened in the catalytic 
aerobic oxidation of primary alcohols. The oxidation of 3-methoxybenzyl alcohol to 
3-methoxybenzaldehyde could be used as a test reaction (Scheme  4-2). Indeed, 
3-methoxybenzaldehyde absorbs in UV at λ = 310 nm where 3-methoxybenzyl 
alcohol does not absorb. Therefore the active catalysts could be identified following 
the absorbance of the reaction mixture at λ = 310 nm. This test reaction has already 
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been used by Branchaud and co-workers,[64] as well as by Kosman and 
co-workers.[98] 
 
catalysed aerobic oxidation 
OH
OMe   
H O
OMe  
  absorption at λ = 310 nm
39  40 
Scheme  4-2: Test reaction for the screening of the library of peptide–copper 
complexes.[64, 98] 
 
4.2 Solid-supported low molecular weight model for galactose 
oxidase 
In another part of this work, a low molecular weight ligand should be synthesised on 
solid support, and its catalytic activity in the aerobic oxidation of primary alcohols 
should be compared to the activity of its soluble counterpart. 
Copper complex 32 has been synthesised by Bulat.[89] This copper complex 
mediated the catalytic aerobic oxidation of benzyl alcohol. However after 3 hours the 
deactivation of the catalyst was observed. As an alternative, the solid-supported 
copper complex 65 should be synthesised. It was thought that the steric environment 
caused by the solid support could prevent the degradation of the catalyst. As a solid 
support, a polystyrene resin could be used. 
 
t-Bu
t-Bu
O
N N S
O
OCu
O
H3C
H
II CH3
 
t-Bu
t-Bu
O
N N S
O
OCu
O
H3C
H
II
 
32 65 
 
Ligand 66 should be synthesised in 2 steps from chlorosulfonated polystyrene resin 
(PS-TsCl) 69 (Figure  4-7). This synthesis uses the advantage of solid-phase 
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synthesis, i.e. employing an excess of reagent, the reaction should be driven to 
completion. The reaction of the PS-TsCl resin 69 with ethylenediamine should give 
rise to the monosulfonated diamine 67. The reaction of compound 67 with 
2,4-di-tert-butyl-salicylaldehyde should result in ligand 66. 
 
t-Bu
t-Bu
OH
N
S
O
O
HN S N
H
O
O
NH2
S
O
O
Cl
t-Bu
t-Bu
OH
O
H+
66 67 68
69  
Figure  4-7: Retro-synthesis of the solid-supported low molecular weight ligand 66. 
 
The activity of ligand 66 in the copper catalysed aerobic oxidation of benzyl alcohol 
and 3-methoxybenzyl alcohol should be compared to the activity of its soluble 
counterpart 31. 
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5 Results 
5.1 Synthesis of the unnatural mod-Cys amino acid: model for the 
Tyr-Cys cross-link of GOase 
The first strategy towards the synthesis of the unnatural PG2-L-mod-Cys(PG1)-OH 
amino acid consists of the synthesis of the O-protected bromo-phenol 48. After the 
bromo/lithium exchange occurred, the organolithium should react with the 
O,N-protected cystine 49 and give Boc-L-mod-Cys(MOM)-OMe 70. 
The second strategy is inspired by the work of Vederas and co-workers and consists 
in the ring opening of a N-protected L-serine-β-lactone by a O-protected 
thiophenol.[95] 
Both strategies lead directly to enantiomerically pure modified L-cysteines. 
 
t-Bu t-Bu
OPG1
S
CO2HNH
PG2
 
PG2-L-mod-Cys(PG1)-OH
Figure  5-1: General structure of the protected unnatural mod-Cys amino acid. 
 
5.1.1 First pathway towards the synthesis of the unnatural mod-Cys amino 
acid 
5.1.1.1 Synthesis of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 48 
The first route started with the commercially available 2,4-di-tert-butylphenol 51 
which was converted to the O-protected bromo phenol 48 in two steps (Scheme  5-1). 
Bromination of 51 gave the ortho-bromophenol 50 in 92 % yield.[99] The latter was 
protected by a MOM protecting group using MOMCl under basic conditions in 82 % 
yield.[100] 
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Br2 MOMCl, i-Pr2NEt 
  
t-Bu
t-Bu
OH
 CCl4, 0 °C t-Bu
t-Bu
OH
Br
CH2Cl2 t-Bu
t-Bu
OMOM
Br
51  50, 92 %  48, 82 % 
Scheme  5-1: Synthesis of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 48 
from 2,4-di-tert-butylphenol 51.[99, 100] 
 
5.1.1.2 Lithiation of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 48 and 
reaction with various electrophiles 
In order to avoid deprotonation by the organolithium, the acid function of the 
commercially available N,N’-bis-(tert-butyloxycarbonyl)-L-cystine 52 was converted to 
the methylester 49 in a reaction with diazomethane (Scheme  5-2).[101] 
 
CH2N2 
 
Boc-HN CO2H
S S
HO2C NH-Boc
 
MeOH, 40–50 °C 
Boc-HN CO2Me
S S
MeO2C NH-Boc
 
52  49, 97 % 
Scheme  5-2: Methylation of N,N’-bis-(tert-butyloxycarbonyl)-L-cystine 52.[101] 
 
A bromine/lithium exchange was carried out on the O-protected bromophenol 48 
using n-butyl lithium and the product was reacted in situ with 
N,N’-bis-(tert-butyloxycarbonyl)-O,O’-bis-(methyl ester)-L-cystine 49.[102, 103] The 
resulting compound was the MOM-protected 2,4-di-tert-butylphenol 71 and not the 
expected cysteine derivative 70 (Scheme  5-3).  
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1) n-BuLi, THF, –78 °C 
 
t-Bu
t-Bu
OMOM
Br
 2) 49, r.t. 
S
OMOM
t-But-Bu
CO2MeNH
Boc
 
48  70 
 
1) n-BuLi, THF, –78° C 
2) 49, r.t. 
 
t-Bu
t-Bu
OMOM
 
  
71, 94 %   
Scheme  5-3: Lithiation of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 
48.[102, 103] 
 
In order to check that the organolithium was indeed formed, the O-protected 
bromophenol 48 was lithiated and the product was reacted in situ with the 
electrophiles: methyl iodide and deutero methanol (Scheme  5-4, Figure  5-2). The 
expected products 72 and 73 were isolated. However the organolithium did not react 
with the disulfide 49. After hydrolysis, the product 71 was isolated. 
 
1) n-BuLi, THF, –78 °C 
 
t-Bu
t-Bu
OMOM
Br
 2) E
+, RT t-Bu
t-Bu
OMOM
E
 
48   
Scheme  5-4: Lithiation of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 48 
and reaction with various electrophiles.[102, 103] 
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electrophile (E+) isolated product yield 
MeI 
t-Bu
t-Bu
OMOM
CH3
 
90 % 
 72  
MeOD 
t-Bu
t-Bu
OMOM
D
 
99 % 
 73  
49 
t-Bu
t-Bu
OMOM
 
94 % 
 71  
Figure  5-2: Electrophiles used and products obtained in the reaction with the 
organolithium formed from 48. 
 
The reaction of the organolithium with the dissulfide 49 as a nucleophile was not 
possible. Therefore the first pathway towards the synthesis of the unnatural mod-Cys 
amino acid was abandoned. 
 
5.1.2 Second path towards the synthesis of the unnatural mod-Cys amino 
acid 
For the synthesis of the modified cysteine mod-Cys following the second strategy, 
two building blocks were prepared: the O-protected 3,5-di-tert-butyl-2-benzenethiol 
[3,5-di-tert-butyl-2-(methoxymethoxy)benzenethiol 55 or 3,5-di-tert-butyl-2-(allyloxy)-
benzenethiol 56] and the N-protected L-serine-β-lactone [N-(tert-butyloxycarbonyl)-
L-serine-β-lactone 57 or N-(benzyloxycarbonyl)-L-serine-β-lactone 58].  
 
5.1.2.1 Synthesis of 1,1’-bis-[3,5-di-tert-butyl-2-(hydroxy)phenyl]disulfane 63 
The O-protected 3,5-di-tert-butyl-2-benzenethiols 55 and 56 were synthesised in five 
steps from 2,4-di-tert-butylphenol 51. According to the procedure described by 
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Pastor,[97] reaction of 51 with sulphur monochloride gave the trithiobisphenol 74. The 
latter was reduced with zinc under acidic conditions to give the thiol 64 in 42 % yield 
over two steps. For the selective protection of the hydroxyl function of the thiol 64, 
the more reactive thiyl function had to be protected first. A thiyl function can easily be 
protected by oxidation to its disulfide. The thiol 64 was oxidised with molecular 
bromine on hydrated silica gel support to the disulfide 63 in 91 % yield, without 
over-oxidation to the corresponding sulfone or sulfoxide.[104] 
 
S2Cl2, TiCl4 t-Bu
t-Bu
OH
 
toluene 
t-Bu
t-Bu
OH
S
S
S
t-Bu
t-Bu
OH
51  74 
  
Zn, HCl 
 
toluene, EtOH 
Br2, H2O 
t-Bu
t-Bu
OH
S S
HO
t-Bu
t-Bu
 
CH2Cl2 t-Bu
t-Bu
OH
SH
 
63, 91 %  64, 42 % 
Scheme  5-5: Synthesis of 2,4-di-tert-butyl-6-mercaptophenol 64 and protection of the 
thiyl function by formation of 1,1’-bis[3,5-di-tert-butyl-2-(hydroxy)phenyl] 
disulfane 63.[97, 104]  
  
The disulfide 63 was recrystallised from acetonitrile. The crystals were suitable for X-
ray analysis. 
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Figure  5-3: X-ray structure of disulfide 63. 
 
5.1.2.2 Protection of the hydroxy functions of 1,1’-bis-[3,5-di-tert-butyl-2-(hydroxy)- 
phenyl]disulfane 63 
The hydroxyl groups of the disulfide 63 were protected by reaction with allylchloride 
under basic conditions to give the disulfide 62 in 66 % yield. 
 
1) NaH, DMF 
 
t-Bu
t-Bu
OH
S S
HO
t-Bu
t-Bu
 
2) allylchloride 
t-Bu
t-Bu
O
S
S
O
t-Bu
t-Bu
CH2
H2C
63  62, 66 % 
Scheme  5-6: Synthesis of 1,1’-bis-[3,5-di-tert-butyl-2-(allyloxy)phenyl]disulfane 62.[105] 
 
In the same way, reaction of the disulfide 63 with MOMCl in the presence of Hünig 
base gave the disulfide 61 in 87 % yield. 
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MOMCl, i-Pr2NEt 
 
t-Bu
t-Bu
OH
S S
HO
t-Bu
t-Bu
 
CH2Cl2 
t-Bu
t-Bu
OMOM
S S
MOMO
t-Bu
t-Bu
63  61, 87 % 
Scheme  5-7: Synthesis of 1,1’-bis-[3,5-di-tert-butyl-2-(methoxymethoxy)phenyl]- 
disulfane 61.[100] 
 
5.1.2.3 Reduction of the disulfides 61 and 62 to the corresponding thiols 
By treatment with sodium borohydride, the disulfide 62 was converted quantitatively 
to the O-protected thiol 56.[106] The thiol 56 could be analysed by NMR but proved to 
be unstable and cyclised rapidly to the product 75. The cyclisation occurs in the 
presence of water during the work up. If no water is present, the product is 
re-oxidised to the disulfide 62 by dioxygen (Scheme  5-8). 
NaBH4, 
isopropanol, reflux 
 
t-Bu
t-Bu
O
S
S
O
t-Bu
t-Bu
CH2
H2C
 
O2 / air 
t-Bu
t-Bu
O
SH
CH2
 
62  56, quant. 
  
 
  t-Bu
t-Bu
O
S CH3
 
  75, quant. 
Scheme  5-8: Reduction of 1,1’-bis[3,5-di-tert-butyl-2-(allyloxy)phenyl]disulfane 62 with 
sodium borohydride.[106] 
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When the thiol 56 was stored under argon, it proved to be stable. Nevertheless, this 
reaction path involving thiol 56 was discarded because of the necessity to obtain the 
end product mod-Cys in a multigram scale. 
 
The reduction of the disulfide 61 with sodium borohydride afforded the O-protected 
thiol 55 in 89 % yield. After purification by column chromatography, product 55 
proved to be more stable than its allyloxy equivalent 56 and could even be 
crystallised from acetonitrile. The crystals were suitable for X-ray analysis which 
confirmed the structure of the product (Figure  5-4). 
 
NaBH4 
 
t-Bu
t-Bu
OMOM
S S
MOMO
t-Bu
t-Bu
 
isopropanol, reflux t-Bu
t-Bu
OMOM
SH
 
61  55, 89 % 
Scheme  5-9: Reduction of 1,1’-bis-[3,5-di-tert-butyl-2-(methoxymethoxy)phenyl]-
disulfane 61 with sodium borohydride.[106] 
 
 
Figure  5-4: X-ray structure of 3,5-di-tert-butyl-2-(methoxymethoxy)benzenethiol 55. 
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5.1.2.4 Synthesis of N-protected L-serine-β-lactones 
A N-protected L-serine-β-lactone is necessary as a second building block for the 
synthesis of mod-Cys according to the second strategy. The lactones 57 and 58 were 
synthesised as described by Vederas and co-workers, following a Mitsunobu 
cyclisation.[95] Boc and Cbz were chosen as protecting groups for the amine function 
since they are stable under the basic conditions of the ring opening. 
Starting from the N-Boc-L-serine 59, the N-Boc-L-serine-β-lactone 57 was formed by 
addition of 59 to the preformed adduct of triphenylphosphine and 
diethylazodicarboxylate at –50 °C. The lactone 57 was isolated, without racemisation 
in 55 % yield. 
PPh3, DEAD 
 
OH
CO2HBoc-HN  
THF, MeCN, –50 °C 
Boc-HN
O
O  
59  57, 55 % 
Scheme  5-10: Cyclisation of N-(tert-butyloxycarbonyl)-L-serine 59 by a Mitsunobu 
reaction.[95, 107]  
 
Following the same protocol, lactone 58 was formed by cyclisation of N-Cbz-L-serine 
60. The addition of 60 to the preformed adduct of triphenylphosphine and 
di-iso-propylazodicarboxylate gave lactone 58 without racemisation in 49 % yield. 
The choice of the azodicarboxylate compound (DEAD versus DIAD) comes from the 
easiness of separation by column chromatography of the product from the by-product 
H2-DIAD or H2-DEAD. 
PPh3, DIAD 
 
OH
CO2HCbz-HN  
THF, –78 °C 
Cbz-HN
O
O  
60  58, 49 % 
Scheme  5-11: Cyclisation of N-(benzyloxycarbonyl)-L-serine 60 by a Mitsunobu 
reaction.[95] 
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5.1.2.5 Opening of the lactones with 3,5-di-tert-butyl-2-(methoxymethoxy)- 
benzenethiol 55 
The lactones 57 and 58 were opened by the thiol 55 under basic conditions, as 
described by Vederas and co-workers.[95] Boc-L-mod-Cys(MOM)-OH 47 and 
Cbz-L-mod-Cys(MOM)-OH 53 were obtained in 85 % and 94 % yield respectively. 
NaH 
 
t-Bu
t-Bu
OMOM
SH
 
+ 
Boc-HN
O
O  
DMF 
S
OMOM
t-But-Bu
CO2HNH
Boc
 
55  57  47, 85 % 
Scheme  5-12: Synthesis of Boc-L-mod-Cys(MOM)-OH 47 by ring opening of 
N-(tert-butyloxycarbonyl)-L-serine-β-lactone 57.[89, 95] 
 
Cs2CO3 
 
t-Bu
t-Bu
OMOM
SH
 
+ 
Cbz-HN
O
O  DMF 
S
OMOM
t-But-Bu
CO2HNH
Cbz
 
55  58  53, 94 % 
Scheme  5-13: Synthesis of Cbz-L-mod-Cys(MOM)-OH 53 by ring opening of 
N-(benzyloxycarbonyl)-L-serine-β-lactone 58.[95, 108] 
 
5.1.2.6 Attempted deprotection of the Boc protecting group of 
Boc-L-mod-Cys(MOM)-OH 47 
The use of amino acids in peptide synthesis is easier when their amino function is 
protected by a Fmoc protecting group, thus allowing automation by quantitative 
evaluation of the coupling steps. The mod-Cys amino acid has so far been 
synthesised with Boc or Cbz protecting group on the amino function (products 47 and 
53). The replacement of Boc or Cbz by a Fmoc protecting group would thus be of 
interest. 
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When cleaving the Boc or Cbz protecting group, the MOM protecting group on the 
hydroxyl function must remain unchanged. 
The Boc protecting goup is cleaved under anhydrous acidic conditions with TFA, 
while the MOM protecting group is cleaved under aqueous acidic conditions. Thus, 
by keeping anhydrous conditions, the Boc protecting group should be removed, while 
the MOM protecting group should not be cleaved.[109] Boc-L-mod-Cys(MOM)-OH 47 
was treated with TFA in dry dichloromethane. Unfortunately, the expected product 76 
was not obtained, but only the product 42 where both Boc and MOM protecting 
groups were cleaved. 
 
TFA 
 S
OMOM
t-But-Bu
CO2HNH
Boc
 
abs. CH2Cl2 
S
OMOM
t-But-Bu
CO2HH2N  
47  76 
 
 
TFA 
abs. CH2Cl2 
 
 
S
OH
t-But-Bu
CO2HH2N  
 
S
OMOM
t-But-Bu
CO2HNH
Fmoc
 
42, 90 %  46 
Scheme  5-14: Treatment of Boc-L-mod-Cys(MOM)-OH 47 with TFA.[109] 
 
Using various working-up conditions did not allow the isolation of the N-deprotected 
O-MOM-protected mod-Cys derivate 76. When trying to prepare the N-Fmoc 
protected mod-Cys 46 in situ, the product which was obtained did not contain any 
MOM protecting group. 
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5.1.2.7 Attempted deprotection of the Cbz protecting group of 
Cbz-L-mod-Cys(MOM)-OH 53 
The Cbz protecting group is usually cleaved under catalytic hydrogenolysis.[110, 111] 
Cbz-L-mod-Cys(MOM)-OH 53 was treated with hydrogen, using palladium on 
charcoal as a catalyst. However after 3 days, the starting material 53 was re-isolated. 
 
H2, Pd/C 
 S
OMOM
t-But-Bu
CO2HNH
Cbz
 
MeOH 
S
OMOM
t-But-Bu
CO2HH2N  
53  76 
 
 
H2, Pd/C 
MeOH 
 
 
S
OMOM
t-But-Bu
CO2HNH
Cbz
 
 
S
OMOM
t-But-Bu
CO2HNH
Fmoc
 
53, 96 %  46 
Scheme  5-15: Catalytic hydrogenolysis of Cbz-L-mod-Cys(MOM)-OH 53.[110, 111] 
 
The reaction was carried out in various solvents (methanol, ethanol, dichloromethane 
or liquid ammonia)[110], under 1 bar and under 50 bar of dihydrogen. In all cases, the 
starting material 53 was re-isolated. 
 
RESULTS 
 - 72 -
5.2 Synthesis of two solid-phase-bound mod-Cys-containing 
decapeptides, complexation with copper and use as catalysts in 
the aerobic oxidation of primary alcohols 
5.2.1 Synthesis of the two copper complexes 84 and 85 of 
solid-phase-bound decapeptides containing the mod-Cys amino acid 
Fmoc-L-mod-Cys(MOM)-OH 46 was not obtained. Nevertheless, Boc-L-mod-Cys 
(MOM)-OH 47 could be used in the synthesis of peptides. 
To show that it was possible to incorporate mod-Cys into a peptide sequence, the 
decapeptides 78 and 79 were synthesised on amino TentaGel resin with a loading of 
0.25 mmol/g (Scheme  5-16). Both peptides contained one mod-Cys amino acid, one 
tyrosine and two histidines, as it is the case at the active site of the enzyme GOase. 
For the synthesis of the decapeptides, the functional groups on the side chains of 
tyrosine and histidine had to be temporally protected. 
A specificity of this synthesis is the use of N-Fmoc-protected amino acids (His, Tyr, 
Phe, Gly, D-Pro) besides Boc-L-mod-Cys(MOM)-OH 47 which is a N-Boc-protected 
amino acid. The coupling steps were carried out following the normal procedure 
using PyBOP and NMM in DMF.[112] After each step, the N-protecting group was 
removed and the next coupling step was carried out under the same conditions. The 
Fmoc protecting groups were cleaved under basic conditions with 20 % piperidine[43] 
and the Boc protecting groups were cleaved under acidic conditions with 10 % 
TFA.[113] The syntheses were carried out in Merrifield flask, thus allowing the filtration 
of the reagents after each reaction step. 
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CO2HFmoc-HN  
CO2HFmoc-HN  CO2HNFmoc  
Fmoc-L-Phe-OH Fmoc-Gly-OH Fmoc-D-Pro-OH 
   
CO2HFmoc-HN
NTrtN
 CO2HFmoc-HN
Ot-Bu
 
S
OMOM
t-But-Bu
CO2HBoc-HN  
Fmoc-L-His(Trt)-OH Fmoc-L-Tyr(t-Bu)-OH Boc-L-mod-Cys(MOM)-OH
Figure  5-5: Amino acids used for the synthesis of the decapeptides 78 and 79. 
 
NH2PEG  
  
77   
 
1) swell in DMF 
2) 2.50 eq AA, 2.50 eq PyBOP, 3 % NMM in DMF 
3) test for free amino functions 
4) 20 % piperidine in DMF or 10 % TFA in CH2Cl2 
5) repetition of the steps 2) to 4) with Fmoc-L-Phe-OH, 
Fmoc-Gly-OH, Boc-L-mod-Cys(MOM)-OH 47, 
Fmoc-L-His(Trt)-OH, Fmoc-L-Tyr(t-Bu)-OH or 
Fmoc-D-Pro-OH until completion of the 2 decapeptides 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
PEG
X1 = mod-Cys
X2 = Tyr(t-Bu) 
X3 = His(Trt) 
X4 = His(Trt) 
X1 = mod-Cys 
X2 = His(Trt) 
X3 = His(Trt) 
X4 = Tyr(t-Bu) 
 78         79 
Scheme  5-16: Synthesis of the two decapeptides 78 and 79 containing the unnatural 
mod-Cys amino acid on amino TentaGel resin (loading = 0.25 mmol/g). 
RESULTS 
 - 74 -
The synthesis was followed by the colour qualitative test for free amino functions 
described by De Clercq and co-workers.[60] According to this test, a few beads were 
taken from the reaction flask and transferred into an acetonitrile solution of the active 
ester of disperse red 1. The reaction mixture was heated and the beads were 
washed. The beads which contained free amino functions appeared red coloured 
while completely coupled beads (without free amino functions) remained colourless. 
When a red colour was observed (positive test), the coupling step was repeated 
(Table  5-1). 
 
O2N N
N N
CH3
O
O
O
NO2  
1[60] 
Figure  5-6: NF31 used in the colour test for the detection of free amino functions. 
 
Moreover, coupling steps including N-Fmoc protected amino acids could be 
quantified by UV-measurement of the dibenzofulvene-piperidine adduct formed 
during cleavage of the protecting group.[43] Table  5-1 summarises the yields obtained 
in each coupling step. 
 
The N-terminus of the decapeptides were acetylated by treatment with acetic 
anhydride and NMM in DMF (Scheme  5-17). The completion of the reaction was 
followed by the NF31 colour test.[60] When the colour test was carried out on the 
products 80 and 81, it was negative. When the test was carried out on the starting 
material 78 and 79, it was positive (Figure  5-7). From this test, it could be assumed 
that all the amino functions have been acetylated. 
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Table  5-1: Yield for each coupling step in the synthesis of the decapeptides 78 and 
79. 
peptide 78 peptide 79 
amino acida) yield [%] amino acida) yield [%]c) 
Phe 100 Phe 100 
Gly 94 Gly 94 
mod-Cys n.d. mod-Cys n.d. 
Tyrb) 61 Hisb) 100 
Gly 78 Gly 89 
D-Pro 89 D-Pro 94 
Glyb) 94 Glyb) 111 
His 94 His 94 
Gly 50 Gly 67 
His 44 Tyr 61 
a) All amino acids are in the L-configuration, except for proline which has the D-configuration. 
b) The coupling step was repeated after observation of a positive colour test. 
c) The values are relative to the first value which was fixed to 100 %. 
  
Figure  5-7: Resin beads after treatment with NF31 colour test. Left: test carried out on 
the peptide 78 with free amino function. Right: test carried out on the 
acetylated peptide 80. 
 
In the next step, the side chain protecting groups were cleaved by two successive 
treatments with TFA (Scheme  5-17). Triethylsilane was added to the cleavage 
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mixture to scavenge the cations formed during the acidic deblocking of the trityl and 
tert-butyl protecting groups.[113] 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
PEG
X1 = mod-Cys 
X2 = Tyr(t-Bu) 
X3 = His(Trt) 
X4 = His(Trt) 
X1 = mod-Cys 
X2 = His(Trt) 
X3 = His(Trt) 
X4 = Tyr(t-Bu) 
 78         79 
 
1) Ac2O, 3 % NMM in DMF 
2) test for free amino functions 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
X1 = mod-Cys 
X2 = Tyr(t-Bu) 
X3 = His(Trt) 
X4 = His(Trt) 
X1 = mod-Cys 
X2 = His(Trt) 
X3 = His(Trt) 
X4 = Tyr(t-Bu) 
 80         81 
90 % TFA, 5 % H2O, 5 % TES 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
 82         83 
1 eq Cu(OAc)2, acetate buffer, MeOH 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu II
PEG
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
 84         85 
Scheme  5-17: Acetylation of the N-terminus of the decapeptides 78 and 79, 
deprotection of the side chains and complexation with copper(II). 
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Finally, the two peptide-ligands 82 and 83 were complexed with copper(II) by 
incubation with 1 equivalent of copper(II) acetate in a buffered methanol solution 
(Scheme  5-17).[90] After washing off with methanol, the resin beads showed a 
green-blue colour ( Figure  5-8). This colour is an indication that the complexation 
with copper was successful. By comparison, the on-bead peptide-ligands 82 and 83 
appeared to be pale yellow coloured. Moreover, when acetylated amino TentaGel 
resin 86 was incubated in a copper(II) acetate buffered methanol solution and 
washed with methanol, the beads remained with a pale yellow colour (Scheme  5-18). 
This indicated that the copper ion was bound neither to the polyethylene glycol 
spacer of the resin, nor to the resin itself. 
 
 
 Figure  5-8: Resin beads loaded with copper complex 84. 
 
Cu(OAc)2, acetate buffer,
MeOH 
N
H
CH3
O
 
86   
Scheme  5-18: Incubation of acetylated amino TentaGel 86 with copper and 
observation of the resin beads under the microscope.[90] 
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5.2.2 Catalysis with the mod-Cys containing peptide–copper(II) complexes 
84 and 85. 
The peptide–copper(II) complexes 84 and 85 were tested in the catalytic aerobic 
oxidation of 3-methoxybenzyl alcohol 39. In the first catalytic reaction, the peptide–
copper(II) complexes were used without pre-activation to the radical–copper(II) state. 
Both peptide–copper(II) complexes 84 and 85 were compared. The catalysis was 
performed at room temperature with 0.50 mol% of copper complex and 7.00 mM of 
substrate in acetonitrile / water (1:1). The flask was filled with dioxygen and closed. 
5.00 mol% of potassium hydroxide was added to the reaction mixture in order to 
estimate its influence on the catalysis. The yield in 3-methoxybenzaldehyde 40 was 
measured by following the absorbance of the solution at λ = 310 nm.[64, 98] The results 
are summarised in Table  5-2. 
 
peptide–copper(II) complex 84 or 85, 
KOH, O2 
 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
Scheme  5-19: Catalytic aerobic oxidation of 3-methoxybenzyl alcohol 39 with 
peptide–copper(II) complexes 84 and 85.[64, 98] 
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Table  5-2: 3-Methoxybenzaldehyde formed after 24 hours by catalytic aerobic 
oxidation of 3-methoxybenzyl alcohol with peptide–copper(II) complexes 
84 and 85. 
peptide–copper(II) 
complex 
 KOH 
3-methoxybenzaldehyde 
after 24 h 
 
yield TON
entry 
 [mol%]  [mol%] [µmol]  [%]  
1 - -  - 0.14  0.39 <1 
2 - -  5.00 0.36  1.01 2.0 
3 84 0.50  - 0.15  0.41 <1 
4 85 0.50  - 0.13  0.36 <1 
5 84 0.50  5.00 0.30  0.83 1.7 
6 85 0.50  5.00 0.38  1.06 2.1 
 
Without addition of potassium hydroxide (entry 3 and 4), no catalytic activity was 
observed. The activity that was observed with the copper complexes and potassium 
hydroxide (entry 5 and 6) is due only to the base since the same activity was 
observed when no copper complex was used (entry 2). 
 
Moreover, the catalysis was performed in neat 3-methoxybenzyl alcohol 39. Here the 
influence of the bases triethylamine and potassium hydroxide were compared. The 
catalysis was performed with 0.10 mol% of copper complex and 20 mol% of base at 
room temperature in a flask filled with dioxygen. The yield in 3-methoxybenzaldehyde 
40 was measured by GC. The activity of the peptide–copper(II) complexes were also 
compared to the activity of the acetylated amino TentaGel 86. The results are 
summarised in Table  5-3. 
 
N
H
CH3
O
86 
Figure  5-9: Acetylated aminoTentaGel 86. 
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peptide–copper(II) complex 84, 85 or 86, 
O2 
 
OH
OMe  base, r.t. 
H O
OMe  
39  40 
Scheme  5-20: Catalytic aerobic oxidation of 3-methoxybenzyl alcohol 39 with 
peptide–copper(II) complexes 84 and 85. 
  
Table  5-3: Influence of the base on the catalytic aerobic oxidation of neat 
3-methoxybenzyl alcohol 39 with peptide–copper(II) complexes 84 and 85. 
catalyst  base 
3-methoxybenzaldehydea) 
after 24 h 
 yield TON 
entry 
 [mol%]   [mol%] [µmol]  [%]  
1 84 0.10  - - -  - - 
2 85 0.10  - - -  - - 
3 84 0.10  NEt3 20.0 -  - - 
4 85 0.10  NEt3 20.0 -  - - 
5 - -  KOH 20.0 0.10  0.06 <1 
6 86b) 0.10  KOH 20.0 1.93  1 10 
7 84 0.10  KOH 20.0 6.28  4 40 
8 85 0.10  KOH 20.0 4.51  3 30 
a) 3-Methoxybenzoic acid was not formed. 
b) 0.10 mol% of copper(II) acetate were added to the reaction mixture. 
 
When only 0.10 mol% of a catalyst in pure substrate was used, a turnover number of 
40 was obtained with the peptide–copper(II) complex 84 (entry 7). The addition of 
potassium hydroxide was necessary for the catalytic activity while the use of 
triethylamine as a base deactivated the catalyst. Without any base, the formation of 
3-methoxybenzaldehyde 40 was not observed (entry 1 and 2). With 20 mol% of 
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triethylamine, no conversion was observed for the both complexes (entry 3 and 4). 
Potassium hydroxide alone showed a very low activity: less than 1 turnover number 
was observed after 24 hours (entry 5). Acetylated amino TentaGel, together with 
copper(II) acetate, showed a lower activity than the peptide–copper(II) complexes 84 
and 85. A turnover number of 10 was observed for the acetylated amino TentaGel 
(entry 6). Turnover numbers of 40 and 30 were observed for the complexes 84 and 
85 respectively (entry 7 and 8). 
 
5.3 Synthesis of N-(9-fluorenylmethoxycarbonyl)-2,2,6,6-tetramethyl 
piperidine-1-oxyl-4-amino-4-carboxylic acid (Fmoc-TOAC-OH) 43 
The TOAC amino acid 41 is an alternative for the mod-Cys amino acid as a mimic of 
the Tyr–Cys cross-link found at the active site of GOase. Indeed, TOAC is an amino 
acid derived from the free radical TEMPO. TEMPO, together with copper(II), 
catalyses the aerobic oxidation of alcohols.[10] The incorporation of TOAC in the 
peptidic chain, which contains also the amino acids histidine and tyrosine, would lead 
to a structural mimic of GOase. Toniolo and co-workers have already shown the 
possibility of incorporating TOAC into a peptidic chain.[114] A temporary protection of 
the nitroxyl radical is not necessary. 
 
N
O
CO2HH2N
H3C CH3
H3C CH3
41 
 
The N-Fmoc-protected TOAC amino acid 43 was synthesised in four steps starting 
from the commercially available 2,2,6,6-tetramethyl-4-oxo-piperidine 87 and 
according to the procedure described by Dulog and co-workers.[93] 
In the first step, the secondary amine 87 was oxidised to its nitroxyl radical 88 with 
hydrogen peroxide and sodium tungstate. The stable nitroxyl radical was obtained in 
93 % yield and recrystallised from n-hexane. The orange needles obtained were 
suitable for X-ray analysis (Figure  5-9). 
 
RESULTS 
 - 82 -
35 % H2O2 / H2O 
 
N
H
O
H3C CH3
H3C CH3
 Na2WO4 
N
O
O
H3C CH3
H3C CH3
 
87  88, 93 % 
Scheme  5-21: Formation of the nitroxyl radical 88 from 2,2,6,6-tetramethyl-4-oxo-
piperidine 87.[93] 
 
 
Figure  5-10: X-ray structure of 2,2,6,6-tetramethyl-4-oxo-piperidine-1-oxyl 88. 
 
The amino acid 41 was prepared from the ketone 88 applying the Bucherer–Bergs 
synthesis.[115] Reaction of the ketone 88 with sodium cyanide and barium hydroxide 
in a mixture of ethanol and water at 60 °C and overnight gave the hydantoin 89 in 
83 % yield (Scheme  5-22). Alkaline hydrolysis of the hydantoin with barium 
hydroxide resulted in the TOAC amino acid 41 with 88 % yield (Scheme  5-23). 
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(NH4)2CO3, NaCN 
 
N
O
O
H3C CH3
H3C CH3
 
EtOH / H2O (3:2) 
60 °C 
N
O
HN O
NH
O
H3C CH3
H3C CH3
 
88  89, 83 % 
Scheme  5-22: Bucherer–Bergs synthesis with 2,2,6,6-tetramethyl-4-oxo-piperidine-1-
oxyl 88.[93, 115] 
Ba(OH)2 
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H3C CH3
H3C CH3
 
H2O, reflux 
N
O
CO2HH2N
H3C CH3
H3C CH3
 
89  41, 88 % 
Scheme  5-23: Synthesis of 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic 
acid (TOAC) 41 from the hydantoin 89.[93, 115] 
 
At the final stage of the synthesis, TOAC 41 was N-protected with Fmoc.[116] This 
reaction was carried out under basic conditions, using Fmoc-OSu in a mixture of 
water and 1,4-dioxane. After stirring the solution at room temperature, followed by an 
acidic work up, a mixture of Fmoc-TOAC 43 and its hydroxylamine derivative 90 was 
obtained. The two of them could be separated by column chromatography and 
Fmoc-TOAC 43 was recrystallised from a mixture of n-hexane and ethyl acetate to 
give little yellow needles. A crystal structure of 43 was obtained (Figure  5-11). 
 
Fmoc-OSu, NaHCO3 
 
 +
N
O
CO2HH2N
H3C CH3
H3C CH3
 1,4-dioxane, H2O 
N
O
CO2H
H3C CH3
Fmoc-HN
H3C CH3
  
N
OH
CO2H
H3C CH3
Fmoc-HN
H3C CH3
 
41  43, 56 %  90, 30 % 
Scheme  5-24: N-protection of TOAC 41 with Fmoc.[116] 
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Figure  5-11: X-ray structure of Fmoc-TOAC 43. 
  
5.4 Synthesis of the peptide library 
In order to check whether TOAC could be quantitatively coupled to a peptide chain, 
the tripeptide 92 was synthesised on Wang resin, cleaved from the resin and 
analysed by LC–MS. 
The Wang resin was loaded with phenylalanine. The first coupling on the hydroxy 
function of a Wang resin was carried out efficiently using di-iso-propylcarbodiimide 
and HOBt as a coupling agent.[48] The coupling of glycine and TOAC took place by 
the standard PyBOP procedure.[112] The three coupling steps were monitored with the 
NF31 colour test,[60] as well as by UV measurement of the dibenzofulvene–piperidine 
adduct after cleavage of the Fmoc protecting groups.[43] 
The colour test for free amino functions was negative after each coupling step, thus 
indicating quantitative couplings for the three amino acids. The UV measurements of 
the dibenzofulvene–piperidine adduct confirmed that the first two amino acids (Phe 
and Gly) had been coupled almost quantitatively (91 % and 100 % yield for Phe and 
Gly respectively). However at the third coupling step, the UV value did not match the 
colour test. Indeed, the UV value suggested a yield of 68 %. 
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OHWang resin: CH2O CH2OH
 
91 
 
1) swell in DMF 
2) 5.00 eq Fmoc-L-Phe-OH, 5.00 eq DIC, 
5.00 eq HOBt, 0.10 eq DMAP 
3) test for free amino functions 
4) 20 % piperidine in DMF 
 
 
OH
 
5) 2.50 eq Fmoc-Gly-OH, 2.50 eq 
PyBOP, 3 % NMM in DMF 
6) repetition of the steps 3) and 4), then 
5) with Fmoc-TOAC-OH and finally 3) 
and 4) 
 
O
N
H
OH
N
O
H2N
N
O
O
CH3H3C
CH3H3C
91  92 
Scheme  5-25: Synthesis of the tripeptide 92 containing the TOAC amino acid on 
Wang resin. 
 
The tripeptide was cleaved from the Wang resin with two successive treatments with 
a mixture of TFA, H2O and TIS.[26] The tripeptide was precipitated by addition of 
diethylether to the filtrate. 
90 % TFA, 5 % H2O, 
5 % TIS 
O
N
H
OH
N
O
H2N
N
O
O
CH3H3C
CH3H3C
   O
N
H
OH
N
O
H2N
N
O
OH
CH3H3C
CH3H3C
92  93 
Scheme  5-26: Cleavage of the tripeptide 92 from the Wang resin. 
 
After filtration and lyophilisation, the product was analysed by LC–MS. Four peaks 
were observed on the chromatogram. Three of them correspond to the tripeptide 
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(m/z 419, m/z 420 and m/z 421) containing either the nitroxyl radical (93), or the 
hydroxyl amine function (94). Another product appeared on the chromatogram with a 
mass of 272, corresponding to the dipeptide H2N-TOAC-Gly-CO2H (95). However the 
dipeptide H2N-Gly-Phe-CO2H was not observed. These results indicated that the 
TOAC amino acid has been coupled quantitatively and that the results of the UV 
measurements are not reliable for the coupling of the TOAC amino acid. 
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Figure  5-12: Baseline corrected LC–MS diagram of the crude product obtained from 
cleavage of the tripeptide 92 (column: RP-18, mobile phase: 
MeCN : H2O : AcOH = 90 : 10 : 0.5). 
 
According to the results of the synthesis of the tripeptide 93, the library of 
decapeptides could be synthesised. 
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The 81-member peptide library 99 was synthesised on amino TentaGel resin with a 
loading of 0.26 mmol/g. The library was synthesised in a combinatorial fashion, 
following the split-mix strategy.[31] The IRORI radiofrequence tagging system was 
used to allow rapid deconvolution of the members of the library.[40] 
81 IRORI MikroKans were filled with 30 mg each of amino TentaGel resin. In addition 
to the resin, an AccuTag was added and the Kan was closed. The Tags were 
encoded, i.e. to each Kan was asigned a code corresponding to one member of the 
library. During the synthesis and for the screening, it was always possible to identify 
the decapeptide present in a Kan. 
The peptides were synthesised according to the Fmoc/PyBOP strategy.[43] Therefore 
couplings were performed with 3 % NMM in DMF, 2.5 equivalents of PyBOP as a 
coupling agent and 2.5 equivalents of amino acid (Scheme  5-27). Each step of the 
reaction was followed by colour test (NF31).[60] The coupling steps were repeated 
until a negative colour test (no free amino functions) was obtained. The coupling of 
the amino acids which were situated directly after TOAC, as well as the last amino 
acids of the sequences, had to be carried out by repeating the procedure three times. 
Each coupling step showed a negative colour test, indicating quantitative coupling 
yields.  
 
CO2HFmoc-HN  
CO2HFmoc-HN  CO2HNFmoc  
Fmoc-L-Phe-OH Fmoc-Gly-OH Fmoc-D-Pro-OH 
   
CO2HFmoc-HN
NTrtN
 CO2HFmoc-HN
Ot-Bu
 
N
O
CO2H
H3C CH3
Fmoc-HN
H3C CH3
 
Fmoc-L-His(Trt)-OH Fmoc-L-Tyr(t-Bu)-OH Fmoc-TOAC-OH 
Figure  5-13: Amino acids used for the synthesis of the 81-member library of 
decapeptides 96. 
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NH2PEG  
  
77   
 
1) swell in DMF 
2) 2.50 eq Fmoc-L-Phe-OH, 2.50 eq PyBOP, 3 % NMM in 
DMF 
3) test for free amino functions 
4) 20 % piperidine in DMF 
5) repetition of the steps 2) to 4) with Fmoc-Gly-OH, 
Fmoc-L-His(Trt)-OH, Fmoc-L-Tyr(t-Bu)-OH, 
Fmoc-TOAC-OH or Fmoc-D-Pro-OH following the 
split-mix methodology until completion of the 
decapeptides 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
PEG
Xn = His(Trt), Tyr(t-Bu), TOAC 
96 
Scheme  5-27: Split-mix synthesis of the 81-member library of decapeptides 96 
containing the unnatural amino acid TOAC on amino TentaGel resin. 
 
The yields of the coupling steps were quantitatively defined by UV absorbance 
measurement of the dibenzofulvene–piperidine adduct after Fmoc cleavage with 
piperidine. The yields are summarised in Table  5-4. All the yields were above 85 %, 
except for the coupling of TOAC, which showed coupling yields between 50 and 
80 %. However, according to the results obtained from the synthesis and the analysis 
of the tripeptide 93, we can conclude that TOAC was coupled quantitatively, even if 
the UV measurements gave some lower values. 
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Table  5-4: Synthesis of the 81-member peptide library. Yield for each coupling step. 
coupling amino acida) yield [%] 
1 Phe 100 
2 Gly 97 
3a His 101 
3b Tyr 100 
3c TOAC 78 
4a His 103 
4b Tyr 101 
4c TOAC 53 
5 Gly 108 
6 D-Pro 99 
7 Gly 103 
8a His 91 
8b Tyr 87 
8c TOAC 46 
9 Gly 88 
10a His 88 
10b Tyr 97 
10c TOAC 57 
a) All amino acids are in the L-configuration, except for proline which has the D-configuration. 
 
The N-termini of the decapeptides were acetylated (Scheme  5-28). The completion 
of the reaction was checked by colour test (NF31).[60] Resin beads from 97 gave a 
negative colour test, while resin beads from 96 gave a positive colour test. 
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Figure  5-14: Resin beads after treatment with NF31 colour test. Left: test carried out 
on the sample beads from library 96. Right: test carried out on the 
sample beads from the acetylated library 97. 
 
The side chain protecting groups (trityl from His and tert-butyl from Tyr) were cleaved 
with a mixture of TFA, water and TES.[113] TES was used to scavenge the cations 
formed during the cleavage. Following some remarks from Toniolo, nitroxyl radicals 
are converted to hydroxyl amine by treatment with TFA.[114] However, free radicals 
can be regenerated by treatment with aqueous ammonia. As a consequence, the 
peptides were treated with a 10 % aqueous ammonia solution in order to regenerate 
the nitroxyl radicals. After washing and drying, the peptide-ligands 99 were ready for 
catalysis. 
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NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
PEG
 
Xn = His(Trt), Tyr(t-Bu), TOAC 
96 
 
 
1) Ac2O, 3 % NMM in DMF 
2) test for free amino functions 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
Xn = His(Trt), Tyr(t-Bu), TOAC 
97 
 
90 % TFA, 5 % H2O, 5 % TES 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
Xn = His, Tyr, TOAC(N-OH) 
98 
 
10 % aq. NH3 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
Xn = His, Tyr, TOAC(N-O·) 
99 
Scheme  5-28: Acetylation of the N-termini, cleavage of the side chain protecting 
groups and regeneration of the nitroxyl radical of the library of 
peptide-ligand 96. 
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The peptide-ligands were incubated with copper(II) acetate (Scheme  5-29).[90] 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
Xn = His, Tyr, TOAC(N-O·) 
99 
 
 
1 eq Cu(OAc)2, acetate buffer, MeOH 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu II
PEG
Xn = His, Tyr, TOAC 
100 
Scheme  5-29: Incubation of the library of peptide-ligand 99 with copper(II) acetate. 
  
Upon complexation with copper(II) acetate, the resin beads carrying the different 
peptide-ligands appeared to be differently coloured. Moreover, incubation of an 
acetylated amino TentaGel resin with copper(II) acetate did not result in any change 
of the beads colour ( 5.2.1, Scheme  5-18). These colours showed that, (i) there is a 
complexation of the copper ion with the on-bead peptide-ligands, and (ii) the 
complexation takes place at the functional amino acids (Tyr, His and TOAC). Indeed 
a general trend in the colour of the beads could be observed (Figure  5-15): the 
on-bead peptide-ligands including some histidine (His) in their structure tend to form 
blue complexes (a), the one including some tyrosine (Tyr) gave rise to green 
complexes (b) and the one including some TOAC resulted in orange complexes (c). 
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a) 
 
b)
 
c) 
 
d)
 
Figure  5-15: Resin beads of some members of the library 99 after incubation with 
copper(II) acetate. Peptide sequences X1, X2, X3, X4 = His, His, His, His 
(a), His, His, His, Tyr (b), TOAC, Tyr, Tyr, His (c). d) Mixture of the resin 
beads from the 81 members of the library. 
 
5.5 Screening of the library for catalytic activity in the aerobic 
oxidation of primary alcohols 
The library of peptide–ligands 99 was screened for activity using 3-methoxybenzyl 
alcohol 39 as the test substrate. This substrate was chosen because its oxidation 
product, 3-methoxybenzaldehyde 40, absorbs in the UV at 310 nm while the alcohol 
does not absorb at this wavelength, as already described by Branchaud and 
Kosman.[64, 98] As a consequence, it was possible with this test substrate to carry out 
a rapid screening of the on-bead peptide–ligands for catalytic aerobic oxidation by 
simply following the UV absorbance of the reaction mixtures. 
The 81 members of the library 99 were screened in parallel after decoding of the 
sequence with the IRORI tagging station. The on-bead peptide-ligands were taken 
out of the Kans to carry out the catalysis.  
For the first screening, the oxidation was carried out in simple experimental 
conditions: no base was added and the reaction flask was simply opened to the air to 
allow dioxygen to react with the copper complexes. The oxidation occurred at room 
temperature in a mixture of acetonitrile and water (1:1). 
The complexes were formed by the addition of the peptide-ligands 99 to a solution of 
copper(II) acetate in acetonitrile / water (1:1), and the substrate was added to this 
reaction mixture. No change of the absorbance at λ = 310 nm was observed after 24 
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hours when only 1 equivalent of copper versus peptide-ligand was used. Two more 
equivalents of copper were necessary in order to observe a formation of 
3-methoxybenzaldehyde. 
Therefore the oxidation was carried out with 1.00 mol% of peptide–ligand and 
3.00 mol% of copper(II) acetate relative to the substrate (Scheme  5-3). 
 
1.00 mol% peptide–ligand from library 99, 
3.00 mol% Cu(OAc)2, air 
 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
absorption at λ = 310 nm
39            40 
Scheme  5-30: Assay for the screening of the library of peptide–ligands 99.[64, 98] 
 
The reaction was followed for 24 hours and some differences in the members of the 
library were observed (Table  5-5, Figure  3-1). It is worth to mention that the peptides 
which did not contain any TOAC residue did not show any catalytic activity (less than 
0.5 % yield of 3-methoxybenzaldehyde). The on-bead peptide–ligands containing one 
TOAC residue showed a low catalytic activity (between 0.5 and 1.5 % 
3-methoxybenzaldehyde formed), with the exception of the peptide–ligand where 
X1=Tyr, X2=His, X3=TOAC and X4=Tyr (99-16) which formed 3 % of oxidation 
product. The on-bead peptide–ligand containing 2 or 3 TOAC moieties showed the 
best results with 2.5 to 5.5 % yield. Six peptide–ligands were particularly interesting 
because of their remarkable catalytic activity (members with a frame in Figure  5-16). 
These are the peptide–ligands 99-09, 99-18, 99-27, 99-63, 99-72 and 99-75 and they 
gave more than 3 % of oxidation product.  
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Figure  5-16: Yield of 3-methoxybenzaldehyde after 24 hours in the catalytic aerobic 
oxidation with the on-bead peptide–ligands from the library 99. From left 
to right are all the members of the library in the order given in the 
experimental section with compound 99-01 to the left and compound 99-
81 to the right. As an example, YYT’T’ corresponds to the peptide–ligands 
where X1 = Tyr, X2 = Tyr, X3 = TOAC and X4 = TOAC. 
 
The yields and the turnover numbers obtained with the best members of the library 
are summarised in Table  5-5. 
Table  8-9 in the experimental section gives the quantity of 3-methoxybenzaldehyde 
formed with all the members of the library. 
For some members of the library, the catalytical experiment has been reproduced 
and the yield has been determined by GC analysis. The quantity of 
3-methoxybenzaldehyde obtained from GC analysis appears in brackets in Table 
 5-5. The reproducibility of the results shows the reliability of the screening method. 
 
% yield of 
aldehyde 
after 24 hours 
peptide-ligand 
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Table  5-5: Yields of 3-methoxybenzaldehyde after 24 hours in the catalytic aerobic 
oxidation with the on-bead peptide-ligands from library 99. 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
peptide 
sequencea) 
3-methoxybenzaldehyde 40 
entry 
peptide–
ligand 
X1 X2 X3 X4 [µmol]b) yield [%]c) TONc) 
1 99-09 Y Y T’ T’ 21.7 (18.5) 5.4 5 
2 99-16 Y H T’ Y 11.5 (11.9) 2.9 3 
3 99-18 Y H T’ T’ 15.1 (17.4) 3.8 4 
4 99-21 Y T’ Y T’ 11.2 (13.6) 2.8 3 
5 99-27 Y T’ T’ T’ 13.1 (11.4) 3.3 3 
6 99-36 H Y T’ T’ 7.53 (5.91) 1.9 2 
7 99-45 H H T’ T’ 8.07 (9.98) 2.0 2 
8 99-52 H T’ T’ Y 8.77 (10.4) 2.2 2 
9 99-63 T’ Y T’ T’ 17.5 (19.6) 4.4 4 
10 99-71 T’ H T’ H 7.29 1.8 2 
11 99-72 T’ H T’ T’ 14.7 (15.3) 3.7 4 
12 99-75 T’ T’ Y T’ 15.6 (12.7) 3.9 4 
13 99-78 T’ T’ H T’ 10.5 (11.6) 2.6 3 
14 99-81 T’ T’ T’ T’ 7.64 1.9 2 
a) Y = tyrosine, H = histidine, T’ = TOAC 
b) The values in bracket correspond to the results obtained by GC analysis. 
c) Calculated from the UV results. 
 
In some additional experiments where the catalysis was carried out without copper 
salt, the product was formed in very little quantity (Table  5-6). The same catalytic 
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experiment was carried out with 3 different peptide-ligands (99-75, 99-78 and 99-81) 
in the presence or without copper(II) acetate. When the copper salt was used, 
between 7.64 and 15.6 µmol of 3-methoxybenzaldehyde were formed after 24 hours 
(entry 1, 3 and 5). When no copper salt was used, less than 1 µmol of 
3-methoxybenzaldehyde were formed after 24 hours (entry 2, 4 and 6). 
 
1.00 mol% peptide–ligand, air 
 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
Scheme  5-31: Aerobic oxidation of 3-methoxybenzyl alcohol with a peptide–ligand 
and without copper salt. 
 
Table  5-6: Comparison of 3 peptide–ligands with and without copper salt in the 
catalytic aerobic oxidation of 3-methoxybenzyl alcohol. 
peptide sequencea)
entry peptide–ligand 
X1 X2 X3 X4 
Cu(OAc)2
[mol%] 
aldehyde after 24 hours
[µmol] 
1 99-75 T’ T’ Y T’ 3.00 15.6 
2 99-75 T’ T’ Y T’ - 0.60 
3 99-78 T’ T’ H T’ 3.00 10.5 
4 99-78 T’ T’ H T’ - 0.50 
5 99-81 T’ T’ T’ T’ 3.00 7.64 
6 99-81 T’ T’ T’ T’ - 0.50 
a) Y = tyrosine, H = histidine, T’ = TOAC 
 
Moreover, the catalysis performed under the same conditions but using soluble 
TOAC and L-Tyr in different proportions did not give as good results as the one 
obtained when the amino acids were involved in a peptide backbone (Table  5-7). 
Only 0.25 µmol of 3-methoxybenzaldehyde were formed after 24 hours in the 
background experiment, i.e. without peptide, without amino acid and without copper 
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salt (entry 1). The experiment with 3 mol% of copper(II) acetate and without presence 
of peptide or amino acid gave 0.57 µmol of 3-methoxybenzaldehyde after 24 hours 
(entry 2). Experiments with soluble Fmoc-TOAC (entry 3-6) or soluble L-tyrosine 
(entry 11-14) between 1 and 4 mol% and without copper salt gave less than 1.5 µmol 
of 3-methoxybenzaldehyde. The oxidation in the presence of copper(II) acetate and 
Fmoc-TOAC gave a maximum of 5 µmol of 3-methoxybenzaldehyde after 24 hours 
using 3 mol% of copper and 4 mol% of Fmoc-TOAC (entry 10). The oxidation in the 
presence of copper(II) acetate and L-tyrosine gave less than 2 µmol of 
3-methoxybenzaldehyde after 24 hours with 1 to 4 mol% L-tyrosine (entry 15-18). 
Finally, with 3 mol% of copper(II) acetate, 2 mol% of Fmoc-TOAC and 2 mol% of 
L-tyrosine, only 0.25 µmol of 3-methoxybenzaldehyde were formed after 24 hours 
(entry 19). These values are below the values obtained for the best peptide-copper 
complexes (more than 10 µmol, Table  5-5). 
 
3.00 mol% Cu(OAc)2, 
1.00-4.00 mol% Fmoc-TOAC or L-tyrosine, air 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
Scheme  5-32: Aerobic oxidation of 3-methoxybenzyl alcohol with soluble amino 
acids. 
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Table  5-7: Catalytic effect of non-peptidic Fmoc-TOAC 43 and L-tyrosine on the 
aerobic oxidation of 3-methoxybenzyl alcohol.  
Cu(OAc)2 Fmoc-TOAC L-tyrosine
entry 
[mol%] [mol%] [mol%] 
aldehyde after 24 hours 
[µmol] 
1 - - - 0.25 
2 3.00 - - 0.57 
3 - 1.00 - 0.43 
4 - 2.00 - 0.38 
5 - 3.00 - 0.42 
6 - 4.00 - 1.45 
7 3.00 1.00 - 4.23 
8 3.00 2.00 - 4.32 
9 3.00 3.00 - 4.25 
10 3.00 4.00 - 5.05 
11 - - 1.00 0.94 
12 - - 2.00 0.89 
13 - - 3.00 1.05 
14 - - 4.00 0.43 
15 3.00 - 1.00 0.25 
16 3.00 - 2.00 2.10 
17 3.00 - 3.00 0.63 
18 3.00 - 4.00 1.82 
19 3.00 2.00 2.00 0.25 
 
In an experiment where the reaction was carried out under argon, the product was 
obtained in a negligible quantity (Table  5-8). 15.09 µmol of 3-methoxybenzaldehyde 
were formed in the catalytic experiment carried out with peptide–ligand 99-18 under 
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dioxygen (entry 1) while only 0.25 µmol were formed when the experiment took place 
in argon (entry 2). 
 
1.00 mol% peptide–ligand 99-18, 
3.00 mol% Cu(OAc)2 
 
OH
OMe  abs. MeCN, r.t. 
H O
OMe  
39  40 
Scheme  5-33: Oxidation of 3-methoxybenzyl alcohol with peptide–ligand 99-18 under 
inert atmosphere. 
  
Table  5-8: Oxidation of 3-methoxybenzyl alcohol with a peptide–copper complex 
under air and under inert atmosphere. 
peptide sequencea) aldehyde after 24 hours
entry peptide–ligand 
X1 X2 X3 X4 
O2 
[µmol] 
1 99-18 Y H T’ T’ yes 15.1 
2 99-18 Y H T’ T’ no 0.25 
a) Y = tyrosine, H = histidine, T’ = TOAC 
 
In the last experiment with the peptide-ligands, six of them were washed with water, 
dried and subsequently used in the catalytic aerobic oxidation of 3-methoxybenzyl 
alcohol (Table  5-9). To three of them, copper(II) acetate was added in the solution. 
Unfortunately, the catalysts were not active anymore since none of the 6 catalysts 
gave more than 2 µmol of 3-methoxybenzaldehyde after 24 hours. 
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1.00 mol% peptide–copper(II) complex, 
air 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
Scheme  5-34: Recycling of the peptide–copper complexes for the aerobic oxidation 
of 3-methoxybenzyl alcohol. 
 
Table  5-9: Yield of 3-methoxybenzyl alcohol after 24 hours for the second use of the 
copper catalysts. 
Cu(OAc)2 peptide sequencea) aldehyde after 24 hours
entry peptide–ligand 
[mol %] X1 X2 X3 X4 [µmol] 
1 99-63 - T’ Y T’ T’ 1.30 
2 99-71 - T’ H T’ H 1.50 
3 99-78 - T’ T’ H T’ 1.30 
4 99-43 2.00 H H T’ Y 1.00 
5 99-44 2.00 H H T’ H 1.60 
6 99-80 2.00 T T T H 2.00 
a) Y = tyrosine, H = histidine, T’ = TOAC 
 
5.6 Synthesis of one of the members of the library on cleavable resin, 
cleavage from the resin and catalysis with this peptide-ligand 
In order to check the quality of the peptides and to confirm their activity, one member 
of the library 99 was re-synthesised on cleavable resin (Wang resin), analysed and 
purified by preparative HPLC. The catalytic activity of this soluble peptide-ligand was 
compared to the activity of its solid-supported equivalent. 
The on-bead peptide-ligand 99-71 was chosen as the candidate to be 
re-synthesised. This choice came from the fact that it was easy to be synthesised. 
This peptide-ligand was not among the best members of the library. 
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NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C
PEG
 
X1 = TOAC 
X2 = His 
X3 = TOAC 
X4 = His 
99-71  
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N
H
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H3C
NO
HN N H3C CH3
H3C
H3C CH3
H3C
H3C
H3C
≡
Phe Gly Gly
D-Pro
Gly
TOAC His
GlyHisAcHN
HO2C
TOAC
101 
Figure  5-17: On-bead peptide-ligand 99-71 chosen to be re-synthesised and its 
soluble equivalent 101. 
 
The peptide-ligand 101 was synthesised on TentaGel resin with an acid labile Wang 
linker. The TentaGel resin was used in order to keep the same solid support as the 
one for the synthesis of the peptide library 99. In this second synthesis, the linker 
was the only variable. The TentaGel Wang resin 102 used was already loaded with 
Fmoc-L-Phe. Therefore the synthesis started with the cleavage of the Fmoc 
protecting group (Scheme  5-35). By UV measurement of the cleavage solution, the 
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loading of the resin was determined to be 0.24 mmol/g. The decapeptide was 
synthesised according to the standard Fmoc/PyBOP strategy.[43] The coupling steps 
were checked by colour test for free amino functions (NF31 test)[60] and in case of a 
positive colour test, the coupling was repeated. Finally, the yield of each coupling 
step was estimated by UV measurement of the cleavage solution. The yield for each 
coupling step are summarised in Table  5-10. 
 
PEG O CH2O
O
NH-Fmoc
Ph  
                                 102                            
 
 
1) 20 % piperidine in DMF 
2) 2.50 eq Fmoc-Gly-OH, 2.50 eq PyBOP, 3 % NMM in DMF 
3) test for free amino functions 
4) 20 % piperidine in DMF 
5) repetition of the steps 2) to 4) with Fmoc-TOAC-OH, 
Fmoc-L-His(Trt)-OH, Fmoc-Gly-OH or Fmoc-D-Pro-OH until 
completion of the decapeptide 
Phe Gly Gly
D-Pro
Gly
TOAC His(Trt)
GlyHis(Trt)H2N
OCO
TOAC
 
                                 103 
Scheme  5-35: Synthesis of the decapeptide 103 on TentaGel Wang resin loaded with 
Fmoc-L-Phe following the standard Fmoc/PyBOP protocol. 
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Table  5-10: Synthesis of the decapeptide 103 on TentaGel Wang resin.  Number 
of coupling steps and yield for each coupling. 
amino acida) Nr of couplings yield [%]
Phe - 100 
Gly 1 104 
TOAC 1 60 
His 3 98 
Gly 1 103 
D-Pro 1 103 
Gly 3 96 
TOAC 1 54 
Gly 3 71 
His 3 72 
a) All amino acids are in the L-configuration, except for proline which has the D-configuration. 
 
In the same way as for the synthesis of the peptide-library 99, the N-terminus of the 
decapeptide 103 was acetylated (Scheme  5-36). The completion of the reaction was 
checked by NF31 colour test. 
Treatment of peptide 104 with a mixture of TFA, water and TIS (90 : 5 : 5) released 
the decapeptide from the resin. The side chain protecting groups were removed at 
the same time. The decapeptide 101 was released as the free carboxylic acid. 
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Phe Gly Gly
D-Pro
Gly
TOAC His(Trt)
GlyHis(Trt)H2N
OCO
TOAC
 
                                 103 
 
 
1) Ac2O, 3 % NMM in DMF 
2) test for free amino functions 
Phe Gly Gly
D-Pro
Gly
TOAC His(Trt)
GlyHis(Trt)N
H
OCO
TOAC
O
H3C
 
                                 104 
 
90 % TFA, 5 % H2O, 5 % TIS 
Phe Gly Gly
D-Pro
Gly
TOAC His
GlyHisAcHN
HO2C
TOAC
 
                                  101 
Scheme  5-36: Acetylation of the N-terminus of peptide 103 and cleavage from the 
Wang linker. 
 
The decapeptide precipitated by addition of diethylether to the filtrate.  From 290 mg 
of product obtained, 50 mg were purified by preparative HPLC using a reverse phase 
column (RP-18) and a mixture of water, acetonitrile and acetic acid (90:10:0.5). 
38 mg of product were obtained.  
Even after purification, the UV trace obtained by LC–MS analysis did not show a 
clean product (Figure  5-18). This chromatogram demonstrated that the decapeptides 
were present as a mixture of compounds 101, 105, 106 and 107, i.e. the 
decapeptides with the TOAC moieties in the form of nitroxyl radical or hydroxylamine. 
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Figure  5-18: Baseline corrected LC–MS diagram of the product obtained after 
purification by preparative HPLC (column: RP-18, mobile phase: 
MeCN : H2O : AcOH = 90 : 10 : 0.5). 
 
The product which was obtained after purification by preparative HPLC (peptide–
ligands 101, 105, 106 and 107) was used in the catalytic aerobic oxidation of 
3-methoxybenzyl alcohol, following the same protocol as with the on-bead peptide-
ligands (Scheme  5-37). After 24 hours, 14.3 µmol of aldehyde 40 were formed. This 
value was higher than the one obtained with the corresponding on-bead 
peptide-ligand which was equal to 7.29 µmol. 
 
1.00 mol% soluble peptide–ligands (101, 
105, 106 and 107), 
3.00 mol% Cu(OAc)2, air 
 
 
OH
OMe  MeCN / H2O (1:1), r.t.  
 
H O
OMe  
39  40 
Scheme  5-37: Catalytic aerobic oxidation of 3-methoxybenzyl alcohol with the 
soluble peptide–ligands 101, 105, 106 and 107. 
 
RESULTS 
 - 108 -
Table  5-11: Catalytic aerobic oxidation of 3-methoxybenzyl alcohol with the 
soluble peptide–ligands 101, 105, 106 and 107. Comparison with the 
on-bead peptide–ligand 99-71. 
 
peptide sequencea)
aldehyde after 24 
hours entry peptide–ligand 
X1 X2 X3 X4 [µmol] 
1 99-71 (on-bead) T’ H T’ H 7.29 
2 101, 105, 106 and 107 (soluble) T’ H T’ H 14.3 
a) Y = tyrosine, H = histidine, T’ = TOAC 
 
5.7 Synthesis of a resin-supported low molecular weight ligand 66, 
complexation with copper and catalysis 
The tosylamide ligand 66 was synthesised on a solid phase.[89] Chlorosulfonated 
polystyrene resin (PS-TsCl) 69 was used as a solid support. Starting from this 
polystyrene-bound tosyl chloride, ligand 66 was synthesised in two steps. Using the 
advantage of solid-phase synthesis, the reagents were used in excess in order to 
bring the reactions to completion. 
The synthesis was carried out in a Merrifield flask, allowing filtration of the solution 
after reaction and easy isolation of the polystyrene-bound ligand. 
In the first step, the PS-TsCl resin 69 was reacted with an excess of ethylenediamine 
in dichloromethane (Scheme  5-38).[117] In order to check the completion of the 
reaction, a NF31 colour test was carried out on the starting material and on the 
product. When treated with the NF31 solution and washed, the starting beads 
remained colourless. On the other hand, treatment of the product 67 with the NF31 
solution and washing gave red coloured beads, indicating the presence of free amino 
functions on the product.[60] Since all the beads had a uniform red colour, it was 
assumed that the mono-tosylated amine 67 was obtained in quantitative yield. 
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H2N-CH2-CH2-NH2 
 S
O
O
Cl
 CH2Cl2 
S N
H
O
O
NH2
69  67, quant. 
 = 1 % cross-linked polystyrene resin 
Scheme  5-38: Synthesis of the resin-supported tosylamide 67.[117] 
 
The monotosylated amine 67 was reacted with an excess of 
2,4-di-tert-butyl-salicylaldehyde 68 to give the on-bead ligand 66 in a quantitative 
yield.[118] The quality of the on-bead product 66 was checked by HR-MAS NMR. 
 
t-Bu
t-Bu
OH
O
H
68 
 
68 
S N
H
O
O
NH2
 CH2Cl2 
t-Bu
t-Bu
OH
N
S
O
O
HN
67  66, quant. 
Scheme  5-39: Reaction of the monotosylated ethylenediamine ligand 67 with 
3,5-di-tert-butyl-2-hydroxybenzaldehyde 68.[118] 
 
The copper complex 65 was formed by reaction of ligand 66 with 1 equivalent of 
copper(II) acetate  in the presence of potassium hydroxide and methanol (Scheme 
 5-40).[90] The observation of the beads under the microscope before and after 
incubation with copper(II) acetate revealed different colours (Figure  5-19). Indeed, 
the beads supporting ligand 66 had a yellow colour while the one supporting the 
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copper complex 65 appeared green. The green colour was uniform, which indicated 
a quantitative complexation of the ligand with copper.  
 
1) Cu(OAc)2, 
KOH, 
MeCN 
t-Bu
t-Bu
OH
N N S
O
O
2) MeOH 
t-Bu
t-Bu
O
N N S
O
OCu
O
H3C
H
II
66  65, quant. 
Scheme  5-40: Complexation of the resin-supported tosylamide 66 ligand with 
copper(II).[90] 
 
  
Figure  5-19: Resin beads of ligand 66 (left) and resin beads of the copper complex 65 
(right). 
 
Ligand 31, which is the soluble equivalent of ligand 66, has been synthesised by 
Bulat.[89] His results have shown that the 1:1 copper(II)-ligand complex 32 is 
organised in a square planar fashion with a molecule of methanol occupying the 
fourth position around the copper ion. The complexation of ligand 66 with copper(II) 
acetate in the presence of methanol probably resulted in complex 65 which has a 
structure similar to the one of complex 32. 
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N N S
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CH3
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t-Bu
O
N N S
O
OCu
O
H3C
H
II CH3
 
31 32 
Figure  5-20: Ligand 31 by Bulat and its copper complex 32. 
 
The catalytic activity of ligand 66 was compared to the one of ligand 31 in the aerobic 
oxidation of benzyl alcohols (Scheme  5-41).  
 
0.50 mol% ligand 66 or 31, 
0.50 mol% Cu salt, 5.00 mol% KOH 
 
OH
 MeCN, O2, r.t. 
OH
 
33  34 
Scheme  5-41: Catalytic aerobic oxidation of benzyl alcohol with the soluble ligand 31 
and the solid-supported ligand 66. 
 
The sulfonamide ligand bound to solid-support 66 showed an activity comparable to 
its soluble equivalent 31 (Table  5-12). With 0.5 mol% of ligand, 0.50 mol% of 
copper(I) chloride and 5.00 mol% of potassium hydroxide, the soluble ligand 31 gave 
19 % yield of benzaldehyde (entry 4) while the on-bead ligand 66 gave 18 % of 
product after 3 hours (entry 2). When copper(II) acetate was used instead of 
copper(I) chloride, the results were similar: 17 % of benzaldehyde were formed with 
the soluble ligand 31 (entry 3) and 18 % with the on-bead ligand 66 (entry 4). 
Some control experiments were also carried out. In the absence of copper salt 
(entry 5), only 2 % of product were formed. The catalytical experiment which was 
carried out in the presence of copper salt and base and without a ligand (entry 6) 
gave 4 % of benzaldehyde after 3 hours. When the experiments were carried out in 
the absence of a base, no more than 1 % of benzaldehyde was obtained (entry 7, 8, 
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9 and 11). Finally, the base did not catalyse the oxidation of benzyl alcohol since only 
1 % of benzaldehyde was formed in the absence of copper salt and ligand (entry 10).  
 
Table  5-12: Yields and turnover after 3 hours for the catalytic aerobic oxidation of 
benzyl alcohol with ligands 66 and 31. 
ligand copper salt yield TON 
entry 
 [mol%]  [mol %] [%]  
1 66 0.50 Cu(II)(OAc)2 0.50 18 36 
2 31 0.50 Cu(II)(OAc)2 0.50 17 34 
3 66 0.50 Cu(I)Cl 0.50 18 36 
4 31 0.50 Cu(I)Cl 0.50 19 38 
5 66 0.50 - - 2 4 
6 - - Cu(II)(OAc)2 0.50 4 8 
7b) 66 0.50 Cu(II)(OAc)2 0.50 1 2 
8b) 66 0.50 - - 1 2 
9b) - - Cu(II)(OAc)2 0.50 1 2 
10 - - - - 1 2 
11b) - - - - 1 2 
a) Benzoic acid was not formed. 
b) The reaction was carried out without potassium hydroxide. 
 
After 3 hours the catalysis stopped. This phenomenon is similar to the one observed 
with ligand 31. Similarly, the appearance of a brown precipitate was observed in the 
reaction flask. This precipitate was attributed to the formation of copper oxide (Figure 
 2-1).[89] 
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Figure  5-21: Resin beads supporting ligand 66 after catalysis. 
 
The catalytic activity of the soluble and solid-phase bound sulfonamide ligands were 
compared in the aerobic oxidation of 3-methoxybenzyl alcohol (Table  5-13). 
 
0.50 mol% ligand 66 or 31 
0.50 mol% Cu(OAc)2, 5.00 mol% KOH 
OH
OMe  MeCN, O2, r.t. 
H O
OMe  
39  40 
Scheme  5-42: Catalytic aerobic oxidation of benzyl alcohol with the sulfonamide 
ligands: soluble 31 and bound to solid phase 66. 
 
With 0.50 mol% of ligand, 0.50 mol% of copper(II) acetate and 5.00 mol% of 
potassium hydroxide, 3-methoxybenzaldehyde was formed in a yield of 16 % with the 
on-bead ligand 66 (entry 1) and in 13 % yield with the soluble ligand 31 (entry 2). 
 
Table  5-13: Yield and turnover after 3.5 hours for the catalytic aerobic oxidation of 
3-methoxybenzyl alcohol with ligands 66 and 31. 
ligand 
entry 
 [mg] [mol%]
% yield in 
3-methoxybenzaldehydea) 
TON 
1 66 9.70 0.50 16 32 
2 31 6.00 0.50 13 26 
a) 3-Methoxybenzoic acid was not formed. 
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Figure  5-22 shows a comparison of the two ligands 31 and 66 in the formation of 
3-methoxybenzaldehyde over 4 hours. The solid-supported ligand 66 has an activity 
comparable to the soluble ligand 31. 
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Figure  5-22: Formation of 3-methoxybenzaldehyde by catalytic aerobic oxidation with 
ligand 31 and 66. 
 
time (mins) 
%
 y
ie
ld
 o
f 3
-m
et
ho
xy
be
nz
al
de
hy
de
 
solid-supported 
sulfonamide 66
soluble 
sulfonamide 31 
DISCUSSION 
 - 115 -
6 Discussion 
6.1 Towards the synthesis of the unnatural amino acid 
Fmoc-mod-Cys(MOM)-OH 46 
The two amino acids 47 and 53, N-Boc and N-Cbz protected respectively, were 
obtained. Towards the synthesis of the N-Fmoc protected amino acid 46, either the 
Boc protecting group of 47 or the Cbz protecting group of 53 should be cleaved. In 
this work, it was not possible to cleave the Boc protecting group without release of 
the MOM protecting group and the Cbz protecting could not be cleaved 
hydrogenolytically. 
 
 
 S
O
t-But-Bu
CO2HRHN
O
CH3
 
 
S
OMOM
t-But-Bu
CO2HFmoc-HN  
R = Boc   47 
R = Cbz   53 
 
46 
 
The cleavage of the Boc protecting group of compound 47 occurred together with the 
cleavage of the MOM protecting group. The reaction was followed by 1H-NMR. These 
results showed that the Boc protecting group was cleaved before the MOM protecting 
group since after 10 minutes the Boc protecting group was cleaved while the MOM 
protecting group was not removed. The cleavage of the MOM protecting group 
occurred during the work-up of the reaction. Trying to work up the reaction under 
anhydrous conditions or bringing the pH of the reaction mixture to a basic one before 
carrying out the work up did not give any better results. 
 
The cleavage of the Cbz protecting group was impossible under classical 
hydrogenolysis. This is probably due to deactivation of the palladium catalyst by the 
sulphur atom. 
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6.2 Synthesis of decapeptides including mod-Cys 
The two peptide-ligands 78 and 79 were synthesised on amino TentaGel resin. 
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
PEG
78         79 
 
The Boc-mod-Cys(MOM)-OH amino acid 47 was included in the peptide sequence of 
78 and 79. The peptide synthesis was carried out in an unusual way since some 
N-Fmoc protected amino acids were used (Fmoc-L-Phe-OH, Fmoc-Gly-OH, 
Fmoc-D-Pro-OH, Fmoc-L-Tyr(t-Bu)-OH and Fmoc-L-His(Trt)-OH), together with the 
N-Boc protected mod-Cys 47. According to the colour test carried out during the 
synthesis, the coupling steps seemed to be quantitative. The results of the UV 
analysis of the Fmoc cleavage solution were typical for a peptide synthesis (Table 
 6-1). The coupling yields decreased at the end of the peptide chain, which is not 
unusual. Only the coupling yield of tyrosine after mod-Cys in peptide 78 was quite 
low (61 % yield). This may be due to steric hindrance which does not occur in the 
coupling of histidine after mod-Cys in peptide 79. 
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Table  6-1: Yield for each coupling step in the synthesis of the decapeptides 78 and 
79, determined by UV measurement of the cleavage solution. 
peptide 78 peptide 79 
amino acida) yield [%] amino acida) yield [%]c) 
Phe 100 Phe 100 
Gly 94 Gly 94 
mod-Cys n.d. mod-Cys n.d. 
Tyrb) 61 Hisb) 100 
Gly 78 Gly 89 
D-Pro 89 D-Pro 94 
Glyb) 94 Glyb) 111 
His 94 His 94 
Gly 50 Gly 67 
His 44 Tyr 61 
a) All amino acids are in the L-configuration, except for proline which has the D-configuration. 
b) The coupling step was repeated after observation of a positive colour test. 
c) The values are relative to the first value which was fixed to 100 %. 
 
For the coupling of the mod-Cys amino acid 47, the phenol function was protected by 
a MOM protecting group. After the peptide coupling of this amino acid, the Boc 
protecting group was removed before carrying out the next step of the peptide 
synthesis. It is very probable that the MOM protecting group was cleaved together 
with the Boc protecting group during the treatment with TFA. The free phenol could 
give rise to some branched peptides since the next coupling step could happen at the 
amino or at the hydroxyl function (Figure  6-1). 
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S
OH
t-But-Bu
CH2N
O
H
N
possible coupling of the next amino acid
possible coupling of the next amino acid  
Figure  6-1: Formation of branched peptides. 
 
However this did not happen. Indeed, the coupling yields of the amino acids 
introduced after mod-Cys were never higher than 100 % relative to the first amino 
acid coupling (Table  6-1). Indeed, a coupling at the hydroxyl function and at the 
amino function would lead to a yield higher than 100 %, while a coupling that would 
occur only at the hydroxyl function would let the amino function free, and therefore 
would lead to a positive colour test for free amino functions. 
 
The synthesis of these two decapeptides 78 and 79 showed that it was possible to 
incorporate the mod-Cys amino acid in a peptide sequence. 
 
After incubation of the solid-supported decapeptides 82 and 83 with 1 equivalent of 
copper(II) acetate, the resin-beads observed under the microscope were of a blue–
green colour (Scheme  6-1). This colour indicated that a peptide–copper complex was 
formed. It was also shown that acetylated amino TentaGel resin did not bind to 
copper ion. This suggests that the copper ion bound to the peptide. The ratio 
peptide-ligand/copper of 1:1 suggested a complex similar to the one observed at the 
active site of GOase (Figure  6-2). 
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1 eq Cu(OAc)2, 
acetate buffer, 
MeOH 
 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
 
 
 
82  84 
Scheme  6-1: Incubation of decapeptides 82 with 1 equivalent of copper(II) acetate 
and observation of the resin beads under the microscope.[90] 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
Cu
Cu
N N
H2O O
O
Tyr 272
S
Cys 228
NHHN
His 496 His 581
Tyr 495
 
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
84 
Figure  6-2: Active site of GOase and copper–complex 84. 
 
6.2.1 Catalysis with the peptide–copper complexes 84 and 85 
The two peptide–copper complexes 84 and 85 showed catalytic activity in the aerobic 
oxidation of 3-methoxybenzyl alcohol. Up to 40 turnovers for 84 and 30 turnovers for 
85 were obtained after 24 hours, using 0.10 mol % of the catalyst. From these 
experiments, it was shown that a base was necessary for the catalytic activity. The 
role of the base was probably to deprotonate the alcohol. Potassium hydroxide led to 
catalytic activity while triethylamine as a base seemed to deactivate the catalyst. This 
deactivation could be explained by the binding of the nitrogen base to the copper ion 
(Scheme  6-2). 
 
DISCUSSION 
 - 120 -
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu
PEG
O Ar
 
 
Ar-CH2-OH, KOH 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu
PEG
 
 
substrate, NEt3 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu
PEG
NEt3
 
Scheme  6-2: Deactivation of the copper complex by binding of NEt3 to the copper ion. 
 
Copper does not bind to amino TentaGel resin, as shown by the colour of the resin 
beads which stayed yellow after incubation with copper(II) acetate. It was also shown 
that amino TentaGel in a copper(II) acetate solution was not active in catalysis. 
Therefore, the catalytic activity was due to the peptide–copper complexes. 
It is also important to note that no brown precipitate was observed in the reaction 
mixture and that the colour of the beads stayed the same during the catalysis 
experiment. In comparison to the low molecular weight copper complexes previously 
synthesised by Bulat,[89] these peptide–copper complexes did not decompose during 
the catalysis. 
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These preliminary catalytical experiments were carried out without pre-oxidation of 
the peptide–copper complexes. Pre-oxidation with potassium hexacyanoferrate(III) or 
ammonium cerium(IV) nitrate could lead to better results. 
 
mod-Cys-O  , Cu(II)
- e
+ einactive active
mod-Cys-O  , Cu(II)
 
Figure  6-3: Activation of the copper complex by oxidation to the tyrosyl radical. 
 
6.3 Synthesis of Fmoc-TOAC  
The Fmoc protection of the amino function of TOAC 41 led to a mixture of the nitroxyl 
radical 43 and the hydroxylamine 90. 
 
1) Fmoc-OSu, 
 NaHCO3 N
O
CO2HH2N
H3C CH3
H3C CH3
2) acidic work up 
N
O
CO2H
H3C CH3
Fmoc-HN
H3C CH3 +
N
OH
CO2H
H3C CH3
Fmoc-HN
H3C CH3
41  43, 56 %  90, 30 % 
 
As already suggested by Toniolo[114] and by Jorgensen,[119] the nitroxyl radical of 
TOAC was reduced to hydroxylamine in acidic conditions. During the work up, the pH 
of the reaction mixture was decreased to 3 by the addition of potassium bisulphate. 
At pH 3, protonation of 43 took place, leading to the formation of 90. 
 
6.4 Synthesis of the 81-member peptide library of decapeptides 99. 
The library of decapeptides 99 was synthesised following the split–mix strategy. 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
Xn = His, Tyr, TOAC 
99  
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The synthesis was followed by carrying out colour tests for free amino functions at 
every coupling step. The colour tests suggested a quantitative coupling for each step. 
Moreover, the peptide synthesis was followed by UV-measurement of the Fmoc 
cleavage solution which contained the dibenzofulvene–piperidine adduct. The results 
of the UV-measurement suggested quantitative coupling, except for the coupling of 
the TOAC amino acid (Table  6-2). Therefore, colour test and UV-measurement were 
in contradiction in the case of the coupling of TOAC. In order to clearify this problem, 
the tripeptide H2N-TOAC-Gly-Phe-CO2H was synthesised on Wang resin, cleaved 
from the resin and analysed by LC–MS. 
 
Table  6-2: Coupling yields for the synthesis of the tripeptide on Wang resin. 
amino acid coupling [%]
Phe a) 91 
Gly 100 
TOAC 68 
   a) L-amino acid 
 
The analysis of the cleaved product by LC–MS showed the presence of the tripeptide 
93, as well as the hydroxylamine 94. The dipeptide H2N-TOAC-Gly-OH 95 was also 
present in the product mixture. This could be explained by the coupling steps of the 
first two amino acids. Phe was coupled with in 91 % yield and Gly with in 100 % 
yield. Therefore 9 % of dipeptide 95 are expected to be present in the mixture of 
products. It is important to note that the dipeptide H2N-Gly-Phe-OH 108 was not 
observed in the reaction mixture, which suggests a quantitative coupling of the TOAC 
amino acid. 
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The results which were obtained during the synthesis of the tripeptide 93 showed that 
the use of UV for quantifying the coupling step was not reliable in the case of TOAC. 
This could be explained by an interaction of TOAC with dibenzofulvene (Figure  6-4). 
H2O
O
N
H
N
O
CH3H3C
CH3H3C
N
H
 
Figure  6-4: Competition between TOAC and piperidine. 
 
The cleavage of the side chain protecting groups of the library of decapeptides 99 
was carried out by treatment with TFA. As already observed during the synthesis of 
Fmoc-TOAC-OH 43 and suggested by Toniolo,[114] TOAC nitroxyl radicals are 
protonated by TFA. Treatment of the decapeptides with an aqueous ammonia 
solution leads to the regeneration of the nitroxyl radicals. Therefore the nitroxyl 
radicals were regenerated in order to have the completely activated peptides for the 
screening of the library. 
 
The complexation of the on-bead peptide-ligands with copper(II) acetate could be 
visualised by the colour changes of the resin beads. The resin beads carrying the 
peptide-ligands were pale yellow. After complexation with 1 equivalent of copper(II) 
acetate, each on-bead copper complex had a particular colour. One copper complex 
could be distinguished from the others. These various colours observed indicated 
that the copper ion coordinated at the functional amino acids (tyrosine, histidine and 
TOAC). Complexation of the copper ion to the resin or to the polyethyleneglycol 
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moiety can be excluded since the incubation of acetylated amino TentaGel with 
copper(II) acetate did not resulted in any changes in the colour of the beads. A 
complexation of the copper ion on the peptide backbone would give the same colour 
for all the members of the library. The ratio peptide-ligand/copper of 1:1 suggested a 
complex similar to the one observed at the active site of Goase, i.e. a complex where 
the copper ion is complexed by one peptide-ligand. 
  
6.5 Screening of the library of decapeptides. 
The library of decapeptides 99 was screened for activity in the catalytic aerobic 
oxidation of 3-methoxybenzyl alcohol. The copper complexes from the library 100 did 
not show any catalytic activity in acetonitrile/water (1:1). 
When the complexes were prepared in situ with 3 equivalents of copper ions relative 
to the amount of the ligand, the formation of 3-methoxybenzaldehyde could be 
observed. When the copper salt was added in excess, the solution appeared blue 
coloured, thus suggesting that the copper excess remained in solution and did not 
coordinate with the peptide-ligands. The difference in the activity could be explained 
by the formation of a substrate–copper complex that would be in an equilibrium with 
the peptide–copper–substrate complex (Figure  6-5). 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu
PEG
O
H CH2 Ar
Cu
O
H CH2 Ar
OAcAcO
 
Figure  6-5: Equilibrium between the soluble substrate–copper complex and the 
solid-supported peptide–copper–substrate complex. 
 
Differences in the catalytic activity of the 81 members of the library 99 were 
observed. After 24 hours, up to 5 % yield were observed for the best catalyst, i.e. the 
catalyst with the peptide sequence X1 = Tyr, X2 = Tyr, X3 = TOAC and X4 = TOAC. 
This corresponds to a turnover frequency of 10–4 s–1. 4 % of the aldehyde were 
formed with the catalysts which had the peptide sequences X1, X2, X3, X4 = TOAC, 
Tyr, TOAC, TOAC and TOAC, TOAC, Tyr, TOAC. 
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Some general trends could be drawn out from the results of the screening. The 
presence of the TOAC amino acid in the peptide sequence was necessary for 
catalytic activity. The best catalysts contained two or three TOAC moieties. Better 
catalytic activity was observed when tyrosine was present in the peptide sequence. 
Tyrosine was probably acting as a base and deprotonated the substrate (Figure  6-6). 
Histidine was not basic enough to deprotonate the substrate. The catalyst with four 
TOAC residues did not show a good activity. In this case, there was not a basic 
moiety for the substrate deprotonation, thus resulting in slower activity. This is 
consistent with the results of Sheldon who showed that in the catalytic system 
consisting of TEMPO, bipyridine and a copper salt, the addition of a base accelerates 
the reaction.[9] 
 
Cu
O
O
CH2H Ar
Tyr
Cu
O
OH
CH2 Ar
Tyr  
Figure  6-6: Deprotonation of the substrate by the tyrosine moiety. 
 
Moreover, the control experiments have shown that dioxygen and copper were 
necessary for the oxidation to take place. That means that dioxygen was the primary 
oxidant and that the oxidation took place at the copper complex. Less aldehyde was 
formed when soluble amino acids were used instead of the peptides. This showed 
that the spatial organisation of the copper complexes played a role in the aerobic 
oxidation. 
It was also important to point out that no precipitate was observed in the reaction 
flask during catalysis, thus suggesting the stability of the catalysts. However the 
catalyst did not show further activity when it was used for a second time, even when 
two equivalents of the copper salt were added into the solution. 
 
One of the members of the library was synthesised on a cleavable resin. The activity 
of the soluble decapeptide in the catalytic aerobic oxidation of 3-methoxybenzyl 
alcohol was higher than the activity of its on-bead counterpart. While 1.8 % of 
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3-methoxybenzyl alcohol were converted to the corresponding aldehyde with the 
on-bead copper complex, 3.6 % of 3-methoxybenzaldehyde were obtained with the 
soluble copper complex. The soluble decapeptides were purified before catalysis. 
Even if the product was not clean, it showed that smaller peptide sequences were not 
present in the reaction mixture. The TOAC moieties in the soluble decapeptide were 
present as a mixture of nitroxyl radical and hydroxylamines, which did not affect the 
catalysis. This suggests a catalytic mechanism in which both nitroxyl radical and 
hydroxylamine functions played a role (Figure  6-7). According to this mechanism, a 
hydrogen atom was abstracted from the alcoholate by the nitroxyl radical, resulting in 
a ketyl radical. The next step is an electron transfer from the ketyl radical to the 
copper(II). During this process, the copper(II) was reduced to copper(I) and the 
aldehyde product was formed, together with the hydroxylamine derivative. The 
hydroxylamine moiety could finally be re-oxidised to the nitroxyl radical by dioxygen. 
 
NO
CuII
O
R HH
NHO
CuII
O
R
H
N
HO
CuI
O
HR
NO
CuII
O2R-CHO
R-CH2-OH
O2
H2O
 
Figure  6-7: Proposed mechanism for the oxidation of the primary alcohol by 
copper(II) and TOAC moiety based on a mechanism proposed by 
Sheldon.[9] 
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6.6 Aerobic oxidation of alcohols with a solid-supported low 
molecular weight copper complex 
The low molecular weight ligand 66 was synthesised on polystyrene resin. 
 
t-Bu
t-Bu
OH
N
S
O
O
HN
66 
 
Compared to its soluble counterpart, this ligand was more easily synthesised. The 
3-step solid phase synthesis gave the product in a quantitative yield without 
purification. Unfortunately, ligand 66 only showed an activity comparable to the 
soluble ligand 31. The catalyst was deactivated after 3 hours. 36 turnover numbers 
were achieved after 3 hours in the oxidation of benzyl alcohol, which corresponded to 
a turnover frequency of 3·10–3 s–1. This activity was higher than the activity of the 
peptide-ligand which oxidises 3-methoxybenzyl alcohol with a turnover frequency of 
10–4 s–1. 
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7 Outlook 
7.1 Synthesis of the Fmoc-protected mod-Cys 
The Fmoc-protected mod-Cys amino acid 46 could not be prepared in this work. In 
order to synthesise this compound 46, the protecting-groups strategy should be 
modified. Since the O-MOM protected thiol 55 has proven to be stable and easy to 
prepare, the changes should concern the other building block, i.e. the lactone. The 
amino function should be protected with a group that is base-resistant and orthogonal 
to the MOM protecting group. In this respect, a photolabile protecting group could be 
a good choice. Particularly, the α,α-dimethyl-3,5-dimethoxybenzyloxycarbonyl group 
is cleaved by irradiation at 282 nm and 276 nm (Figure  7-1). The amino function can 
be protected with such a group by reaction with α,α-dimethyl-3,5-dimethoxybenzyl-
oxycarbonyl azide. This protecting group is light sensitive, and thus could be 
removed without cleaving the sulfide bond and without cleaving the MOM protecting 
group. 
O
ON
H
O
O
H3C CH3
OMe
MeO
SH
O O
CH3
t-Bu
t-Bu
t-Bu t-Bu
O O
CH3
S
CO2HNH
O
OH3C CH3
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MeO
t-Bu t-Bu
O O
CH3
S
CO2HH2N
t-Bu t-Bu
O O
CH3
S
CO2HNH
O
O
+
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hν
Fmoc-OSu
55
46 76
109 110
 
Figure  7-1: Alternative route towards the synthesis of Fmoc-L-mod-Cys(MOM)-OH 
46.[120] 
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7.2 Further work concerning the peptide-ligands 
The screening of the library of peptide-ligands has shown that some members were 
more active in the catalytic aerobic oxidation of 3-methoxybenzyl alcohol. Further 
work could consist in the optimisation of the reaction conditions, i.e. screening of 
different solvents, addition of a buffer, etc. This could be better done in solution with 
purified peptides. Screening of a range of substrates should also be done in order to 
determine the scope of the catalysts. 
 
7.3 Copper complexes for the aerobic oxidation of alcohols 
Sheldon has reported on the activity of a bipyridine–TEMPO–copper complex in the 
catalytic aerobic oxidation of alcohols.[9] The combination of TEMPO- and 
bipyridine-like functions in a single ligand could result in a more active and stable 
copper catalyst. Hoveyda and co-workers have reported the library of ligand 111.[121] 
These peptide–Schiff base ligands were tested in the copper-catalysed allylic 
alkylation of aryl substituted allylic phosphates, thus demonstrating the ability of 
these ligands to form copper complexes. 
 
N
N
O
H
N
N
H
O
C4H9
R1
R2
111[121] 
 
A library of such peptide–Schiff base ligands with a pyridine-carboxaldehyde-derived 
imine could be synthesised on a solid phase (Figure  7-2). The peptide sequence 
should include the TOAC amino acid 41. Such a structure would allow the variation of 
the length of the peptide and the synthesis of a diversified library of ligands. 
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N
O
H
N
R1
N
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O
R2  
N
O
CO2HH2N
H3C CH3
H3C CH3
 
112 41 
Figure  7-2: Dipeptide–Schiff base ligand with a pyridine-carboxaldehyde-derived 
imine. 
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8 Experimental part 
8.1 General procedures and use of devices 
Solvents: All solvents were distilled before use. Anhydrous solvents were first 
refluxed with the appropriate drying agent and then distilled. As a drying agent, 
calcium hydride was used for acetonitrile and n-hexane, sodium / benzophenone for 
toluene, tetrahydrofuran and diethylether, magnesium for isopropanol, methanol and 
ethanol. Absolute N,N-dimethylformamide was obtained from a 99 % grade which 
was refluxed over calcium hydride and distilled. 
 
Substrates: The substrates benzyl alcohol and 3-methoxybenzyl alcohol were 
distilled prior to catalysis experiments. 
 
Inert gas: Argon from the company Linde with a purity of 99.998 % was used after 
being dried over silica gel desiccant and phosphorus pentoxide (both with colour 
indicator for humidity), and deoxygenated with a BTS catalyst. 
 
Kugelrohr distillation: Kugelrohr distillations were performed on a Büchi B-580 
instrument. 
 
Melting points: Melting points were measured with a Büchi Tottoli instrument. The 
values were not corrected. 
 
Infrared spectroscopy (FT-IR): The IR spectra were measured with a Perkin–Elmer 
1600 Series FT-IR instrument. The samples were measured as potassium bromide 
or caesium iodide discs. The positions of the bands are given in cm–1, the intensities 
are given as s = strong, m = medium, w = weak, br = broad and the kind of bands are 
ν = streching, δ = deformation (oop = out of plane). 
 
Nuclear magnetic resonance (NMR): The NMR measurements of soluble low 
molecular weight molecules were performed at room temperature on a Bruker 
AC 300, equipped with a narrow bore magnet (Oxford, 7.0 Tesla) and a Bruker 
Aspect 3000 computer. The on-bead measurements were performed on a Bruker 
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Avance DRX 500, equipped with multinuclear HR-MAS probe, a narrow bore magnet 
(Bruker SpectroSpin, 11.7 Tesla) and a SGI O2 workstation. The chemical shifts (δ) 
are relative to the internal standard TMS. The coupling constants (J) are given in 
Hertz. In the interpretation of the spectra, the abbreviations are the following: 
s = singlet, d = doublet, t = triplet, q = quadruplet, m = multiplet. 
 
Mass spectrometry (HR-MS): The mass spectra were measured on a Finnigan 
MAT 900 ST instrument. 
 
Elemental analysis (EA): Before analysis, the samples were recrystallised and 
dried. The elemental analyses were carried out on an Elementar Analysensysteme 
GmbH Vario EL. The percentages of the elements carbon, hydrogen and nitrogen in 
the samples were determined. 
 
X-Ray analysis: The samples were analysed with a Nonius KappaCCD-
diffractometer equipped with the program Denzo. The calculations of the structures 
were performed with the software SheIXS86 and SheIXL93. 
 
Thin layer chromatography (TLC): The TLC analyses were carried out on 
POLYGRAM Sil G/UV254 plates (0.25 mm thick, silica gel with fluorescent indicator) 
from Macherey-Nagel. The spots of products were visualised in UV (λ = 254 nm) or 
revealed with phosphomolybdic acid. 
 
Column chromatography: For purifications by column chromatography, silica gel or 
aluminium oxide were used as a stationary phase. The silica gel used was purchased 
from Macherey–Nagel (MN-Kieselgel 60, 0.040–0.063 nm, 230–400 mesh) and the 
aluminium oxide was purchased from Fluka (0.05–0.15 nm, pH 7.0). 
 
Gas chromatography (GC): For the gas chromatography analyses, a Hewlett–
Packard HP 5890 Series II was used. The device was equipped with a flame 
ionisation detector and a HP-5 capillary column (95 % methylsiloxane, 5 % 
phenylsiloxane; 30 m, 0.2 mmID, 0.32 µm thick). Nitrogen was used as a mobile 
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phase. The chromatograms were analysed with the software HP ChemStation from 
Hewlett–Packard. 
 
Program 1 was used for the detection of benzyl alcohol and its oxidation products, as 
well as for the detection of 3-methoxybenzyl alcohol and its oxidation products. 
Diphenylether was used as the internal standard. The program was defined as 
follows: 
 Injector temperature: 250 °C 
 Detector temperature: 250 °C 
 Initial temperature: 100 °C for 5 minutes 
 Gradient of 10 °C/min until 200 °C 
 
Table  8-1: Retention times (τr) of the substrates, products and internal standard with 
GC program 1. 
compound τr [min]
benzyl alcohol 5.42 
benzaldehyde 4.19 
benzoic acid 8.49 
3-methoxybenzyl alcohol 9.73 
3-methoxybenzaldehyde 8.24 
3-methoxybenzoic acid 12.38 
diphenylether 11.44 
 
High performance liquid chromatography / mass spectrometry (LC–MS): 
Analytical LC–MS of the peptides was carried out on an Agilent 1100 Series 
Purification Platform. The HPLC system was equipped with a RP-18 column from 
Macherey–Nagel (EC-Nucleodur 250/4, 100 Å pore size, 5 µm particles) and a 
diode–array multi-wavelength detector. A mixture of acetonitrile and water with 0.1 % 
or 0.5 % of acetic acid was used as the mobile phase. 
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Preparative high performance liquid chromatography (preparative HPLC): The 
peptides were purified on a Merck–Hitachi NovaPrep 200 equipped with a RP-18 
column from Macherey–Nagel (EC-Nucleodur, 100 Å pore size, 16 µm particles) and 
a Merck–Hitachi L-7400 UV detector. A mixture of acetonitrile and water with 0.1 % 
or 0.5 % of acetic acid was used as the mobile phase. 
 
Ultraviolet spectroscopy (UV): The UV spectra were measured with a Beckman 
Coulter DU 800 spectrophotometer. 
 
Microscopy: The on-bead peptide-ligands were observed with a Zeiss Axioplan 2, 
equipped with a CCD-camera. The video processing was carried out with the 
KS Grabbers and KS 100 software. 
 
Scanning UV-vis spectroscopy: The screening of the library was carried out on a 
Tecan SpectraFluor Plus titerplate reader, equipped with a 310 nm absorption filter. 
The samples were analysed in Nunc 96 well titerplates and the results were 
processed with the Easywin software. 
 
Laboratory journal: The number given at the beginning of each synthesis, catalysis 
or experimental work refers to the page in the laboratory journal. 
 
Temperature of the reactions: All the reactions were performed at room 
temperature, except stated otherwise. 
 
8.2 General protocols for solid phase peptide synthesis 
8.2.1 Chemicals and special equipment 
The TentaGel™ and Wang™ resins were purchased from Rapp Polymere, the tosyl 
chloride resin was purchased from Argonaut Technologies and the Fmoc-protected 
amino acids were purchased from NovaBiochem. 
The peptide syntheses were performed in Schlenk flasks equipped with a filter plate 
and a gas inlet (Merrifield flask). The reaction mixtures were swirled on a shaker at 
220 rpm. 
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8.2.2 Synthesis of the peptide library and encoding of the peptides 
The peptide library was synthesised with the help of the IRORI Accu-Tag™ 100 
Combinatorial Chemistry System. The synthesis was performed in MicroKan™ 
(capacity up to 30 mg of resin) or MacroKan™ (capacity up to 300 mg of resin) 
containers equipped with radiofrequency tags. 
 
8.2.3 Swelling of the resins 
Before use, the resins were allowed to swell for 1 hour. TentaGel resin was swollen 
in DMF, Wang resin was swollen in a mixture of dichloromethane and DMF (8:2) and 
chlorosulfonated polystyrene resin was swollen in dichloromethane. 
 
8.2.4 Coupling with PyBOP as a coupling agent[112] 
The pre-swollen resin was suspended in absolute DMF containing 3 % NMM. 2.5 eq 
of PyBOP and 2.5 eq of the corresponding amino acid (calculated on the loading of 
the resin) were added to the suspension and the reaction mixture was shaken at 
room temperature under argon for 12 hours. The solution turned yellow after a few 
hours. The solution was filtered and the resin was washed 3 times with DMF. In case 
of difficult sequences, the coupling was repeated 2 or 3 times. 
 
8.2.5 Determination of free amino functions with the NF31 colour test[60] 
O2N N
N N
CH3
O
O
O
NO2  
NF31, 1 
 
A few beads of the product were transferred into a vial and suspended in 1.00 mL of 
a 0.01 mM solution of 1 in acetonitrile. After heating to 70 °C for 10 minutes, the 
beads were washed successively 3 times with DMF, methanol and dichloromethane. 
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Beads containing free amino functions appeared red while completely coupled beads 
(without free amino functions) remained colourless. 
 
8.2.6 Cleavage of Fmoc protecting groups and quantification of the coupling 
steps 
8.2.6.1 Calibration curves for the determination of peptide coupling yields by UV 
II-MAG-22 
 
In order to quantify the amount of peptides attached to the resin, a calibration curve 
which correlated the concentration of the dibenzofulvene–piperidine adduct with the 
absorbance was prepared. A 100 mL graduated flask was charged with 39.0 mg 
(100 µmol) of Fmoc-L-Phe-OH and 10 mL of a 20 % piperidine solution in absolute 
DMF. The solution was shaken at room temperature for 10 minutes and the 
graduated flask was filled to 100 mL by the addition of absolute DMF. The solution 
was diluted with absolute DMF in order to obtain 10 samples with concentrations 
ranging from 0.05 to 0.50 mM. The UV absorbances at λ = 290 nm and λ = 300 nm of 
these samples were measured. The linear plot of the absorbance (A) against the 
concentration (c) of dibenzofulvene–piperidine gave the following equations (Figure 
 8-1, Table  8-2). These linear plots were used to determine the coupling yields during 
peptide synthesis. 
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Figure  8-1: Calibration curves for the yield determination of peptide couplings per UV. 
 
c [mmol/L] 
A 
300 nm
290 nm 
A = 5.5781c - 0.0795 
R2 = 0.9955 
A = 5.0575c - 0.1572 
R2 = 0.9882 
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Table  8-2: Absorbance (A) for yield determination of peptide couplings per UV. 
A 
c [mmol/L] 
λ = 290 nm λ = 300 nm 
0.05 0.0945 0.1565 
0.10 0.3606 0.4731 
0.15 0.6771 0.8203 
0.20 0.8482 1.0474 
0.25 1.0704 1.3035 
0.30 1.3830 1.6603 
0.35 1.5340 1.8363 
0.40 1.7860 2.1031 
0.45 2.0262 2.3475 
0.50 2.5557 2.7966 
 
8.2.6.2 Cleavage of Fmoc protecting groups 
The resin was suspended in a 20 % solution of piperidine in absolute DMF and 
shaken at room temperature for 30 minutes. The treatment with piperidine was 
repeated twice for 20 minutes. The solution was filtered and the resin was washed 
4 times with absolute DMF. The solutions were collected, combined and the UV 
absorbance at λ = 300 nm was measured in order to calculate the yield of the 
coupling. 
 
8.2.7 Cleavage of Boc protecting groups 
A 20 % solution of TFA in dry dichloromethane was added to the resin. The 
suspension was shaken at room temperature for 10 minutes and the resin was 
washed 3 times with dichloromethane to remove all traces of TFA. 
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8.2.8 Determination of the loading of amino TentaGel resin 
 
NH2PEG NH2amino TentaGel:  
77 
 
1) swell in DMF 
2) 2.50 eq Fmoc-L-Phe-OH, 2.50 eq 
PyBOP, 3 % NMM in DMF 
 
 
NH2  
3) test for free amino functions 
4) 20 % piperidine in DMF 
 
NHCOPheH2N
77  113 
 
A 100 mL Merrifield flask was charged with 100 mg (theoretical 
loading = 0.26 mmol/g) of amino TentaGel resin 77 and 10 mL of absolute DMF. The 
resin was allowed to swell by gentle shaking at room temperature for 1 hour. The 
solvent was filtered and 10 mL of a solution at 3 % of NMM in absolute DMF was 
added, as well as 25.0 mg (65.0 µmol, 2.50 eq) of Fmoc-L-Phe-OH and 34.0 mg 
(65.0 µmol, 2.50 eq) of the coupling agent PyBOP. The suspension was shaken at 
room temperature under argon for 12 hours. The solution was filtered and the resin 
was washed 3 times with 10 mL of DMF. A NF31 test was performed in order to 
check the completion of the reaction. Since a negative test was observed, the Fmoc 
protecting group was cleaved, the filtrate solutions were collected and the loading of 
the resin was determined with the help of the calibration curve (Figure  8-1). The 
loading of the resin was calculated to be 0.22 mmol amino functions per gram of 
resin. 
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8.2.9 Determination of the loading of Wang resin 
 
OHWang resin: CH2O CH2OH
 
91 
 
1) swell in DMF 
2) 5.00 eq Fmoc-L-Phe-OH, 5.00 eq DIC, 
5.00 eq HOBt, 0.10 eq DMAP 
 
 
OH
 
3) test for free amino functions 
4) 20 % piperidine in DMF 
 
COOPheH2N
91  114 
 
A 100 mL Merrifield flask was charged with 100 mg (theoretical 
loading = 0.97 mmol/g) of Wang resin 91 and 10 mL of a mixture of dry 
dichloromethane and absolute DMF (8:2). The resin was allowed to swell by gentle 
shaking at room temperature for 1 hour. The solvent was filtered and a new mixture 
of dry dichloromethane and absolute DMF (8:2) was added, followed by 188 mg 
(485 µmol, 5.00 eq) of Fmoc-L-Phe-OH, 61.0 mg (485 µmol, 5.00 eq) of N,N’-di-iso-
propyl-carbodiimide, 65.5 mg (485 µmol, 5.00 eq) of HOBt and 1.20 mg (9.70 µmol, 
0.10 eq) of 4-dimethylaminopyridine. The resulting suspension was shaken at room 
temperature under argon for 12 hours. The solution was filtered and the resin was 
washed 3 times with 10 mL of dichloromethane and 3 times with 10 mL of DMF. 
Since an NF31 test proved the coupling to be complete, the Fmoc protecting group 
was cleaved with a 20 % solution of piperidine in DMF. The loading of the resin was 
determined to be 1.10 mmol/g. 
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8.3 Synthesis of the unnatural amino acid mod-Cys: model for the 
Tyr–Cys cross-link of GOase 
8.3.1 Synthesis of 2,4-di-tert-butyl-6-bromophenol, 50[99] 
I-MAG-21 
 
Br2 
 
t-Bu
t-Bu
OH
 
CCl4, 0 °C t-Bu
t-Bu
OH
Br
 
51  50 
 
In a 250 mL three-necked flask equipped with a thermometer, a dropping funnel and 
a reflux condenser, a solution of 20.6 g (100 mmol, 1.00 eq) of 2,4-di-tert-butylphenol 
51 in 100 mL of carbon tetrachloride was prepared. The solution was stirred and 
cooled to 0 °C. A solution of 6.00 mL (117 mmol, 1.20 eq) of bromine in 50 mL of 
carbon tetrachloride was added and the resulting reaction mixture was stirred at 0 °C 
for 3 hours. A solution of 1.00 g of sodium sulfite in 50 mL of water was added to the 
brown solution. The two layers were separated, the organic layer was washed with 
water, dried over magnesium sulphate, and the solvent was evaporated under 
reduced pressure to give 26.1 g (91.5 mmol, 92 %) of 50 as a pale brown solid. 
 
OH
Br
H3C
H3C
H3C
H3C CH3
CH3
Hb
Ha 12
3
4 5
6
50 
 
C14H21BrO 
 
285.22 g·mol-1 
 
Yield 
 
26.1 g, 91.5 mmol, 92 % (Lit.: 60 %)[99] 
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Melting point 
 
56 °C (Lit.: 57–58 °C)[99] 
FT-IR (CsI disc) ν [cm–1] = 3512 [s, ν(O–H)], 3002 [w, ν(aryl–H)], 2967 [s, 
ν(alkyl–C–H)], 2914 [m, ν(alkyl–C–H)], 1574 [m, ν(C=C)], 1404 [m, 
δas(C–H from t-Bu)], 1365 [m, δs(C–H from t-Bu)], 1281 [s, ν(C–O)], 
871 [s, δoop(aryl–H)], 841 [s, δoop(aryl–H)], 746 [s, δoop(aryl–H)], 715 
[s, δoop(aryl–H)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.29 (s, 9H, t-Bu), 1.41 (s, 9H, t-Bu), 5.65 (s, 
1H, OH), 7.25 (d, 4JHa,Hb = 2.36, 1H, Ha or Hb), 7.33 (d, 4JHa,Hb = 
2.36, 1H, Ha or Hb). 
 
13C-NMR (75 MHz, CDCl3) δ = 30.2 (q, CH3 / t-Bu), 32.3 (q, CH3 / t-Bu), 35.2 
(s, Cq / t-Bu), 36.3 (s, Cq / t-Bu), 112.7 (s, aryl–C6), 124.5 (d, aryl–
C3), 127.0 (d, aryl–C5), 137.5 (s, aryl–C2 or C4), 144.4 (s, aryl–C2 or 
C4), 148.8 (s, aryl–C1). 
 
TLC 
 
Rf = 0.81 (silica gel, n-hexane : dichloromethane = 2 : 1). 
 
8.3.2 Synthesis of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene, 
48[100] 
I-MAG-12 
 
MOMCl, i-Pr2NEt 
 
t-Bu
t-Bu
OH
Br
 CH2Cl2 t-Bu
t-Bu
OMOM
Br
 
50  48 
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Under argon, a dry 100 mL two-necked flask was charged with 2.00 g (7.02 mmol, 
1.00 eq) of 2,4-di-tert-butyl-6-bromophenol 50 and 20 mL of dry dichloromethane. 
2.40 mL (18.9 mmol, 2.70 eq) of chloromethyl methyl ether and 3.30 mL (18.9 mmol, 
2.70 eq) of di-iso-propylethylamine were added to the solution and the reaction 
mixture was stirred at room temperature under argon for 6 days. The solution turned 
red. 20 mL of water were added to the reaction mixture. The product was extracted 
with dichloromethane, the combined organic layers were washed with water, dried 
over magnesium sulphate and the solvent was evaporated under reduced pressure. 
An orange oil was obtained that was purified by kugelrohr distillation (4·10–1 mbar, 
118 °C) to give 1.90 g (5.77 mmol, 82 %) of product 48 as a colorless oil. 
 
O
Br
O
CH3
H3C
H3C
H3C
H3C CH3
CH3
Hb
Ha
1 2
3
45
6
48 
 
C16H25BrO2 
 
329.27 g·mol–1 
 
Yield 
 
1.90 g, 5.77 mmol, 82 % 
FT-IR (NaCl plate) ν [cm–1] = 3004 [w, ν(aryl–H)], 2973 [s, ν(alkyl–C–H)], 
2956 [m, ν(alkyl–C–H)], 2921 [m, ν(alkyl–C–H)], 1598 [m, ν(C=C)], 
1407 [m, δas(C–H from t-Bu)], 1362 [m, δs(C–H from t-Bu)], 1245 [s, 
ν(C–O)], 1156 [s, ν(C–O)], 1079 [s, ν(C–O)], 879 [s, δoop(aryl–H)], 
734 [s, δoop(aryl–H)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.28 (s, 9H, t-Bu), 1.42 (s, 9H, t-Bu), 3.68 (s, 
3H, O–CH3), 5.21 (s, 2H, O–CH2–O), 7.30 (d, 4JHa,Hb = 2.41, 1H, Ha 
or Hb), 7.39 (d, 4JHa,Hb = 2.41, 1H, Ha or Hb). 
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13C-NMR (75 MHz, CDCl3) δ = 30.8 (q, CH3 / t-Bu), 31.3 (q, CH3 / t-Bu), 34.6 
(s, Cq / t-Bu), 35.8 (s, Cq / t-Bu), 57.7 (q, O–CH3), 99.2 (t, O–CH2–
O), 117.4 (s, aryl–C3), 123.8 (d, aryl–C6), 128.7 (d, aryl–C4), 142.8 
(s, aryl–C1 or C5), 144.3 (s, aryl–C1 or C5), 147.5 (s, aryl–C2). 
 
TLC 
 
Rf = 0.40 (silica gel, n-hexane : dichloromethane = 2 : 1). 
 
8.3.3 Lithiation of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene, 48 
and reaction with the electrophile MeI[102, 103] 
I-MAG-17 
 
1) n-BuLi, THF, -78 °C 
 
t-Bu
t-Bu
OMOM
Br
 
2) MeI, RT t-Bu
t-Bu
OMOM
CH3
 
48  72 
 
Under argon, a dry 25 mL three-necked flask was charged with a solution of 400 mg 
(1.22 mmol, 1.00 eq) of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 48 in 
5 mL of dry THF. The solution was cooled down to –78 °C, 1.20 mL (1.46 mmol, 
1.20 eq) of a 1.20 M n-butyllithium solution in n-hexane were added and the reaction 
mixture was stirred at –78 °C for one hour. 152 µl (2.44 mmol, 2.00 eq) of methyl 
iodide were added, the reaction mixture was allowed to warm up to room 
temperature and stirred for an additonal period of 36 hours. Then 5 mL of water were 
added to the reaction mixture. The product was extracted with ethyl acetate, washed 
with water, dried over magnesium sulphate, and the solvent was evaporated under 
reduced pressure to give 290 mg (1.10 mmol, 90 %) of 72 as a yellow oil. 
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O
CH3
O
CH3
H3C
H3C
H3C
H3C CH3
CH3
Ha
Hb 1 2
3
45
6
72 
 
C17H28O2 
 
264.40 g·mol–1 
Yield 
 
290 mg, 1.10 mmol, 90 % 
1H-NMR (300 MHz, CDCl3) δ = 1.29 (s, 9H, t-Bu), 1.41 (s, 9H, t-Bu), 2.32 (s, 
3H, CH3), 3.65 (s, 3H, O–CH3), 4.99 (s, 2H, O–CH2–O), 7.04 (d, 
4JHa,Hb = 2.51, 1H, Hb), 7.19 (d, 4JHa,Hb = 2.51, 1H, Ha). 
 
13C-NMR (75 MHz, CDCl3) δ = 14.6 (q, CH3), 31.2 (q, CH3 / t-Bu), 31.4 (s, Cq 
/ t-Bu), 31.5 (q, CH3 / t-Bu), 40.9 (s, Cq / t-Bu), 55.3 (q, O–CH3), 
95.2 (t, O–CH2–O), 119.8 (d, aryl–C6), 123.2 (s, aryl–C3), 124.2 (d, 
aryl–C4), 135.3 (s, aryl–C1), 141.4 (s, aryl–C5), 150.2 (s, aryl–C2). 
 
TLC 
 
Rf = 0.48 (silica gel, n-hexane : dichloromethane = 2 : 1). 
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8.3.4 Lithiation of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene, 48 
and reaction with the electrophile MeOD[102] 
I-MAG-18 
 
1) n-BuLi, THF, –78 °C 
 
t-Bu
t-Bu
OMOM
Br
 2) MeOD, RT t-Bu
t-Bu
OMOM
D
 
48  73 
 
Under argon, a dry 25 mL three-necked flask was charged with a solution of 400 mg 
(1.22 mmol, 1.00 eq) of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 48 in 
5 mL of dry THF. The solution was cooled down to –78 °C, 1.20 mL (1.46 mmol, 
1.20 eq) of a 1.20 M n-butyllithium solution in n-hexane was added and the reaction 
mixture was stirred at –78 °C for one hour. 99.0 µl (2.44 mmol, 2.00 eq) of 
methanol-d1 were added, the reaction mixture was allowed to warm up to room 
temperature and stirred for an additional period of 36 hours. Then 5 mL of water were 
added to the reaction mixture.The product was extracted with ethyl acetate, washed 
with water, dried over magnesium sulphate, and the solvent was evaporated under 
reduced pressure to give 305 mg (1.21 mmol, 99 %) of 73 as a white solid. 
 
O
D
O
CH3
H3C
H3C
H3C
H3C CH3
CH3
Ha
Hb 1
2
3 4
5
6
73 
 
C16H25DO2 
 
251.38 g·mol–1 
Yield 
 
305 mg, 1.21 mmol, 99 % 
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1H-NMR (300 MHz, CDCl3) δ = 1.28 (s, 9H, t-Bu), 1.39 (s, 9H, t-Bu), 3.48 (s, 
3H, O–CH3), 5.19 (s, 2H, O–CH2–O), 7.14 (td, 4JHa,Hb = 2.52, 3JHb,D 
= 3.66, 1H, Ha), 7.31 (d, 4JHa,Hb = 2.52, 1H, Hb). 
 
TLC 
 
Rf = 0.70 (silica gel, n-hexane : dichloromethane = 2 : 1). 
 
8.3.5 Synthesis of N,N’-bis-tert-butyloxycarbonyl-L-cystine-O,O’-bis-methyl 
ester, 49[101] 
I-MAG-25 
 
CH2N2 
 
Boc-HN CO2H
S S
HO2C NH-Boc
 MeOH, 40–50 °C Boc-HN CO2Me
S S
MeO2C NH-Boc
 
52  49 
 
Diazomethane was formed by dropping 4.80 g (22.2 mmol, 3.00 eq) of 
N-nitroso-N-methyl-4-toluenesulfonamide, dissolved in 190 mL of diethylether, into a 
solution of 1.30 g (22.2 mmol, 3.00 eq) of potassium hydroxide in a mixture of 20 mL 
of ethanol and 7 mL of water. The addition was performed over 3 hours. The yellow 
coloured diazomethane formed was distilled at a temperature of 45 °C and came in 
contact with the diacid to be methylated, i.e. 3.26 g (7.39 mmol, 1.00 eq) of 
N-N’-bis-tert-butyloxycarbonyl-L-cystine 52 in 70 mL of methanol. Once the 
distillation was over, the solvent was evaporated under reduced pressure to give a 
colourless oil which was dissolved in a minimum of diethylether and precipitated by 
addition of n-pentane. The product was filtered to give 3.37 g (7.19 mmol, 97 %) of 
49 as a white solid. 
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S
N
H
O
O
H3C
H3C
H3C
O
O
CH3
Ha
Hc
Hb 2
49 
 
C18H32N2O8S2 
 
468.59 g·mol–1 
Yield 
 
3.37 g, 7.19 mmol, 97 % 
Melting point 
 
96 °C (Lit.: 96–97 °C)[122] 
FT-IR (CsI disc) ν [cm–1] = 3384 [m, ν(N–H)], 2984 [w, ν(alkyl–C–H)], 
1749 [s, ν(C=O from ester)], 1684 [s, ν(C=O from amide)], 1395 
[m, δas(C–H from t-Bu)], 1369 [m, δs(C–H from t-Bu)], 1288 [m, ν(C–
O)], 1255 [m, ν(C–O)], 1170 [s, ν(C–O)], 1057 [m, ν(C–O)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.43 (s, 18H, t-Bu), 3.15 (m, 2H, Ha or Hb), 
3.22 (m, 2H, Ha or Hb), 3.75 (s, 6H, O–CH3), 4.59 (m, 2H, Hc), 6.34 
(s, 2H, NH). 
 
13C-NMR (75 MHz, CDCl3) δ = 28.2 (q, CH3 / t-Bu), 41.1 (t, S–CH2), 52.6 (q, 
O–CH3), 59.0 (d, CH), 80.4 (s, Cq / t-Bu), 155.1 (s, NH–CO–O), 
173.4 (s, CO–O). 
 
TLC 
 
Rf = 0.34 (silica gel, dichloromethane). 
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8.3.6 Lithiation of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene, 48 
and reaction with the electrophile N,N’-bis-tert-butyloxycarbonyl-L-
cystine-O,O’-bis-methyl ester, 49[102] 
I-MAG-20 
 
Boc-HN CO2Me
S S
MeO2C NH-Boc
49 
 
1) n-BuLi, THF, –78 °C 
 t-Bu
t-Bu
OMOM
Br
 2) 49, RT 
S
OMOM
t-But-Bu
CO2MeNH
Boc
 
48  47 
 
Under argon, a dry 25 mL three-necked flask was charged with a solution of 88 mg 
(267 µmol, 1.00 eq) of 1,5-di-tert-butyl-3-bromo-2-(methoxymethoxy)benzene 48 in 
5 mL of dry THF. The solution was cooled down to –78 °C, 0.30 mL (320 µmol, 
1.20 eq) of a 1.20 M n-butyllithium solution in n-hexane was added and the reaction 
mixture was stirred at –78 °C for one hour. 250 mg (535 µmol, 2.00 eq) of N,N’-bis-
tert-butyloxycarbonyl-L-cystine-O,O’-bis-methyl ester 49 were added, the reaction 
mixture was allowed to warm up to room temperature and stirred for an additional 
period of 12 hours. Then 5 mL of water were added to the reaction mixture.The 
product was extracted with ethyl acetate, washed with water and dried over 
magnesium sulphate. After evaporation of the solvent under reduced pressure, the 
product was purified by chromatography (silica gel, n-hexane : dichloromethane = 
2 : 1). The expected product 47 was not formed. Instead, 63 mg (252 µmol, 94 %) of 
the product 71 were isolated as a white solid. 
 
EXPERIMENTAL PART 
 - 149 -
O O
CH3
H3C
H3C
CH3
H3C
H3C
CH3
Ha
Hb
Hc
12
3
4
5
6
71 
 
C16H26O2 
 
250.38 g·mol-1 
 
Yield 
 
63 mg, 252 µmol, 94 % 
Melting point 
 
47 °C 
FT-IR (CsI disc) ν [cm–1] = 3005 [w, ν(aryl–H)], 2961 [s, ν(alkyl–C–H)], 
1605 [m, ν(C=C)], 1399 [m, δas(C–H from t-Bu)], 1360 [m, δs(C–H 
from t-Bu)], 1232 [s, ν(C–O)], 1148 [s, ν(C–O)], 1074 [s, ν(C–O)], 
1005 [s, ν(C–O)], 929 [m, δoop(aryl–H)], 889 [m, δoop(aryl–H)], 820 
[m, δoop(aryl–H)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.30 (s, 9H, t-Bu), 1.40 (s, 9H, t-Bu), 3.49 (s, 
3H, O–CH3), 5.20 (s, 2H, O–CH2–O), 7.02 (d, 3JHb,Hc = 8.56, 1H, 
Hc), 7.15 (dd, 4JHa,Hb = 2.42, 3JHb,Hc = 8.56, 1H, Hb), 7.32 (d, 4JHa,Hb 
= 2.42, 1H, Ha). 
 
13C-NMR (75 MHz, CDCl3) δ = 29.9 (q, CH3 / t-Bu), 31.6 (q, CH3 / t-Bu), 34.3 
(s, Cq / t-Bu), 35.1 (s, Cq / t-Bu), 56.0 (q, O–CH3), 94.1 (t, O–CH2–
O), 113.6 (d, aryl–C6), 123.5 (d, aryl–C3 or C5), 123.9 (d, aryl–C3 or 
C5), 137.4 (s, aryl–C2), 143.5 (s, aryl–C4), 153.9 (s, aryl–C1). 
 
TLC Rf = 0.63 (silica gel, n-hexane : dichloromethane = 1 : 2). 
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8.3.7 Synthesis of 2,4-di-tert-butyl-6-mercaptophenol, 64[89, 97] 
I-MAG-55 
 
S2Cl2, TiCl4 t-Bu
t-Bu
OH
 toluene 
t-Bu
t-Bu
OH
S
S
S
t-Bu
t-Bu
OH
 
51  74 
 Zn, HCl
 
toluene, EtOH 
t-Bu
t-Bu
OH
SH
 
 
64 
 
Under argon, a dry 500 mL three-necked flask was charged with a solution of 40.0 g 
(194 mmol, 1.00 eq) of 2,4-di-tert-butylphenol 51 in 200 mL of anhydrous toluene. 
The solution was cooled to 0 °C and 216 µL (1.94 mmol, 0.01 eq) of titanium(IV) 
chloride were added with a syringe. The temperature was raised up to +5 °C and 
7.80 mL (97.0 mmol, 0.50 eq) of sulphur monochloride were dropped in. Once the 
reaction started, the temperature was lowered to –5 °C and the rest of sulphur 
monochloride was added. The solution was stirred at room temperature under argon 
for 12 hours. The reaction mixture was hydrolysed by adding 100 mL of a 5 N 
hydrochloric acid solution. The phases were separated and the organic phase was 
washed, first with a saturated solution of sodium bicarbonate, then with water. The 
organic layer was dried over sodium sulphate and the solvent was evaporated under 
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reduced pressure. The trisulfide 74 was obtained as an orange oil, which was used in 
the next reaction without further purification. 
In a 1 L three-necked flask equipped with a condenser, the previously obtained 
product 74 was dissolved in 200 mL of toluene and 100 mL of ethanol. 300 mL of a 
3 N hydrochloric acid solution were added. 32.0 g (485 mmol, 5.00 eq) of zinc were 
added in little portions to the biphasic mixture. An exothermic reaction was observed. 
The reaction mixture was stirred at room temperature for 12 hours. The crude 
product was extracted with toluene, washed with water, dried over sodium sulphate, 
and the solvent was evaporated under reduced pressure. The product was 
crystallised from 200 mL of acetonitrile and the yellow solid obtained was purified by 
kugelrohr distillation (2·10–1 mbar, 120 °C) to give 19.4 g (81.5 mmol, 42 %) of the 
product 64 as a pale yellow solid. 
 
OH
SH
H3C
H3C
H3C
H3C CH3
CH3
Hb
Ha 12
3
4 5
6
64 
 
C14H22OS 
 
238.39 g·mol–1 
Yield 
 
19.4 g, 81.5 mmol, 42 % (Lit.: 23 %)[97] 
Melting point 
 
68 °C (Lit.: 70–73 °C)[97] 
FT-IR (KBr disc) ν [cm–1] = 3414 [s, νs(O–H)], 2957 [s, νs(C–H)], 2867 [s, 
νas(C–H)], 2501 [m, νs(S–H)], 1722 [w], 1578[w], 1466 [s, δas(C–H)], 
1442 [s, δas(C–H)], 1400 [m], 1361 [s, δs(C–H)], 1279 [s], 1246 [s], 
1180 [s, ν(C–O)], 1099 [m], 924 [m], 875 [m, δoop(aryl–H)], 818 [w], 
750 [w], 720 [w], 645 [w]. 
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1H-NMR (300 MHz, CDCl3) δ = 1.29 (s, 9H, t-Bu), 1.41 (s, 9H, t-Bu), 2.86 (t, 
4Jaryl–H,SH = 1.02, 1H, SH), 6.62 (s, 1H, OH), 7.32 (dd, 4JHa,Hb = 
2.44, 4Jaryl–H,SH = 0.94, 1H, Hb), 7.39 (dd, 4JHa,Hb = 2.44, Jaryl–H,SH = 
1.10, 1H, Ha). 
 
13C-NMR (75 MHz, CDCl3) δ = 29.4 (q, CH3 / t-Bu), 31.5 (q, CH3 / t-Bu), 34.3 
(s, Cq / t-Bu), 35.2 (s, Cq / t-Bu), 110.7 (s, aryl–C6), 125.6 (d, aryl–
C3 or C5), 130.6 (d, aryl–C3 or C5), 135.4 (s, aryl–C2), 142.3 (s, 
aryl–C4), 153.0 (s, aryl–C1). 
 
TLC 
 
Rf = 0.60 (silica gel, n-hexane : dichloromethane = 3 : 1). 
 
8.3.8 Synthesis of 1,1’-bis-[3,5-di-tert-butyl-2-(hydroxy)phenyl]disulfane, 
63[89, 97, 104] 
V-MAG-2 
 
Br2, hydrated silica gel 
 
t-Bu
t-Bu
OH
SH
 CH2Cl2 
t-Bu
t-Bu
OH
S S
HO
t-Bu
t-Bu
64  63 
 
A 1 L round-bottomed flask was charged with 50.0 g of silica gel and 25 mL of water. 
The reaction mixture was stirred until a free flowing powder was obtained. 250 mL of 
dichloromethane were added, followed by a solution of 10.0 g (41.9 mmol, 1.00 eq) 
of 2,4-di-tert-butyl-6-mercaptophenol 64 in 50 mL of dichloromethane. 36.1 mL 
(41.9 mmol, 1.00 eq) of a 1.16 M solution of bromine in dichloromethane was added 
dropwise to the reaction mixture. The characteristic brown colour of the bromine 
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disappeared as soon as the bromine solution came in contact with the reaction 
mixture in the flask. When a faint brown colour persisted, the addition was stopped. 
The silica gel was removed by filtration, the residue was washed with 
dichloromethane and the solvent was evaporated under reduced pressure to give an 
orange oil. The product 63 was crystallised from acetonitrile to give 9.10 g 
(19.2 mmol, 91 %) of a yellow solid. 
 
OH
S S
HO
H3C
H3C
H3C CH3
H3C CH3CH3
CH3
H3C
Ha
Hb
Ha
Hb
CH3
CH3
CH31
23
4
5 6
1'
2' 3'
4'
5'6'
63 
 
C28H42O2S2 
 
474.76 g·mol–1 
Yield 
 
9.10 g, 19.2 mmol, 91 % 
Melting point 
 
109 °C (acetonitrile, Lit.: 111–114 °C)[97] 
FT-IR (CsI disc) ν [cm–1] = 3432 [m, ν(O–H)], 3430 [s, ν(O–H)], 2998 [w, 
ν(aryl–H)], 2960 [s, ν(alkyl–C–H)], 2914 [m, ν(alkyl–C–H)], 2868 [m, 
ν(alkyl–C–H)], 1478 [s, δas(C–H)], 1467 [s, δs(C–H)], 1441 [s], 1399 
[m, δas(C–H from t-Bu)], 1363 [s, δs(C–H from t-Bu)], 1337 [m], 
1282 [m], 1245 [s], 1204 [m], 1177 [s, ν(C–O)], 1137 [w], 1102 [m], 
879 [w, δoop(aryl–H)], 756 [w, δoop(aryl–H)]. 
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1H-NMR (300 MHz, CDCl3) δ = 1.22 (s, 18H, t-Bu), 1.37 (s, 18H, t-Bu), 6.57 
(s, 2H, OH), 7.19 (d, 4JHa,Hb = 2.43, 2H, Ha), 7.34 (d, 4JHa,Hb = 2.43, 
2H, Hb). 
 
13C-NMR (75 MHz, CDCl3) δ = 29.4 (q, CH3 / t-Bu), 31.5 (q, CH3 / t-Bu), 34.4 
(s, Cq / t-Bu), 35.4 (s, Cq / t-Bu), 119.4 (s, aryl–C1), 128.1 (d, aryl–
C4 or C6), 130.5 (d, aryl–C4 or C6), 135.7 (s, aryl–C3), 142.8 (s, 
aryl–C5), 153.3 (s, aryl–C2). 
 
MS (positive EI, MeOH) m/z (%, formula) = 474 (98, [M]+), 268 (32), 
238 (90, [C14H22OS]+), 223 (95), 207 (24), 181 (64, [C10H13OS]+), 
57 (100, [C4H9]+). 
 
HR-MS 
 
(positive EI) measured 
474.263 
calculated [M]+ 
474.2626 
│∆u│ 
0.005 
 
 C H  
calculated [%] 70.84 8.92  
measured [%] 70.98 9.02  
Elemental 
analysis 
 
 
 
accuracy 0.20 1.12  
TLC 
 
Rf = 0.62 (silica gel, n-hexane : dichloromethane = 6 : 1). 
temperature 293(2) K 
wavelength 0.71073 Å 
crystal system, space group triclinic, P–1 
X-ray 
unit cell dimensions a = 9.9511(10) Å, α = 73.356(6)° 
b = 10.1570(12) Å, β = 83.200(6)° 
c = 14.8759(9) Å, γ = 76.789(5)° 
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volume 1400.2(2) Å3 
Z 2 
calculated density 1.126 g/cm3 
absorption coefficient 0.211 mm–1 
F(000) 516 
crystal size 0.2 x 0.2 x 0.3 mm 
Θ range 1.43° until 27.42° 
limiting indices –12 < h < 7 
–13 < k < 12 
–19 < l < 14 
reflections collected / unique 7846 / 6003 [R(int) = 0.0325] 
reflection observed [I>2σ(I)] 3780 
refinement method full-matrix least squares on F2 
data / restraints / parameters 6003 / 6 / 451 
goodness-of-fit on F2 0.983 
R indices [I>2σ(I)] R1 = 0.0526, wR2 = 0.1286 
R indices (all data) R1 = 0.0982, wR2 = 0.1497 
 
largest diff. peak and hole 
 
0.324 and –0.446 eÅ–3 
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8.3.9 Synthesis of 1,1’-bis-[3,5-di-tert-butyl-2-(allyloxy)phenyl]disulfane, 
62[105] 
II-MAG-61 
 
1) NaH, DMF 
 
t-Bu
t-Bu
OH
S S
HO
t-Bu
t-Bu
 
2) allylchloride 
t-Bu
t-Bu
O
S
S
O
t-Bu
t-Bu
CH2
H2C
 
63  62 
 
Under argon, a dry 100 mL three-necked flask equipped with a condenser was 
charged with a solution of 1.00 g (2.11 mmol, 1.00 eq) of 1,1’-bis(3,5-di-tert-butyl-
2-(hydroxy)phenyl)disulfane 63 in 25 mL of absolute DMF. To this solution 510 mg 
(21.1 mmol, 10.0 eq) of sodium hydride were added. The solution turned red rapidly. 
It was stirred at room temperature for an hour. Then 0.70 mL (8.44 mmol, 4.00 eq) of 
allylchloride was added and the reaction mixture was stirred for an additional period 
of 12 hours at room temperature. The reaction mixture was hydrolysed by adding 
20 mL of water, the product was extracted with dichloromethane, washed with water, 
dried over magnesium sulphate and the solvent was evaporated under reduced 
pressure. The product was crystallised from acetonitrile to give 770 mg (1.39 mmol, 
66 %) of 62 as a white solid. 
 
O
S
S
O
H3C
H3C
CH3
CH3
CH3
H3C
H3C
H3C CH3
CH3
CH3
H3C
CH2
H2C
Hb
Ha
Hb
Ha
1
23
4
5 6 1'
2' 3'
4'
5'6'
62 
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C34H50O2S2 
 
554.89 g·mol–1 
Yield 
 
770 mg, 1.39 mmol, 66 % 
Melting point 
 
112 °C (acetonitrile) 
FT-IR 
 
(CsI disc) ν [cm–1] = 2962 [s, ν(aryl–H)], 2921 [m, ν(alkyl–C–H)], 
2869 [m, ν(alkyl–C–H)], 1619 [w, ν(C=C)], 1590 [w, ν(C=C)], 1566 
[w, ν(C=C)], 1471 [s, δas(C–H)], 1436 [s, δs(C–H)], 1398 [m, δas(C–
H from t-Bu)], 1362 [s, δs(C–H from t-Bu)], 1283 [m], 1228 [s], 1102 
[m, ν(C–O)], 980 [s, δoop(C=CH2)], 931 [m, δoop(C=CH2)], 880 [w, 
δoop(aryl–H)], 823 [w, δoop(aryl–H)], 763 [w, δoop(aryl–H)], 648 [w, 
δoop(aryl–H)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.22 (s, 18H, t-Bu), 1.41 (s, 18H, t-Bu), 
4.58–4.60 (d, 3J = 5.14, 4H, O–CH2), 5.29–5.33 (dd, 3J = 10.5, 2J = 
1.49, 2H, =CH2-trans), 5.48–5.54 (dd, 3J = 17.2, 2J = 1.68, 2H, =CH2-
cys), 6.09–6.23 (m, 2H, HC=), 7.20 (d, 4JHa,Hb = 2.38, 2H, Ha), 7.48 
(d, 4JHa,Hb = 2.38, 2H, Hb). 
 
13C-NMR (75 MHz, CDCl3) δ = 29.0 (q, CH3 / t-Bu), 30.9 (q, CH3 / t-Bu), 34.3 
(s, Cq / t-Bu), 35.1 (s, Cq / t-Bu), 73.9 (t, O–CH2), 116.6 (t, =CH2), 
123.2 (d, aryl–C4 or C6), 124.3 (d, aryl–C4 or C6), 129.7 (s, aryl–C1), 
133.2 (d, HC=), 142.1 (s, aryl–C3), 146.0 (s, aryl–C5), 152.8 (s, 
aryl–C2). 
 
MS (positive EI, MeOH) m/z (%, formula) = 554 (12, [M]+), 277 (100, 
[C17H25OS]+), 57 (78, [C4H9]+). 
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HR-MS 
 
 
(positive EI) measured 
554.325 
calculated [M]+ 
554.3252 
│∆u│ 
0.005 
 C H  
calculated [%] 73.59 9.08  
measured [%] 73.52 9.18  
Elemental 
analysis 
 
accuracy 
 
0.10 1.10  
TLC 
 
Rf = 0.65 (silica gel, c-hexane : dichloromethane = 6 : 1). 
 
8.3.10 Synthesis of 3,5-di-tert-butyl-2-(allyloxy)benzenethiol, 56[106] 
II-MAG-75 
 
NaBH4 
 
t-Bu
t-Bu
O
S
S
O
t-Bu
t-Bu
CH2
H2C
 
isopropanol, reflux t-Bu
t-Bu
O
SH
CH2
 
62  56 
 
H2O 
 
t-Bu
t-Bu
O
SH
CH2
 
 
t-Bu
t-Bu
O
S CH3
 
56  75 
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O2 
 
t-Bu
t-Bu
O
SH
CH2
 
 
t-Bu
t-Bu
O
S
S
O
t-Bu
t-Bu
CH2
H2C
 
56  62 
 
Under argon, a dry 50 mL three-necked flask equipped with a condenser was 
charged with a solution of 100 mg (200 µmol, 1.00 eq) of 1,1’-bis-(3,5-di-tert-butyl-
2-(allyloxy)phenyl)disulfane 62 in 15 mL of anhydrous isopropanol. To this solution 
35.0 mg (800 µmol, 4.00 eq) of sodium borohydride were added and the reaction 
mixture was stirred under reflux of isopropanol for 30 minutes. The solution was 
hydrolysed by adding 10 mL of water, the product was extracted with 
dichloromethane, washed with water, dried over magnesium sulphate and the solvent 
was evaporated under reduced pressure. The product was analysed by NMR directly 
after the purification and product 56 could be identified, but it cyclised rapidly to form 
the product 75. 110 mg (390 µmol, 99 %) of product 75 were obtained as a yellow 
solid. Stored under dioxygen, product 56 dimerises to the disulfide 62. In a similar 
experiment where 56 was stored under air, 95.0 mg (170 µmol, 85 %) of the starting 
material 62 were isolated. 
 
O
SH
CH2
H3C CH3
H3C
H3C
CH3
H3C
Ha
Hb
1
23
4
5 6
56 
 
C17H26OS 
 
278.45 g·mol–1 
Conversion quant. (verified by TLC and NMR) 
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1H-NMR (300 MHz, CDCl3) δ = 1.29 (s, 18H, t-Bu), 1.40 (s, 18H, t-Bu), 3.61 
(s, 1H, SH), 4.55 (d, 3J = 4.68, 2H, O–CH2), 5.32 (dd, 3J = 10.3, 2J 
= 1.00, 1H, =CH2-trans), 5.53 (dd, 3J = 17.0, 2J = 1.32, 1H, =CH2-cys), 
6.07–6.20 (m, 1H, HC=), 7.16 (s, 2H, Ha+Hb). 
 
13C-NMR (75 MHz, CDCl3) δ = 30.9 (s, Cq / t-Bu), 31.0 (q, CH3 / t-Bu), 31.4 
(q, CH3 / t-Bu), 31.5 (s, Cq / t-Bu), 71.6 (t, O–CH2), 116.6 (t, =CH2), 
122.4 (s, aryl–C1), 125.5 (d, HC=), 133.7 (d, aryl–C4 or C6), 134.4 
(d, aryl–C4 or C6), 142.9 (s, aryl–C3), 146.4 (s, aryl–C5), 151.9 (s, 
aryl–C2). 
 
TLC 
 
Rf = 0.68 (silica gel, c-hexane). 
 
O
S CH3H3C
H3C CH3
H3C
H3C
CH3
Hb
Ha
1
23
4
5 6
75 
 
C17H26OS 
 
278.45 g·mol–1 
Yield 
 
110 mg, 390 µmol, 99 % 
Melting point 
 
 
 
109 °C (acetonitrile) 
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FT-IR 
 
(CsI disc) ν [cm–1] = 2961 [s, ν(aryl–H)], 2920 [m, ν(alkyl–C–H)], 
2876 [m, ν(alkyl–C–H)], 1607 [m, ν(C=C)], 1570 [w, ν(C=C)], 1566 
[w, ν(C=C)], 1473 [s, δas(C–H)], 1436 [s, δs(C–H)], 1262 [s, νas(C–
O)], 1224 [m], 1096 [s], 1036 [s, νs(C–O)], 862 [w, δoop(aryl–H)], 
812 [s, δoop(aryl–H)], 800 [s, δoop(aryl–H)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.26–1.36 (d, 3J = 29.1, 3H, CH3), 1.41 (s, 
18H, 2 x t-Bu), 3.45–3.56 (m, 1H, CH), 3.85 (dd, 2J = 11.1, 3J = 
7.86, 1H, CH2), 4.35–4.39 (dd, 2J = 11.1, 3J = 2.97, 1H, CH2), 6.89 
(d, 4JHa,Hb = 2.38, 2H, Hb), 7.02 (d, 4JHa,Hb = 2.38, 2H, Ha). 
 
13C-NMR (75 MHz, CDCl3) δ = 29.9 (q, CH3 / t-Bu), 31.1 (q, CH3), 31.6 (q, 
CH3 / t-Bu), 34.3 (d, CH), 34.5 (s, Cq / t-Bu), 35.2 (s, Cq / t-Bu), 
70.4 (t, O–CH2), 118.5 (s, aryl–C1), 120.4 (d, aryl–C6), 121.7 (d, 
aryl–C4), 138.7 (s, aryl–C3), 143.7 (s, aryl–C5), 148.5 (s, aryl–C2). 
 
MS (positive EI, CH2Cl2) m/z (%, formula) = 278 (50, [M]+), 263 (100, 
[M – CH3]+), 57 (34, [C4H9]+). 
 
HR-MS 
 
 
(positive EI) measured 
278.171 
calculated [M]+ 
278.1704 
│∆u│ 
0.005 
TLC 
 
Rf = 0.47 (silica gel, c-hexane). 
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8.3.11 Synthesis of 1,1’-bis-[3,5-di-tert-butyl-2-(methoxymethoxy)phenyl]-
disulfane, 61[100] 
II-MAG-14 
 
MOMCl, i-Pr2NEt 
 
t-Bu
t-Bu
OH
S S
HO
t-Bu
t-Bu
 
CH2Cl2 
t-Bu
t-Bu
OMOM
S S
MOMO
t-Bu
t-Bu
63  61 
 
In a 250 mL dry three-necked flask under argon, 18.7 g (39.0 mmol, 1.00 eq) of 
1,1’-bis-(3,5-di-tert-butyl-2-(hydroxy)phenyl)disulfane 63 were dissolved in 110 mL of 
dry dichloromethane. To this solution 37.0 mL (213 mmol, 5.40 eq) of 
di-iso-propylethylamine and 28.0 mL (213 mmo l, 5.40 eq) of chloromethyl methyl 
ether were added. The reaction mixture was stirred at room temperature under argon 
for 12 hours. The reaction mixture was hydrolysed by adding 100 mL of water, the 
product was extracted with dichloromethane, washed with water, dried over 
magnesium sulphate and the solvent was evaporated under reduced pressure. 
Finally the product was purified by flash chromatography (silica gel, 
n-hexane : dichloromethane = 1 : 2) to yield 19.0 g (33.8 mmol, 87 %) of product 61 
as a white solid. The product was recrystallised from acetonitrile. 
 
O
S S
O
H3C
H3C
H3C
H3C CH3
H3C
CH3
CH3
CH3
CH3
CH3
CH3OH3C
O CH3
Ha
Hb
Hb
Ha
1
23
4
5 6
1'
2' 3'
4'
5'6'
61 
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C32H50O4S2 
 
562.87 g·mol–1 
Yield 
 
19.0 g, 33.8 mmol, 87 % 
Melting point 
 
41 °C (acetonitrile) 
FT-IR (KBr disc) ν [cm–1] = 2953 [s, ν(aryl–H)], 2871 [m, ν(alkyl–C–H)], 
2856 [m, ν(alkyl–C–H)], 1651 [w, ν(C=C)], 1558 [w, ν(C=C)], 1450 
[m, δas(C–H)], 1434 [s, δs(C–H)], 1396 [m, δas(C–H from t-Bu)], 
1361 [s, δs(C–H from t-Bu)], 1282 [m], 1234 [m], 1200 [s, ν(C–O)], 
1169 [s, ν(C–O)], 1083 [s, ν(C–O)], 929 [s], 907 [s], 881 [w, 
δoop(aryl–H)], 764 [w, δoop(aryl–H)], 648 [w, δoop(aryl–H)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.20 (s, 18H, t-Bu), 1.41 (s, 18H, t-Bu), 3.67 
(s, 6H, O–CH3), 5.09 (s, 4H, O–CH2–O), 7.23 (d, 4JHa,Hb = 2.45, 
2H, Ha), 7.46 (d, 4JHa,Hb = 2.45, 2H, Hb). 
 
13C-NMR (75 MHz, CDCl3) δ = 31.0 (q, CH3 / t-Bu), 31.3 (q, CH3 / t-Bu), 31.3 
(s, Cq / t-Bu), 35.5 (s, Cq / t-Bu), 57.7 (q, O–CH3), 99.8 (t, O–CH2–
O), 124.3 (d, aryl–C4 or C6), 125.8 (d, aryl–C4 or C6), 130.0 (s, 
aryl–C1), 142.8 (s, aryl–C3), 146.7 (s, aryl–C5), 151.6 (s, aryl–C2). 
 
MS 
 
(positive EI, CH2Cl2) m/z (%, formula) = 562 (15, [M]+), 281 (50, 
[C16H25O2S]+), 250 (100, [C16H25O2S – 2 × CH3 – H]+), 235 (45, 
[C16H25O2S – 3 × CH3 – H]+), 193 (40), 57 (18, [C4H9]+). 
 
HR-MS 
 
 
(positive EI) measured 
562.315 
calculated [M]+ 
562.3150 
│∆u│ 
0.005 
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 C H  
calculated [%] 68.28 8.95  
measured [%] 68.26 9.08  
Elemental 
analysis 
 
accuracy 
 
0.03 1.45  
TLC 
 
Rf = 0.66 (silica gel, n-hexane : dichloromethane = 1 : 2). 
 
8.3.12 Synthesis of 3,5-di-tert-butyl-2-(methoxymethoxy)benzenethiol, 55[106] 
II-MAG-16 
 
1) NaBH4, isopropanol, 
reflux 
 
t-Bu
t-Bu
OMOM
S S
MOMO
t-Bu
t-Bu
 
2) H+ / H2O t-Bu
t-Bu
OMOM
SH
 
61  55 
 
Under argon, in a dry 500 mL three-necked flask equipped with a condenser, 19.0 g 
(34.0 mmol, 1.00 eq) of 1,2-bis-(3,5-di-tert-butyl-2-(methoxymethoxy)phenyl)disulfane 
61 were dissolved in 220 mL of dry isopropanol. To this solution 3.80 g (101 mmol, 
3.00 eq) of sodium borohydride were added and the reaction mixture was stirred 
under reflux of isopropanol for one hour. The reaction mixture was cooled down to 
room temperature and the solution was hydrolysed with 100 mL of a 0.05 N 
hydrochloric acid solution. The product was extracted with dichloromethane, dried 
over magnesium sulphate and the solvent was evaporated under reduced pressure. 
The crude product was immediately purified by chromatography (aluminium oxide, 
c-hexane : dichloromethane = 1 : 2) to give 17.0 g (60.0 mmol, 89 %) of product 55 
as a white solid. The purified product 55 was stable in the fridge for several months 
without decomposition. 
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O
SH
O
CH3
H3C CH3
H3C
H3C
H3C
CH3
Ha
Hb
1
23
4
5 6
55 
 
C16H26O2S 
 
282.44 g·mol–1 
Yield 
 
17.0 g, 60.0 mmol, 89 % 
Melting point 
 
32 °C (acetonitrile) 
FT-IR 
 
(CsI disc) ν [cm–1] = 2959 [s, ν(aryl–H)], 2873 [m, ν(alkyl–C–H)], 
2855 [m, ν(alkyl–C–H)], 2569 [w, ν(S–H)], 1590 [w, ν(C=C)], 1559 [w, 
ν(C=C)], 1472 [m, δas(C–H)], 1436 [m, δs(C–H)], 1396 [s, δas(C–H 
from t-Bu)], 1362 [s, δs(C–H from t-Bu)], 1284 [m], 1231 [m], 1199 [s, 
ν(C–O)], 1165 [s, ν(C–O)], 1075 [s, ν(C–O)], 959 [s], 951 [s], 852 [w, 
δoop(aryl–H)], 749 [w, δoop(aryl–H)], 614 [w, δoop(aryl–H)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.27 (s, 9H, t-Bu), 1.40 (s, 9H, t-Bu), 3.67 (s, 
3H, O–CH3), 3.85 (s, 1H, SH), 5.12 (s, 2H, O–CH2–O), 7.15 (s, 2H, 
aryl). 
 
13C-NMR (75 MHz, CDCl3) δ = 31.1 (q, CH3 / t-Bu), 31.3 (q, CH3 / t-Bu), 34.5 
(s, Cq / t-Bu), 35.5 (s, Cq / t-Bu), 57.5 (q, O–CH3), 98.3 (t, O–CH2–O), 
122.3 (d, aryl–C4), 125.4 (s, aryl–C1), 125.7 (d, aryl–C6), 143.2 (s, 
aryl–C3), 146.6 (s, aryl–C5), 149.9 (s, aryl–C2). 
 
  
EXPERIMENTAL PART 
 - 166 -
MS (positive EI, CH2Cl2) m/z (%, formula) = 282 (12, [M]+), 250 (38, [M –
 S]+), 235 (100, [M – S – CH3]+), 57 (18, [C4H9]+).  
 
HR-MS (positive EI) measured 
282.164 
calculated [M]+ 
282.1653 
│∆u│ 
0.005 
 
TLC 
 
Rf = 0.72 (silica gel, n-hexane : dichloromethane = 1 : 2). 
temperature 100(2) K 
wavelength 0.71073 Å 
crystal system, space group monoclinic, C 2/c 
unit cell dimensions a = 38.660(4) Å, α = 90° 
b = 5.8546(4) Å, β = 122.965(2)° 
c = 34.053(4) Å, γ = 90° 
volume 6466.5(11) Å3 
Z 16 
calculated density 1.160 g/cm3 
absorption coefficient 0.197 mm–1 
F(000) 2464 
crystal size 0.2 x 0.3 x 0.3 mm 
Θ range 2.11° until 27.00° 
limiting indices –48 < h < 30 
–7 < k < 5 
–36 < l < 43 
reflections collected / unique 12646 / 6669 [R(int) = 0.0576] 
reflection observed [I>2σ(I)] 3447 
X-ray 
refinement method full-matrix least squares on F2 
EXPERIMENTAL PART 
 - 167 -
data / restraints / parameters 6669 / 0 / 397 
goodness-of-fit on F2 0.934 
R indices [I>2σ(I)] R1 = 0.0559, wR2 = 0.1243 
R indices (all data) R1 = 0.1356, wR2 = 0.1479 
 
largest diff. peak and hole 
 
0.688 and –0.293 eÅ–3 
 
8.3.13 Synthesis of N-(tert-butyloxycarbonyl)-L-serine-β-lactone, 57[89, 95, 107] 
II-MAG-30 
 
PPh3, DEAD 
 
OH
CO2HBoc-HN  THF, MeCN, –50 °C 
Boc-HN
O
O  
59  57 
 
Under argon, a dry 250 mL three-necked flask equipped with a dropping funnel was 
charged with 6.70 g (25.6 mmol, 1.05 eq) of dry triphenylphosphine and a mixture of 
90 mL of dry acetonitrile and 10 mL of dry THF. The solution was cooled down to 
-50 °C, 4.00 mL (25.6 mmol, 1.05 eq) of diethylazodicarboxylate were added and the 
reaction mixture was stirred at –50 °C under argon for one hour. Then a solution of 
5.00 g (24.4 mmol, 1.00 eq) of N-(tert-butyloxycarbonyl)-L-serine 59 in a mixture of 
90 mL of dry acetonitrile and 10 mL of dry THF was added slowly. The reaction 
mixture was stirred at –50 °C for 3 hours, then at room temperature overnight. The 
solvent was evaporated under reduced pressure and the product was purified by 
chromatography (silica gel, c-hexane : ethyl acetate = 6.5 : 3.5) to give 2.50 g 
(13.4 mmol, 55 %) of product 57 as a white solid. 
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N
H
O
O
O
OH3C
H3C
H3C
57 
 
C8H13NO4 
 
187.19 g·mol–1 
Yield 
 
2.50 g, 13.4 mmol, 55 % (Lit.: 72 %)[95] 
Melting point 
 
119 °C (Lit.: 120 °C)[95] 
FT-IR (CsI disc) ν [cm–1] = 3363 [s, ν(N–H)], 2979 [m, ν(alkyl–C–H)], 
1845 [s, ν(O–C=O)], 1682 [s, ν(N–C=O)], 1532 [s, δ(C–H)], 1373 
[s, δ(C–H from t-Bu)], 1292 [s], 1261 [s], 1166 [s, ν(C–O)], 1106 [s, 
ν(C–O)], 1010 [m], 891 [s], 624 [m]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.44 (s, 9H, t-Bu), 4.37–4.44 (m, 2H, CH2), 
5.05–5.09 (m, 1H, CH), 5.27 (s, br, 1H, NH). 
 
13C-NMR (75 MHz, CDCl3) δ = 28.3 (q, CH3 / t-Bu), 59.6 (d, CH), 66.8 (t, 
CH2), 81.6 (s, Cq / t-Bu), 154.6 (s, N–C=O), 169.3 (s, O–C=O). 
 
Specific 
rotation 
 
[α]22589 = –4.3° (CHCl3, c = 1.00) 
[α]22405 = –14.3° (CHCl3, c = 1.00) 
[α]22589 = –9.1° (CH2Cl2, c = 0.93) (Lit.: –10.8 °)[123] 
 
TLC 
 
Rf = 0.38 (silica gel, c-hexane : ethyl acetate = 6.5 : 3.5, visualised 
with phosphomolybdic acid). 
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8.3.14 Synthesis of N-(benzyloxycarbonyl)-L-serine-β-lactone, 58[95] 
IV-MAG-60 
 
PPh3, DIAD 
 
OH
CO2HCbz-HN  THF, –78 °C 
Cbz-HN
O
O  
60  58 
 
Under argon, a dry 250 mL three-necked flask equipped with a dropping funnel was 
charged with 6.70 g (25.5 mmol, 1.05 eq) of dry triphenylphosphine and 100 mL of 
dry THF. The solution was cooled down to –78 °C, 5.10 mL (25.5 mmol, 1.05 eq) of 
di-iso-propylazodicarboxylate were added and the reaction mixture was stirred at 
-78 °C under argon for 30 minutes. A solution of 5.80 g (24.2 mmol, 1.00 eq) of 
N-(benzyloxycarbonyl)-L-serine 60 in 100 mL of dry THF was added slowly. The 
reaction mixture was stirred at –78 °C for 3 hours and at room temperature overnight. 
The solvent was evaporated under reduced pressure and the product was isolated by 
2 successive chromatographic columns (silica gel, c-hexane : ethyl acetate = 11 : 9 
and dichloromethane : ethyl acetate = 18 : 2) to give 2.60 g (11.8 mmol, 49 %) of 
product 58 as a white solid. 
 
N
H
O
O
O
O
58 
 
C11H11NO4 
 
221.21 g·mol–1 
Yield 
 
2.60 g, 11.8 mmol, 49 % (Lit.: 60 %)[95] 
Melting point 129-130 °C (Lit.: 133–134 °C)[95] 
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FT-IR 
 
(CsI disc) ν [cm–1] = 3367 [s, ν(N–H)], 2996 [m, ν(aryl–H)], 2983 [w, 
ν(alkyl–C–H)], 1848 [s, ν(O–C=O)], 1688 [s, ν(N–C=O)], 1606 [s, 
ν(C=C)], 1533 [s, ν(C=C)], 1466 [m, δ(C–H)], 1378 [m, δas(C–H 
from t-Bu)], 1346 [m, δs(C–H from t-Bu)], 1271 [s], 1195 [w], 1110 
[s, ν(C–O)], 1020 [s, ν(C–O)], 885 [s, δoop(aryl–H)], 754 [s, δoop(aryl–
H from benzyl)], 703 [m, δoop(aryl–H from benzyl)]. 
 
1H-NMR 
 
(300 MHz, CDCl3) δ = 4.43–4.45 (m, 2H, CH2–(CH)), 5.14 (m, 3H, 
CH2–Ph + CH–(NH)), 5.56 (s, br, 1H, NH), 7.35 (s, 5H, aryl–H). 
 
13C-NMR 
 
(75 MHz, CDCl3) δ = 59.6 (d, CH–(NH)), 66.3 (t, CH2–Ph), 67.8 (t, 
CH2), 128.3 (d, aryl–CH), 128.5 (d, aryl–CH), 128.6 (d, aryl–CH), 
135.4 (s, aryl–C), 155.2 (s, N–C=O), 168.7 (s, O–C=O). 
 
Specific 
rotation 
 
[α]589 = –4.4° (CHCl3, c = 1.00) 
[α]546 = –5.1° (CHCl3, c = 1.00) 
[α]405 = –14.6° (CHCl3, c = 1.00) 
[α]365 = –21.0° (CHCl3, c = 1.00) 
[α]334 = –28.9° (CHCl3, c = 1.00) 
 
MS (dip/ms) m/z (%, formula) = 221 (10, [M]+), 177 (38), 91 (100, [Ph-
CH2]+). 
 
TLC 
 
Rf = 0.59 (silica gel, dichloromethane : ethyl acetate = 18 : 2, 
visualized with phosphomolybdic acid). 
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8.3.15 Synthesis of N-(tert-butyloxycarbonyl)-S-(3,5-di-tert-butyl-2-methoxy-
methoxyphenyl)-L-cysteine [Boc-L-mod-Cys(MOM)-OH], 47[89, 95] 
II-MAG-33 
 
NaH 
t-Bu
t-Bu
OMOM
SH
 
+ 
Boc-HN
O
O  DMF 
S
OMOM
t-But-Bu
CO2HNH
Boc
 
55  57  47 
 
In a dry 500 mL three-necked flask equipped with a condenser, a dropping funnel 
and under argon, 266 mg (11.1 mmol, 1.05 eq) of sodium hydride were suspended in 
50 mL of absolute DMF. To this suspension, a solution of 3.00 g (10.6 mmol, 
1.00 eq) of 3,5-di-tert-butyl-2-(methoxymethoxy)-benzenethiol 55 in 50 mL of 
absolute DMF was dropped. The solution was stirred at room temperature under 
argon for one hour. A solution of 2.10 g (11.1 mmol, 1.05 eq) of 
N-(tert-butyloxycarbonyl)-L-serine-β-lactone 57 in 125 mL of absolute DMF was 
added and the reaction mixture was stirred at room temperature under argon for 
additional 12 hours. The reaction mixture was neutralised by the addition of 100 mL 
of a 0.05 M hydrochloric solution. The product was extracted with ethyl acetate, 
washed with water and the organic layer was dried over magnesium sulphate. The 
solvent was evaporated under reduced pressure and the product was purified by 
flash chromatography (silica gel, c-hexane : dichloromethane : methanol = 4 : 4 : 1) 
to give 4.20 g (9.00 mmol, 85 %) of 47 as a white solid. The product was 
recrystallised from ethanol. 
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S
O O
CH3
CO2HNH
O
O
H3C
H3C
H3C
H3C
H3C
CH3
CH3
CH3
H3C
Ha
Hb 1 2
3
45
6
47 
 
C24H39NO6S 
 
469.63 g·mol–1 
Yield 
 
4.20 g, 9.00 mmol, 85 % 
Melting point 
 
61–63 °C (ethanol)  
FT-IR 
 
(CsI disc) ν [cm–1] = 2967 [s, ν(aryl–H)], 1718 [s, ν(C=O)], 1662 [s, 
ν(C=O)], 1540 [m, ν(C=C)], 1516 [s, ν(C=C)], 1404 [m, δs(C–H)], 
1164 [s, ν(C–O)]. 
 
1H-NMR (300 MHz, CDCl3) δ = 1.25 (s, 9H, t-Bu), 1.36 (s, 9H, t-Bu), 1.38 (s, 
9H, t-Bu), 3.30 (m, 2H, S–CH2), 3.64 (s, 3H, O–CH3), 4.36 (m, 1H, 
CH), 5.15 (d, 2J = 4.61, 2H, O–CH2–O), 5.21 (d, 2J = 4.61, 2H, O–
CH2–O), 5.87 (s, 1H, NH), 7.25 (d, 4JHa,Hb = 2.43, 1H, Hb), 7.32 (d, 
4JHa,Hb = 2.43, 1H, Ha), 11.3 (s, 1H, CO2H). 
 
13C-NMR (75 MHz, CDCl3) δ = 27.7 (q, CH3 / t-Bu from Boc), 30.5 (q, CH3 / t-
Bu), 30.7 (q, CH3 / t-Bu), 34.1 (s, Cq / t-Bu), 35.0 (s, Cq / t-Bu), 36.3 
(t, S–CH2), 53.9 (d, CH), 57.2 (q, O–CH3), 79.7 (s, Cq / O–t-Bu), 
99.1 (t, O–CH2–O), 124.0 (d, aryl–C6), 127.8 (s, aryl–C1), 128.8 (d, 
aryl–C4), 142.5 (s, aryl–C3), 146.2 (s, aryl–C5), 152.9 (s, aryl–C2), 
155.8 (s, N–CO), 175.8 (s, COOH). 
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MS (negative ESI, MeOH) m/z (%, formula) = 936.89 (10, [dimer]–), 
468.22 (100, [M – H]–), 394.11 (25), 281.25 (10). 
 
TLC 
 
Rf = 0.52 (silica gel, c-hexane : dichloromethane : methanol = 
4 : 4 : 1). 
 
 
8.3.16 Synthesis of N-(benzyloxycarbonyl)-S-(3,5-di-tert-butyl-2-methoxy-
methoxyphenyl)-L-cysteine [Cbz-L-mod-Cys(MOM)-OH], 53[108]  
IV-MAG-88 
 
Cs2CO3 
 
t-Bu
t-Bu
OMOM
SH
 
+ 
Cbz-HN
O
O  DMF 
S
OMOM
t-But-Bu
CO2HNH
Cbz
 
55  60  53 
 
Under argon, a dry 100 mL three-necked flask equipped with a condenser and a 
dropping funnel was charged with a solution of 652 mg (2.00 mmol, 1.00 eq) of 
caesium carbonate in 25 mL of absolute DMF. 564 mg (2.00 mmol, 1.00 eq) of 
3,5-di-tert-butyl-2-(methoxymethoxy)-benzenethiol 55 were added and the solution 
was stirred at room temperature under argon for one hour. 450 mg (2.00 mmol, 
1.00 eq) of N-(benzyloxycarbonyl)-L-serine-β-lactone 60 were added and the reaction 
mixture was stirred under argon at room temperature for additional 12 hours. The 
reaction mixture was neutralised by the addition of 10 mL of a 0.05 M hydrochloric 
solution. The product was extracted with ethyl acetate, washed with water and the 
organic layer was dried over magnesium sulphate. The solvent was evaporated 
under reduced pressure and the product was purified by flash chromatography (silica 
gel, c-hexane : dichloromethane : methanol = 4 : 4 : 1) to give 950 mg (1.88 mmol, 
94 %) of 53 as a white solid. The product was recrystallised from ethanol. 
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S
O O
CH3
CO2HNH
O
O
H3C
H3C
H3C
CH3
CH3
CH3
Ha
Hb 1 2
3
45
6
53 
 
C27H37NO6S 
 
503.65 g·mol–1 
Yield 
 
950 mg, 1.88 mmol, 94 % 
Melting point 
 
74 °C (ethanol) 
FT-IR 
 
(CsI disc) ν [cm–1] = 2925 [s, ν(aryl–H)], 1738 [s, ν(C=O)], 1667 [s, 
ν(C=O)], 1646 [s, ν(C=C)], 1616 [s, ν(C=C)], 1558 [s, ν(C=C)], 
1538 [s, ν(C=C)], 1506 [s, ν(C=C)], 1456 [s, ν(C=C)], 1362 [m, 
δs(C–H)], 1162 [s, ν(C–O)], 1082 [s, ν(C–O)], 950 [w, δoop(aryl–H)], 
857 [w, δoop(aryl–H)]. 
 
1H-NMR 
 
(300 MHz, CDCl3) δ = 1.25 (s, 9H, t-Bu), 1.37 (s, 9H, t-Bu), 3.11 
(dd, 2J = 13.07, 3J = 9.01, 1H, S–CH2), 3.44 (dd, 2J = 13.15, 3J = 
3.50, 1H, S–CH2), 3.53 (s, 3H, O–CH3), 4.06 (td, 2J = 8.24, 3J = 
3.60, 1H, CH), 5.00 (s, 2H, CH2–Ph), 5.05 (d, 2J = 4.58, 1H, O–
CH2–O), 5.15 (d, 2J = 4.58, 1H, O–CH2–O), 6.46 (s, 1H, NH), 7.17 
(d, 4JHa,Hb = 2.07, 1H, Hb), 7.23 (s, 1H, CH arom. from benzyl), 7.27 
(d, 4JHa,Hb = 2.44, 1H, Ha), 7.31 (s, 1H, CH arom. from benzyl), 7.33 
(s, 3H, CH arom. from benzyl), 11.2 (s, 1H, CO2H). 
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13C-NMR 
 
(75 MHz, CDCl3) δ = 26.3 (s, Cq / t-Bu), 30.7 (q, CH3 / t-Bu), 31.1 
(q, CH3 / t-Bu), 34.3 (s, Cq / t-Bu), 35.0 (t, S–CH2), 54.3 (d, CH), 
56.9 (q, O–CH3), 65.2 (t, CH2–Ph), 98.2 (t, O–CH2–O), 121.9 (d, 
aryl–C6), 124.8 (d, aryl–C4), 127.6 (d, ortho–PhCH2), 127.7 (d, 
para–PhCH2), 128.2 (d, meta–PhCH2), 129.5 (s, aryl–C1), 137.0 (s, 
aryl–C3), 141.9 (s, aryl–PhCH2), 145.8 (s, aryl–C5), 151.1 (s, aryl–
C2), 155.7 (s, N–CO), 173.1 (s, COOH). 
 
Specific 
rotation 
 
[α]589 = –36.0° (CHCl3, c = 1.00) 
[α]546 = –43.1° (CHCl3, c = 1.00) 
[α]405 = –92.0° (CHCl3, c = 1.00) 
[α]365 = –123.6° (CHCl3, c = 1.00) 
[α]334 = –163.3° (CHCl3, c = 1.00) 
 
MS (negative ESI, MeOH) m/z (%, formula) = 1004.69 (50, [dimer]–), 
722.90 (20), 502.12 (100, [M – H]–), 458.11 (35), 394.17 (10). 
 
TLC 
 
Rf = 0.38 (c-hexane : dichloromethane : methanol = 4 : 4 : 1). 
 
8.3.17 Attempted deprotection of the Boc protecting group of 
Boc-L-mod-Cys(MOM)-OH, 47 
II-MAG-49 
 
TFA 
 
S
OMOM
t-But-Bu
CO2MeNH
Boc
 
abs. CH2Cl2 
S
OMOM
t-But-Bu
CO2HH2N  
47  76 
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A 5 mL Schlenk tube was charged with 50 mg (106 µmol, 1.00 eq) of the N-Boc 
protected Boc-L-mod-Cys(MOM)-OH 47, 55.1 µl (742 µmol, 7.00 eq) of TFA and 
1 mL of dry dichloromethane. The reaction mixture was stirred at room temperature 
for 20 minutes. 1 mL of a 0.10 M aqueous sodium hydroxide solution was added to 
the reaction mixture. The product was extracted with dichloromethane, dried over 
magnesium sulphate and the solvent was evaporated under reduced pressure. 
31.0 mg (95.2 µmol, 90 %) of product 42 were isolated as a white solid. 
 
S
OH
CO2HH2N
H3C
H3C
H3C
CH3
CH3
CH3
Ha
Hb 1 2
3
45
6
42 
 
C27H37NO6S 
 
325.47 g·mol–1 
Yield 
 
31.0 mg, 95.2 µmol, 90 % 
1H-NMR 
 
(300 MHz, d6-DMSO) δ = 1.24 (s, 9H, t-Bu), 1.35 (s, 9H, t-Bu), 
3.18–3.21 (m, 2H, S–CH2), 3.86–3.90 (m, 1H, CH), 7.21 (d, 4JHa,Hb 
= 2.35, 1H, aryl–H), 7.38 (d, 4JHa,Hb = 2.35, 1H, aryl–H). 
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8.3.18 Attempted deprotection of the Cbz protecting group of 
Cbz-L-mod-Cys(MOM)-OH, 53 
IV-MAG-89 
 
H2, Pd/C 
 
S
OMOM
t-But-Bu
CO2HNH
Cbz
 
MeOH 
S
OMOM
t-But-Bu
CO2HH2N  
53  76 
 
Under argon, a 5 mL two-necked flask was charged with 50 mg (99.3 µmol, 1.00 eq) 
of the N-Cbz protected Cbz-L-mod-Cys(MOM)-OH 53, 10 mg (3.38 µmol, 34.0 meq) 
of palladium catalyst (10 % Pd on charcoal) and 1 mL of dry methanol. The reaction 
flask was evacuated and filled with dihydrogen (40 bar). The reaction mixture was 
stirred at room temperature for 3 days. The catalyst was removed by filtration and the 
solvent was evaporated under reduced pressure. 48.0 mg (95.3 µmol, 96 %) of the 
starting material 53 were re-isolated. 
 
S
O O
CH3
CO2HNH
O
O
H3C
H3C
H3C
CH3
CH3
CH3
Ha
Hb 1 2
3
45
6
53 
 
C27H37NO6S 
 
503.65 g·mol–1 
Yield 
 
48.0 mg, 95.3 µmol, 96 % 
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1H-NMR 
 
(300 MHz, CDCl3) δ = 1.25 (s, 9H, t-Bu), 1.37 (s, 9H, t-Bu), 3.11 
(dd, 2J = 13.07, 3J = 9.01, 1H, S–CH2), 3.44 (dd, 2J = 13.15, 3J = 
3.50, 1H, S–CH2), 3.53 (s, 3H, O–CH3), 4.06 (td, 2J = 8.24, 3J = 
3.60, 1H, CH), 5.00 (s, 2H, CH2–Ph), 5.05 (d, 2J = 4.58, 1H, O–
CH2–O), 5.15 (d, 2J = 4.58, 1H, O–CH2–O), 6.46 (s, 1H, NH), 7.17 
(d, 4JHa,Hb = 2.07, 1H, Hb), 7.23 (s, 1H, CH arom. from benzyl), 7.27 
(d, 4JHa,Hb = 2.44, 1H, Ha), 7.31 (s, 1H, CH arom. from benzyl), 7.33 
(s, 3H, CH arom. from benzyl), 11.2 (s, 1H, CO2H). 
 
TLC 
 
Rf = 0.38 (c-hexane : dichloromethane : methanol = 4 : 4 : 1). 
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8.4 Synthesis of two mod-Cys-containing decapeptides on amino 
TentaGel resin 
8.4.1 Synthesis of the two decapeptides 78 and 79 
II-MAG-45 
 
NH2PEG NH2amino TentaGel:  
77 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
X1 = mod-Cys 
X2 = Tyr(t-Bu) 
X3 = His(Trt) 
X4 = His(Trt) 
X1 = mod-Cys 
X2 = His(Trt) 
X3 = His(Trt) 
X4 = Tyr(t-Bu) 
 78 79 
 
1) swell in DMF 
2) 2.50 eq Fmoc-AA-OH, 2.50 eq PyBOP, 3 % NMM in 
DMF 
3) test for free amino functions 
4) 20 % piperidine in DMF or 10 % TFA in CH2Cl2 
 
 
 
 
 
NH2  
77 
5) repetition of the steps 2) to 4) with the N-protected amino 
acids Fmoc-L-Phe-OH, Fmoc-Gly-OH, Boc-L-mod-
Cys(MOM)-OH 47, Fmoc-L-His(Trt)-OH, Fmoc-L-Tyr(t-
Bu)-OH or Fmoc-D-Pro-OH according to the given 
decapeptide sequence 
 
78 or 79 
 
A 100 mL Merrifield flask was charged with 200 mg (theoretical loading = 
0.25 mmol/g) of amino TentaGel resin 77 and 20 mL of absolute DMF. The resin was 
allowed to swell by gentle shaking at room temperature for 1 hour. The solvent was 
filtered and the peptide was synthesised by repetition of the following steps: 
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1) Coupling: Fmoc-protected amino acids and Boc-protected amino acids were used 
for the synthesis. The coupling steps followed the same scheme for all amino acids, 
i.e. coupling in 20 mL of a 3 % NMM solution in DMF with 2.50 eq of the N-protected 
amino acid (Fmoc-L-Phe-OH, Fmoc-Gly-OH, Boc-L-mod-Cys(MOM)-OH 47, Fmoc-L-
His(Trt)-OH, Fmoc-L-Tyr(t-Bu)-OH or Fmoc-D-Pro-OH) and 65.0 mg (125 µmol, 
2.50 eq) of the coupling agent PyBOP. 
 
2) Test for free amino functions: An NF31 test was performed after each step in 
order to check the completion of the reaction. In case of a positive test, the coupling 
step was repeated. In case of a negative test the protecting group was cleaved. 
 
3) Cleavage of the protecting groups: The Fmoc protecting groups were cleaved 
with 20 mL of a 20 % solution of piperidine in DMF. The Boc protecting groups were 
cleaved with 20 mL of a 10 % solution of trifluoroacetic acid in dichloromethane. In 
case of Fmoc-protected amino acids, the coupling step could be quantified with the 
help of the calibration curve (Figure  8-1). In case of Boc-protected amino acids, the 
coupling step could not be quantified, so a NF31 test was performed after the 
cleavage in order to check that the deprotection was total. Before execution of the 
NF31 test, the resin was washed 3 times with a solution of DMF containing 3 % of 
NMM in order to neutralise the excess in trifluoroacetic acid. 
 
Table  8-3 summarises the amount of amino acids used, as well as the yields for 
each coupling step. 
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Table  8-3: Quantity of amino acid used and yields for the coupling steps in the 
synthesis of peptide 78 and peptide 79. 
peptide 78 peptide 79 
amino acida) loading  yield  amino acida) loading  yieldc) 
 [mg] [mmol/g] [%]  [mg] [mmol/g] [%] 
Phe 48.0 0.18 100 Phe 48.0 0.18 100 
Gly 37.0 0.17 94 Gly 37.0 0.17 94 
mod-Cys 59.0 n.d. n.d. mod-Cys 59.0 n.d. n.d. 
Tyrb) 57.0 0.11 61 Hisb) 77.0 0.18 100 
Gly 37.0 0.14 78 Gly 37.0 0.16 89 
D-Pro 42.0 0.16 89 D-Pro 42.0 0.17 94 
Glyb) 37.0 0.12 94 Glyb) 37.0 0.20 111 
His 77.0 0.12 94 His 77.0 0.17 94 
Gly 37.0 0.09 50 Gly 37.0 0.12 67 
His 77.0 0.08 44 Tyr 57.0 0.11 61 
a) All amino acids are in the L-configuration, except for proline which has the D-configuration. 
b) The coupling step was repeated. 
c) The values are relative to the first value which was fixed to 100 %. 
 
 
 
 
 
 
 
 
 
 
 
EXPERIMENTAL PART 
 - 182 -
8.4.2 Acetylation of the N-terminus of the decapeptides 
II-MAG-53 
 
78 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
79 
X1 = mod-Cys 
X2 = Tyr(t-Bu) 
X3 = His(Trt) 
X4 = His(Trt) 
1) Ac2O, 3 % NMM in 
DMF 
2) test for free amino 
functions 
X1 = mod-Cys 
X2 = His(Trt) 
X3 = His(Trt) 
X4 = Tyr(t-Bu) 
80 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
O
H3C 81 
 
20 mL of a 3 % NMM solution in absolute DMF were added to the resin (200 mg, 
50.0 µmol, 1.00 eq). 12.0 µL (125 µmol, 2.50 eq) of acetic anhydride were added to 
the suspension and the reaction mixture was shaken at room temperature under 
argon for 12 hours. The reaction mixture was filtered and the resin washed 3 times 
with DMF. A NF31 test was carried out on a few beads of 80 and 81 in order to check 
the completion of the reaction. The colour test was negative, indicating that the 
reaction had been successful. By comparison, the test performed on the starting 
material 78 and 79 was positive. 
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8.4.3 Cleavage of the side chain protecting groups 
II-MAG-54 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
X1 = mod-Cys 
X2 = Tyr(t-Bu) 
X3 = His(Trt) 
X4 = His(Trt) 
X1 = mod-Cys 
X2 = His(Trt) 
X3 = His(Trt) 
X4 = Tyr(t-Bu) 
 80 81 
 
90 % TFA, 5 % H2O, 5 % TES 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
 82 83 
 
The resin was washed 3 times with dichloromethane, then 3 times with methanol in 
order to remove the DMF. The peptides were shaken in 20 mL of a mixture of 90 % 
TFA, 5 % water and 5 % triethylsilane at room temperature for 5 hours. The 
procedure was repeated to ensure total deprotection of the side chains. The yellow 
solution was filtered and the resin was washed successively with dichloromethane, 
methanol and water. 
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8.4.4 Formation of the peptide–copper(II) complexes 
II-MAG-55 
 
82 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
83 
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
Cu(OAc)2, acetate 
buffer, MeOH 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
84 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu II 85 
 
200 mg (50.0 µmol, 1.00 eq) of the solid-supported peptide-ligands were washed 
twice with methanol. Then 20 mL of methanol, 9.10 mg (50.0 µmol, 1.00 eq) of 
copper(II) acetate, 115 µL of acetic acid and 164 mg of sodium acetate (100 mM 
acetate buffer) were added to the resin. The reaction mixture was shaken at room 
temperature under argon for 5 hours and the resin was washed 3 times with 
methanol. The colour of the beads before and after complexation was compared. 
While the peptide–ligands had a pale yellow colour, the complexes had a green–blue 
colour. 
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8.5 Oxidation of 3-methoxybenzyl alcohol 39 catalysed by the mod-
Cys containing peptide–copper(II) complexes 84 and 85 
8.5.1 Catalysis with solvent 
II-MAG-58 
peptide–copper(II) complex 84 or 85, 
KOH, O2 
 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
A 10 mL round-bottomed flask was charged with 4.50 µL (36.0 µmol, 7.00 mM, 
1.00 eq) of 3-methoxybenzyl alcohol 39, 1.00 mg (0.18 µmol, 0.50 mol%) of peptide–
copper(II) complex 84 or 85, 0.10 mg (1.80 µmol, 5.00 mol%) of potassium hydroxide 
and 5 mL of a mixture of acetonitrile and water (1:1). Under an atmosphere of 
dioxygen, the reaction mixture was shaken at room temperature for 24 hours. The 
reaction was followed by measuring the UV absorbance at λ = 310 nm of 250 µL 
samples. The results are summarised in Table  8-4. 
 
Table  8-4: 3-methoxybenzaldehyde 40 formed after 24 hours by catalytic aerobic 
oxidation of 3-methoxybenzyl alcohol 39 with peptide–copper(II) complexes 
84 and 85. 
peptide–copper(II) complex  KOH 3-methoxybenzaldehyde  yield  TON
 [mol%]  [mol%] [µmol]  [%]   
- -  - 0.14  0.39  <1 
- -  5.00 0.36  1.01  2.0 
84 0.50  - 0.15  0.41  <1 
85 0.50  - 0.13  0.36  <1 
84 0.50  5.00 0.30  0.83  1.7 
85 0.50  5.00 0.38  1.06  2.1 
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8.5.2 Catalysis without solvent 
II-MAG-68 
 
peptide–copper(II) complex 84, 85 or 86, 
base, O2 
 
OH
OMe  r.t. 
H O
OMe  
39  40 
 
20.0 µL (161 µmol, 1.00 eq) of 3-methoxybenzyl alcohol 39 were mixed with 1.00 mg 
(0.18 µmol, 0.10 mol%) of peptide–copper(II) complex 84 or 85, as well as 2.00 mg 
(35.7 µmol, 20.0 mol%) of potassium hydroxide or 5.00 µL (35.6 µmol, 20.0 mol%) of 
triethylamine. Under an atmosphere of dioxygen, the reaction mixture was shaken at 
room temperature for 24 hours. To check the progress of the reaction, aliquots were 
taken with a pipette, filtered and diluted in dichloromethane for GC analysis (GC 
program 1). 
For comparison, 20.0 µL (161 µmol, 1.00 eq) of 3-methoxybenzyl alcohol 39 were 
mixed with 1.00 mg (0.18 µmol, 0.10 mol%) of acetylated amino TentaGel 86, 33 µg 
(0.18 µmol, 0.10 mol%) of copper(II) acetate and 2.00 mg (35.7 µmol, 20.0 mol%) of 
potassium hydroxide. The reaction was performed and followed in the same 
conditions as above. 
 
N
H
CH3
O
acetylated amino TentaGel:
                                         86 
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Table  8-5: Influence of the base on the catalytic aerobic oxidation of neat 
3-methoxybenzyl alcohol 39 with peptide–copper(II) complexes 84 and 85 
after 24 hours. 
catalyst base 3-methoxybenzaldehydea)   yield TON
 [mol%]  [mol%] [µmol]  [%]  
    84 0.10 - - -  - - 
    85 0.10 - - -  - - 
    84 0.10 NEt3 20.0 -  - - 
    85 0.10 NEt3 20.0 -  - - 
     - - KOH 20.0 0.10  0.06 <1 
    86 0.10 KOH 20.0 1.93  1 10 
    84 0.10 KOH 20.0 6.28  4 40 
    85 0.10 KOH 20.0 4.51  3 30 
a) 3-Methoxybenzoic acid was not formed. 
 
8.6 Synthesis of N-(9-fluorenylmethoxycarbonyl)-2,2,6,6-tetramethyl- 
piperidine-1-oxyl-4-amino-4-carboxylic acid (Fmoc-TOAC-OH), 43 
8.6.1 Synthesis of 2,2,6,6-tetramethyl-4-oxo-piperidine-1-oxyl, 88[93] 
III-MAG-32 
 
35 % H2O2 / H2O 
 
N
H
O
H3C CH3
H3C CH3
 
Na2WO4 
N
O
O
H3C CH3
H3C CH3
 
87  88 
 
In a 500 mL round-bottomed flask, a solution of 50.0 g (322 mmol, 1.00 eq) of 
2,2,6,6-tetramethylpiperidin-4-one 87 and 5.50 g (16.7 mmol, 0.05 eq) of sodium 
tungstate dihydrate in 300 mL of water was cooled down to 5 °C. 80 mL of a 35 % 
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aqueous solution of hydrogen peroxide were added with stirring and the suspension 
was stirred vigorously at room temperature for 16 hours. The yellow solution turned 
orange. The solution was saturated with potassium carbonate and the product was 
extracted with diethylether. The organic layer was dried over magnesium sulphate 
and the solvent was evaporated under reduced pressure to give an orange solid that 
was recrystallised from n-hexane. 50.8 g (297 mmol, 93 %) of the desired product 88 
were obtained as orange needles. 
 
N
O
O
H3C CH3
H3C CH3
88 
 
C9H16NO2· 
 
170.23 g·mol–1 
Yield 
 
50.8 g, 298 mmol, 93 % (Lit.: 88 %)[93] 
Melting point 
 
46 °C (Lit.: 36–37 °C) 
FT-IR (CsI disc) ν [cm–1] = 2982 [m, ν(alkyl–C–H)], 1720 [s, ν(C=O)], 1468 
[m, δas(C–H)], 1410 [m, δs(C–H)], 1365 [m, δas(C–H from CH3)], 1325 
[m, δs(C–H from CH3)], 1239 [s]. 
 
MS (CH2Cl2) m/z (formula) = 170 ([M+]), 114 ([M – 4¯CH2]+). 
 
TLC 
 
Rf = 0.28 (silica gel, dichloromethane). 
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temperature 100(2) K 
wavelength 0.71073 Å 
crystal system, space group monoclinic, C 2/c 
unit cell dimensions a = 35.3622(10) Å, α = 90° 
b = 5.95880(10) Å, β = 99.4690(10)° 
c = 27.9559(10) Å, γ = 90° 
volume 5810.5(3) Å3 
Z 24 
calculated density 1.168 g/cm3 
absorption coefficient 0.082 mm–1 
F(000) 2232 
crystal size 0.05 x 0.2 x 0.3 mm 
Θ range 1.48° until 27.00° 
limiting indices –43 < h < 44 
–6 < k < 7 
–35 < l < 35 
reflections collected / unique 11363 / 6308 [R(int) = 0.0646] 
reflection observed [I>2σ(I)] 3780 
refinement method full-matrix least squares on F2 
data / restraints / parameters 6003 / 6 / 451 
goodness-of-fit on F2 0.983 
R indices [I>2σ(I)] R1 = 0.0526, wR2 = 0.1286 
R indices (all data) R1 = 0.0982, wR2 = 0.1497 
X-ray 
largest diff. peak and hole 
 
0.324 and –0.446 eÅ–3 
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8.6.2 Synthesis of 2,2,6,6-tetramethyl-2’,5’-dioxopiperidine-4-spiro-4-imidazo 
lidine-1-oxyl, 89[93, 124] 
III-MAG-32 
 
(NH4)2CO3, NaCN 
 
N
O
O
H3C CH3
H3C CH3
 
EtOH : H2O (3:2) 
60 °C 
N
O
HN O
NH
O
H3C CH3
H3C CH3
 
88  89 
 
In a 250 mL three-necked flask equipped with a reflux condenser, 44.0 g (258 mmol, 
1.00 eq) of 2,2,6,6-tetramethyl-4-oxo-piperidine-1-oxyl 88 and 98.9 g (1.03 mol, 
4.00 eq) of ammonium carbonate were dissolved in 150 mL of a 3:2 mixture of 
ethanol and water. A solution of 25.3 g (516 mmol, 2.00 eq) of sodium cyanide in 
60 mL of water was added with stirring. The reaction mixture was stirred and heated 
to 60°C for 20 hours. The colour of the solution turned from red to orange. The 
product was extracted with ethyl acetate, dried over magnesium sulphate and the 
solvent was evaporated under reduced pressure to give 51.4 g (214 mmol, 83 %) of 
89 as an orange solid. 
 
N
O
HN O
NH
O
H3C CH3
H3C CH3
89 
 
C11H18N3O3· 
 
240.28 g·mol-1 
Yield 51.4 g, 214 mmol, 83 % (Lit.: 95 %)[93] 
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Melting point 
 
255 °C (dec.), (Lit.: 272 °C)[124] 
FT-IR (CsI disc) ν [cm–1] = 3169 [br, ν(N–H)], 1775 [m, ν(C=O)], 1722 [s, 
ν(C=O)], 1414 [m, δ(C–H)], 1366 [m, δ(C–H from CH3)], 1243 [m], 
1037 [m], 768 [w], 670 [w], 455[w]. 
 
MS (CH2Cl2) m/z (formula) = 240 ([M+]), 226 ([C10H16N3O3+]), 210 
([C9H12N3O32+]), 154, 139. 
 
TLC 
 
Rf = 0.43 (silica gel, dichloromethane : methanol = 19 : 1). 
 
8.6.3 Synthesis of 2,2,6,6-tetramethylpiperidine-1-oxyl-4-amino-4-carboxylic 
acid (TOAC), 41[93, 124] 
III-MAG-32 
 
Ba(OH)2 
 
N
O
HN O
NH
O
H3C CH3
H3C CH3
 
H2O, reflux 
N
O
CO2HH2N
H3C CH3
H3C CH3
 
89  41 
 
In a 2 L round-bottomed flask equipped with a reflux condenser, 40.0 g (166 mmol, 
1.00 eq) of 2,2,6,6-tetramethyl-2’,5’-dioxopiperidine-4-spiro-4-imidazolidine-1-oxyl 89 
and 210 g (666 mmol, 4.00 eq) of barium hydroxide octahydrate were dissolved in 
800 mL of water. The reaction mixture was heated to reflux for 48 hours. It was then 
saturated with dry ice and filtered. The filtrate was acidified to pH 6–7 with 
hydrochloric acid and the solvent was evaporated under reduced pressure to give the 
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crude product which was recrystallised from a 80 % aqueous ethanol solution. 31.5 g 
(146 mmol, 88 %) of the product 41 were obtained as a yellow solid. 
 
N
O
CO2HH2N
H3C CH3
H3C CH3
41 
 
C10H19N2O3· 
 
215.27 g·mol–1 
Yield 
 
31.5 g, 146 mmol, 88 % (Lit.: 71 %)[93] 
Melting point 
 
225–230 °C (dec.) (Lit.: 228–230 °C)[124] 
FT-IR (CsI disc) ν [cm–1] = 3151 [m, ν(N–H)], 3046 [m, ν(O–H)], 1620 [s, 
ν(C=O)], 1527 [s], 1463 [m], 1403 [s, δ(C–H from CH3)], 1354 [m, 
δ(C–H from CH3)], 1321 [s, δ(C–H)], 1225 [m, δ(C–H]), 1175 [m], 
1065 [m], 910 [w], 822 [m], 788 [w], 555 [w], 416 [m]. 
 
 
8.6.4 Synthesis of N-(9-fluorenylmethoxycarbonyl)-2,2,6,6-tetramethyl- 
piperidine-1-oxyl-4-amino-4-carboxylic acid (Fmoc-TOAC-OH), 43[116] 
IV-MAG-82 
 
Fmoc-OSu, NaHCO3 
 
N
O
CO2HH2N
H3C CH3
H3C CH3
 
1,4-dioxane, H2O 
N
O
CO2H
H3C CH3
Fmoc-HN
H3C CH3
 
41  43 
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In a 250 mL round-bottomed flask, 5.50 g (25.5 mmol, 1.00 eq) of TOAC 41 and 
2.10 g (25.5 mmol, 1.00 eq) of sodium bicarbonate were suspended in 80 mL of 
water. A solution of 12.9 g (38.3 mmol, 1.50 eq) of N-(9-fluorenylmethoxy-
carbonyloxy)-succinimide (Fmoc-OSu) in 50 mL of 1,4-dioxane was added. The 
reaction mixture was stirred at room temperature in the darkness for 3 days. The pH 
was brought to 8 by the addition of sodium bicarbonate. The 1,4-dioxane was 
evaporated under reduced pressure and the unreacted Fmoc-OSu was extracted 
from the remaining aqueous phase with diethylether. The pH was adjusted to 3 with 
potassium bisulphate and the product was extracted with ethyl acetate. The organic 
layer was washed with a 10 % potassium bisulphate solution, then with water, dried 
over magnesium sulphate and the solvent was evaporated under reduced pressure. 
The product 43 was formed together with the hydroxylamine 90. They could be 
separated by chromatography (silica gel, dichloromethane : methanol = 19 : 1) to 
yield 6.20 g (14.2 mmol, 56 %) of the pure product 43 as a yellow solid which could 
be crystallised from a mixture of ethyl acetate and n-hexane (1:1) to give small yellow 
needles. 
 
N
O
N
H
CO2H
CH3
CH3
H3C
H3C
O
O
43 
 
C25H29N2O5· 
 
437.51 g·mol–1 
Yield 
 
6.20 g, 14.2 mmol, 56 % (Lit.: 62 %)[116] 
Melting point 
 
165 °C (Lit.: 161–163 °C)[116] 
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FT-IR (CsI disc) ν [cm–1] = 3342 [s, ν(N–H)], 2986 [m, ν(alkyl–C–H)], 1724 
[s, ν(C=O)], 1722 [s, ν(C=O)], 1529 [s], 1474 [w, δ(C–H)], 1451 [m, 
δ(C–H)], 1374 [w, δ(C–H)], 1294 [m], 1244 [s, ν(C–O)], 1242 [s, 
ν(C–O)], 1172 [s, ν(C–O)], 1108 [s, ν(C–O)], 1032 [w], 741 [s, 
δoop(aryl–H)], 692 [m, δoop(aryl–H)]. 
 
MS (positive ESI, DMSO / MeOH) m/z (formula) = 439 ([M + 2 × H]+). 
 
HR-MS 
 
(positive ESI) measured 
439.223 
calculated [M + 2 × H]+ 
439.2233 
│∆mu│ 
0.005 
 
TLC 
 
Rf = 0.62 (silica gel, dichloromethane : methanol = 19 : 1). 
X-ray 
 
A X-ray structure was obtained (Figure  5-11). However, the quality 
of the crystals did not allow the computation of the data. 
 
 
N
OH
N
H
CO2H
CH3
CH3
H3C
H3C
O
OHaHb
Hc
Hd Ha
Hb
Hc
Hd
1
2
34
5
6
7
8
9
10
11
12
90 
 
C25H30N2O5 
 
438.52 g·mol–1 
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Yield 
 
3.10 g, 7.10 mmol, 28 % 
FT-IR (CsI disc) ν [cm–1] = 3412 [br, ν(O–H)], 3069 [m, ν(aryl–H)], 2993 
[m, ν(alkyl–C–H)], 1727 [s, ν(C=O)], 1606 [s, ν(C=O)], 1501 [s, 
ν(C=C)], 1451 [s, δas(C–H)], 1387 [s, δs(C–H)], 1251 [s, ν(C–O)], 
1183 [m, ν(C–O)], 1118 [m, ν(C–O)], 1051 [m, ν(C–O)], 744 [m, 
δoop(aryl–H)], 742 [s, δoop(aryl–H)], 741 [s, δoop(aryl–H)], 656 [w, 
δoop(aryl–H)], 622 [m, δoop(aryl–H)], 589 [m, δoop(aryl–H)], 544 [w, 
δoop(aryl–H)]. 
 
1H-NMR (300 MHz, DMSO) δ = 1.05 (s, 6H, CH3), 1.18 (s, 6H, CH3), 1.92 
(m, 2H, CH2), 2.36 (m, 2H, CH2), 4.20–4.24 (m, 3H, CH+CH2 from 
Fmoc), 7.30 (dd, 3JHa,Hb = 7.40, 3jHb,Hc = 6.20, 2H, Hb), 7.40 (dd, 
3JHc,Hd = 7.42 , 3JHb,Hc = 6.91, 2H, Hc), 7.70 (d, 3JHa,Hb = 7.46, 2H, 
Ha), 7.87 (d, 3JHc,Hd = 7.31, 2H, Hd). 
 
13C-NMR (75 MHz, DMSO) δ = 25.2 (q, CH3), 41.6 (t, CH2), 45.9 (d, CH–
Fmoc), 71.8 (t, CH2–Fmoc), 120.2 (d, aryl–C5 + C8), 124.8 (d, aryl–
C2 + C11), 127.2 (d, aryl–C3 + C10), 127.9 (d, aryl–C4 + C9), 140.7 
(s, aryl–C6 + C7), 142.5 (s, aryl–C1 + C12), 151.0 (s, N–CO), 169.6 
(s, COOH). 
 
TLC 
 
Rf = 0.60 (silica gel, dichloromethane : methanol = 19 : 1). 
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8.7 Synthesis of the ligand library of the general scheme Ac-NH-X-
Gly-X-Gly-D-Pro-Gly-X-X-Gly-Phe-CO-NH-TentaGel (TOAC library) 
8.7.1 Synthesis of the tripeptide H2N-TOAC-Gly-Phe-CO2H 92 on Wang resin 
and cleavage from the resin 
V-MAG-5 
 
8.7.1.1 Synthesis of the tripeptide 92 on Wang resin 
 
OHWang resin: CH2O CH2OH
 
91 
 
1) swell in DMF 
2) 5.00 eq Fmoc-L-Phe-OH, 5.00 eq 
DIC, 5.00 eq HOBt, 0.10 eq DMAP
3) test for free amino functions 
4) 20 % piperidine in DMF 
 
OH
 
5) 2.50 eq Fmoc-Gly-OH, 2.50 eq 
PyBOP, 3 % NMM in DMF 
6) repetition of the steps 3) and 4), 
then 5) with Fmoc-TOAC-OH and 
finally 3) and 4) 
O
N
H
OH
N
O
H2N
N
O
O
CH3H3C
CH3H3C
91  92 
 
A 100 mL Merrifield flask was charged with 100 mg (theoretical 
loading = 0.97 mmol/g) of Wang resin and 10 mL of a mixture of dry DCM and 
absolute DMF (8:2). The resin was allowed to swell by gentle shaking at room 
temperature for 1 hour. The Wang resin was loaded with Fmoc-L-Phe-OH according 
to the general procedure ( 8.2.9). The loading of the resin was determined to be 
1.10 mmol/g. The second and third amino acid (Fmoc-Gly-OH and Fmoc-TOAC-OH) 
were coupled according to the standard PyBOP / Fmoc protocol ( 8.2.4 and  8.2.6). 
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NF31 colour tests indicated the completion of each coupling step. The yields for each 
coupling step determined by UV-quantification of the dibenzofulvene–piperidine 
adduct are summarised in Table  8-6. 
 
Table  8-6: Coupling yields for the synthesis of the tripeptide 92 on Wang resin. 
amino acid loading [mmol/g] coupling [%]
Phe a) 1.10 91 
Gly 1.21 100 
TOAC 0.75 68 
   a) L-amino acid 
 
8.7.1.2 Cleavage of the tripeptide 92 from the Wang resin 
 
90 % TFA, 5 % H2O, 
5 % TIS 
O
N
H
OH
N
O
H2N
N
O
O
CH3H3C
CH3H3C
 
 
O
N
H
OH
N
O
H2N
N
O
OH
CH3H3C
CH3H3C
92  93 
 
The resin loaded with the tripeptide 92 was washed 3 times with dichloromethane 
and 3 times with methanol in order to remove the DMF. It was shaken 5 hours in 
10 mL of a mixture of 90 % of TFA, 5 % of water and 5 % of triisopropylsilane. The 
treatment with TFA, water and triisopropylsilane was repeated for another period of 
5 hours. The yellow solution was filtered and the filtrate was concentrated under 
reduced pressure. The product precipitated by addition of diethylether. The product 
was filtered, dissolved in water and lyophilised to give 38 mg (90.6 µmol, 83 %) of a 
white powder. The crude product was analysed by LC–MS. 
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Figure  8-2: Baseline corrected LC–MS diagram of the crude product (column: RP-18, 
mobile phase: MeCN : H2O : AcOH = 90 : 10 : 0.5). 
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8.7.2 Combinatorial synthesis of the 81mer library of decapeptides (TOAC 
library)[40, 41, 125] 
III-MAG-76 
 
NH2PEG NH2amino TentaGel:  
77 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
Xn = His(Trt), Tyr(t-Bu), TOAC
96 
 
1) swell in DMF 
2) 2.50 eq Fmoc-L-Phe-OH, 2.50 eq PyBOP, 3 % NMM in DMF 
3) test for free amino functions 
4) 20 % piperidine in DMF 
NH2   
77 5) repetition of the steps 2) to 4) with the Fmoc-protected amino 
acids, Fmoc-Gly-OH, Fmoc-L-His(Trt)-OH, Fmoc-L-Tyr(t-
Bu)-OH, Fmoc-TOAC-OH 43 or Fmoc-D-Pro-OH, following the 
split-mix methodology 
 
96 
 
81 IRORI MikroKans™ were filled each with 30.0 mg (theoretical 
loading = 0.26 mmol/g) of amino TentaGel 77. Each MikroKan was equipped with a 
radiofrequency IRORI AccuTag™ which was programmed with a code, each code 
corresponding to a specific sequence of amino acids. The code of the AccuTag could 
be read at any time during the synthesis of the peptides. The MicroKans were placed 
in a flask containing 100 mL of absolute DMF, and the resin was allowed to swell by 
gentle shaking of the flask at room temperature under argon for 2 hours. 
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The synthesis of the library was accomplished by repetitions of the 3 following steps: 
coupling, test for free amino functions, cleavage. The split-mix method was followed, 
i.e. after each step the AccuTags were read with the IRORI AccuTag scanning 
station and divided in different flasks in order to couple on each peptide the 
corresponding amino acid. 
 
1) Coupling: A 3 % solution of NMM in absolute DMF, 2.50 eq of PyBOP and 
2.50 eq of the corresponding amino acid were added to the resin. The reaction 
mixture was shaken at room temperature under argon for 12 hours. In case of 
coupling of the amino acids following TOAC 43, as well as for the last amino acids of 
the sequences, the coupling solution was filtered and the coupling was repeated with 
fresh reagents and shaken for an additional period of 6 hours. The solution was then 
filtered and the resin washed 3 times with DMF. 
 
2) Test for free amino functions, NF31 test: A few beads were taken out of one of 
the MikroKans™ and transferred into a vial, 1.00 mL of a 0.01 mM solution of NF31 
in acetonitrile was added and the reaction mixture was warmed to 70 °C for 10 
minutes. The solution was filtered and the beads were washed 3 times with each of 
the following solvents: DMF, methanol and dichloromethane. The test was 
considered negative if the beads were colourless after washing; in this case the 
synthesis was pursued with stage 3). In the case of a positive test (red beads), the 
coupling step was repeated. 
 
3) Cleavage of Fmoc protecting groups: The MikroKans™ were shaken at room 
temperature under argon for 2 hours in a 20 % solution of piperidine in absolute 
DMF. The treatment with piperidine was repeated 2 more times for one hour. The 
solution was filtered and the resin was washed 3 times with absolute DMF. The 
solutions were collected, combined and the UV absorbance at λ = 300 nm was 
measured in order to calculate the yield of the coupling. 
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The quantities of Fmoc protected amino acids and PyBOP used for each step are 
summarised in Table  8-7, together with the yield of each coupling step (Figure  8-3). 
 
Table  8-7: Synthesis of the 81-member peptide library. Quantities of amino acid and 
PyBOP used, yield for each coupling step. 
amino acida)  PyBOP loading yield 
coupling 
 [mg] [mmol]  [mg] [mmol] [mmol/g] [%] 
1 Phe 612 1.58  822 1.58 0.218 100 
2 Gly 470 1.58  822 1.58 0.212 97 
3a His 326 0.53  274 0.53 0.220 101 
3b Tyr 242 0.53  274 0.53 0.219 100 
3c TOAC 230 0.53  274 0.53 0.170 78 
4a His 326 0.53  274 0.53 0.225 103 
4b Tyr 242 0.53  274 0.53 0.220 101 
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amino acida)  PyBOP loading yield 
coupling 
 [mg] [mmol]  [mg] [mmol] [mmol/g] [%] 
4c TOAC 230 0.53  274 0.53 0.116 53 
5 Gly 470 1.58  822 1.58 0.235 108 
6 D-Pro 533 1.58  822 1.58 0.216 99 
7 Gly 470 1.58  822 1.58 0.224 103 
8a His 326 0.53  274 0.53 0.199 91 
8b Tyr 242 0.53  274 0.53 0.190 87 
8c TOAC 230 0.53  274 0.53 0.100 46 
9 Gly 470 1.58  822 1.58 0.192 88 
10a His 326 0.53  274 0.53 0.192 88 
10b Tyr 242 0.53  274 0.53 0.211 97 
10c TOAC 230 0.53  274 0.53 0.125 57 
a) All amino acids are in the L-configuration, except for proline which has the D-configuration. 
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Figure  8-3: Coupling step yields determined by UV for the synthesis of the 81-member 
peptide library. 
 
From the yields of each coupling step, the total yields for the 81 members of the 
library were calculated (Table  8-8). 
Y
ie
ld
 [%
] 
a) a) a) a) 
a) average value 
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Table  8-8: Total yield for each peptide-member of the library. 
peptide-ligand X1 X2 X3 X4 total yield [%] 
96-01 Tyr Tyr Tyr Tyr 80 
96-02 Tyr Tyr Tyr His 73 
96-03 Tyr Tyr Tyr TOAC 47 
96-04 Tyr Tyr His Tyr 84 
96-05 Tyr Tyr His His 76 
96-06 Tyr Tyr His TOAC 48 
96-07 Tyr Tyr TOAC Tyr 42 
96-08 Tyr Tyr TOAC His 38 
96-09 Tyr Tyr TOAC TOAC 25 
96-10 Tyr His Tyr Tyr 82 
96-11 Tyr His Tyr His 74 
96-12 Tyr His Tyr TOAC 48 
96-13 Tyr His His Tyr 85 
96-14 Tyr His His His 76 
96-15 Tyr His His TOAC 50 
96-16 Tyr His TOAC Tyr 44 
96-17 Tyr His TOAC His 40 
96-18 Tyr His TOAC TOAC 26 
96-19 Tyr TOAC Tyr Tyr 42 
96-20 Tyr TOAC Tyr His 38 
96-21 Tyr TOAC Tyr TOAC 25 
96-22 Tyr TOAC His Tyr 44 
96-23 Tyr TOAC His His 40 
96-24 Tyr TOAC His TOAC 26 
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peptide-ligand X1 X2 X3 X4 total yield [%] 
96-25 Tyr TOAC TOAC Tyr 22 
96-26 Tyr TOAC TOAC His 20 
96-27 Tyr TOAC TOAC TOAC 13 
96-28 His Tyr Tyr Tyr 81 
96-29 His Tyr Tyr His 74 
96-30 His Tyr Tyr TOAC 47 
96-31 His Tyr His Tyr 85 
96-32 His Tyr His His 77 
96-33 His Tyr His TOAC 50 
96-34 His Tyr TOAC Tyr 43 
96-35 His Tyr TOAC His 39 
96-36 His Tyr TOAC TOAC 25 
96-37 His His Tyr Tyr 83 
96-38 His His Tyr His 75 
96-39 His His Tyr TOAC 48 
96-40 His His His Tyr 86 
96-41 His His His His 78 
96-42 His His His TOAC 51 
96-43 His His TOAC Tyr 44 
96-44 His His TOAC His 40 
96-45 His His TOAC TOAC 26 
96-46 His TOAC Tyr Tyr 43 
96-47 His TOAC Tyr His 39 
96-48 His TOAC Tyr TOAC 25 
96-49 His TOAC His Tyr 44 
EXPERIMENTAL PART 
 - 205 -
peptide-ligand X1 X2 X3 X4 total yield [%] 
96-50 His TOAC His His 40 
96-51 His TOAC His TOAC 26 
96-52 His TOAC TOAC Tyr 23 
96-53 His TOAC TOAC His 21 
96-54 His TOAC TOAC TOAC 13 
96-55 TOAC Tyr Tyr Tyr 62 
96-56 TOAC Tyr Tyr His 57 
96-57 TOAC Tyr Tyr TOAC 37 
96-58 TOAC Tyr His Tyr 65 
96-59 TOAC Tyr His His 59 
96-60 TOAC Tyr His TOAC 38 
96-61 TOAC Tyr TOAC Tyr 33 
96-62 TOAC Tyr TOAC His 30 
96-63 TOAC Tyr TOAC TOAC 19 
96-64 TOAC His Tyr Tyr 64 
96-65 TOAC His Tyr His 58 
96-66 TOAC His Tyr TOAC 37 
96-67 TOAC His His Tyr 67 
96-68 TOAC His His His 60 
96-69 TOAC His His TOAC 39 
96-70 TOAC His TOAC Tyr 34 
96-71 TOAC His TOAC His 31 
96-72 TOAC His TOAC TOAC 20 
96-73 TOAC TOAC Tyr Tyr 33 
96-74 TOAC TOAC Tyr His 30 
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peptide-ligand X1 X2 X3 X4 total yield [%] 
96-75 TOAC TOAC Tyr TOAC 19 
96-76 TOAC TOAC His Tyr 34 
96-77 TOAC TOAC His His 31 
96-78 TOAC TOAC His TOAC 20 
96-79 TOAC TOAC TOAC Tyr 17 
96-80 TOAC TOAC TOAC His 16 
96-81 TOAC TOAC TOAC TOAC 11 
 
8.7.3 Acetylation of the N-terminus of the decapeptides 
IV-MAG-6 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4H2N
Xn = His(Trt), Tyr(t-Bu), TOAC
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4NH
Xn = His(Trt), Tyr(t-Bu), TOAC
O
H3C
96 97 
 
1) Ac2O, 3 % NMM in DMF 
96 
2) test for free amino functions
97
 
The 81 MicroKans™ containing the library of decapeptides (0.63 mmol of peptides) 
were added to 100 mL of a 3 % NMM solution in absolute DMF. 150 µL (1.58 mmol, 
2.50 eq) of acetic anhydride were added to this solution and the reaction mixture was 
shaken at room temperature under argon for 12 hours. The reaction mixture was 
filtered and the resin washed 3 times with DMF. A few beads of 97 were withdrawn 
from a MikroKan™ and a NF31 test was performed in order to check the completion 
of the reaction. The colour test was negative, indicating that the reaction had been 
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successful. By comparison, the test performed on the starting material 96 was 
positive. 
 
8.7.4 Cleavage of the side chain protecting groups 
IV-MAG-8 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Xn = His(Trt), Tyr(t-Bu), TOAC(N-O ).  
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Xn = His, Tyr, TOAC(N-OH)  
97 98 
 
90 % TFA, 5 % H2O, 5 % TES 
97 
 
98
 
The 81 MikroKans™ containing 0.63 mmol of peptides were washed 3 times with 
dichloromethane, then 3 times with methanol in order to remove the DMF. The 
peptides were shaken in a mixture of 90 % TFA, 5 % water and 5 % triethylsilane at 
room temperature for 5 hours. The solution was filtered and the procedure was 
repeated to ensure complete deprotection of the side chains. The yellow solution was 
filtered and the resin was washed successively with dichloromethane, methanol and 
water. 
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8.7.5 Regeneration of the nitroxyl radical of the TOAC moieties 
IV-MAG-9 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Xn = His, Tyr, TOAC(N-OH)  
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Xn = His, Tyr, TOAC(N-O ).  
98 99 
 
10 % aq. NH3, air 
98 
 
99
 
The 81 MikroKans™ containing 0.63 mmol of decapeptides were shaken 4 hours in 
10 % aqueous ammonia. The solution was filtered and the procedure was repeated a 
second time. The library of peptides was washed successively with water and 
methanol. Finally, the resin carrying the peptide–ligands was dried under reduced 
pressure. 
 
8.7.6 Complexation of the peptide–ligands with copper(II) 
IV-MAG-49 
 
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Xn = His, Tyr, TOAC(N-O ).  
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Xn = His, Tyr, TOAC
Cu II
 
99 100 
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Cu(OAc)2 / acetate buffer 
99 
MeOH 
100
 
10.0 mg (2.00 µmol, 1.00 eq) of the solid-supported peptide–ligands were washed 
twice with methanol. Then 2 mL of methanol, 350 µg (2.00 µmol, 1.00 eq) of 
copper(II) acetate, 11.0 µL of acetic acid and 20.0 mg of sodium acetate (100 mM 
acetate buffer) were added to the resin. The reaction mixture was shaken at room 
temperature under argon for 5 hours and the resin was washed 3 times with 
methanol. The colour of the beads before and after complexation was compared. 
While the peptide-ligands had a white to pale yellow colour, the complexes gave a 
range of colours from yellow–orange to green–blue according to the structure of the 
peptide. Peptides containing histidine residues tend to give blue-coloured complexes. 
Peptides containing tyrosine residues tend to give green-coloured complexes. 
Peptides containing TOAC residues tend to give orange-coloured complexes. 
 
8.8 Screening of the TOAC library, 99 
8.8.1 Catalytic aerobic oxidation of 3-methoxybenzyl alcohol 39 with 
copper(II) complexes of peptide–ligands 99 
IV-MAG-13 
 
1.00 mol% peptide–ligand, 
3.00 mol% Cu(OAc)2, air 
 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
 
0.73 mg (4.00 µmol, 1.00 mol%) of copper(II) acetate were dissolved in 2.00 mL of a 
1:1 mixture of acetonitrile and water in a 5 mL vial. 20.0 mg (4.00 µmol, 1.00 mol%) 
of solid-supported peptide–ligand from the TOAC library 99 were added, followed by 
50.0 µL (400 µmol, 200 mM, 1.00 eq) of the test substrate 3-methoxybenzyl alcohol 
39. The resulting mixture was shaken at room temperature with the vial open to air. 
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The reaction was followed by UV. For this purpose, aliquots of 50.0 µL were 
withdrawn from the reaction mixture and added to 500 µL of acetonitrile / water (1:1). 
The resulting solution was filtered through cotton wool and 50.0 µL of the filtrate were 
transferred into a 384-well titerplate for analysis at λ = 310 nm. 
As no evolution of the absorbance was observed after 24 hours, 1.45 mg (8.00 µmol, 
2.00 mol%) of copper(II) acetate were added to each vial. 
The quantity of 3-methoxybenzaldehyde formed after 1.5, 2.5, 3.5 and 24 hours is 
summarised in Table  8-9. The time t = 0 corresponds to the time when the additional 
copper(II) acetate was added. 
 
For some of the members of the library, the catalysis was repeated (adding 
diphenylether as the internal standard) and the reaction mixture was analysed by GC 
after 24 hours. These results appear in brackets in Table  8-9. 
 
Table  8-9: Screening of the TOAC library 99 for catalytic aerobic oxidation of 
3-methoxybenzyl alcohol 39. 
peptide sequencea)  µmol of 3-methoxybenzaldehyde after: peptide–
ligand X1 X2 X3 X4  1.5 h 2.5 h 3.5 h 24 hb) 
99-01 Y Y Y Y  0.49 0.55 0.63 0.66 
99-02 Y Y Y H  0.21 0.17 0.15 0.34 
99-03 Y Y Y T’  0.15 0.56 0.70 4.94 (4.03)
99-04 Y Y H Y  0.95 1.13 1.17 1.40 
99-05 Y Y H H  0.54 0.51 0.62 0.76 
99-06 Y Y H T’  0.26 0.56 0.77 3.36 
99-07 Y Y T’ Y  0.39 0.91 1.16 4.96 (4.56)
99-08 Y Y T’ H  1.71 2.55 3.08 3.95 (4.02)
99-09 Y Y T’ T’  0.51 1.27 2.02 21.7 (18.5)
99-10 Y H Y Y  0.05 0.01 0.05 0.00 
99-11 Y H Y H  0.00 0.07 0.09 0.09 
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peptide sequencea)  µmol of 3-methoxybenzaldehyde after: peptide–
ligand X1 X2 X3 X4  1.5 h 2.5 h 3.5 h 24 hb) 
99-12 Y H Y T’  0.21 0.52 0.83 4.27 
99-13 Y H H Y  0.16 0.28 0.31 0.00 
99-14 Y H H H  0.06 0.13 0.14 0.00 
99-15 Y H H T’  0.36 0.69 1.07 4.09 
99-16 Y H T’ Y  0.40 0.75 1.05 11.5 (11.9)
99-17 Y H T’ H  0.52 1.07 1.51 6.12 
99-18 Y H T’ T’  0.65 1.67 2.64 15.1 (17.4)
99-19 Y T’ Y Y  0.24 0.61 1.01 6.57 (8.04)
99-20 Y T’ Y H  0.31 0.67 1.03 4.08 
99-21 Y T’ Y T’  0.61 1.28 1.76 11.2 (13.6)
99-22 Y T’ H Y  0.31 0.83 1.32 6.77 
99-23 Y T’ H H  0.28 0.51 0.81 5.15 
99-24 Y T’ H T’  0.76 1.17 1.40 6.64 
99-25 Y T’ T’ Y  0.43 0.83 1.31 5.14 
99-26 Y T’ T’ H  0.66 1.13 1.33 7.17 
99-27 Y T’ T’ T’  0.96 1.77 2.61 13.1 (11.4)
99-28 H Y Y Y  0.18 0.00 0.03 0.00 
99-29 H Y Y H  0.00 0.00 0.00 0.16 
99-30 H Y Y T’  0.22 0.29 0.69 3.49 
99-31 H Y H Y  0.03 0.00 0.00 0.09 
99-32 H Y H H  0.47 0.46 0.47 0.59 
99-33 H Y H T’  0.33 0.62 0.98 4.87 
99-34 H Y T’ Y  0.30 0.50 0.80 3.45 
99-35 H Y T’ H  0.25 0.41 0.70 3.58 
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peptide sequencea)  µmol of 3-methoxybenzaldehyde after: peptide–
ligand X1 X2 X3 X4  1.5 h 2.5 h 3.5 h 24 hb) 
99-36 H Y T’ T’  0.57 0.97 1.58 7.53 (5.91)
99-37 H H Y Y  0.00 0.00 0.01 0.30 
99-38 H H Y H  0.01 0.03 0.11 0.05 
99-39 H H Y T’  0.16 0.29 0.50 3.57 
99-40 H H H Y  0.00 0.00 0.00 0.10 
99-41 H H H H  0.32 0.31 0.32 0.51 
99-42 H H H T’  0.14 0.28 0.44 3.16 (3.02)
99-43 H H T’ Y  0.13 0.29 0.36 2.24 
99-44 H H T’ H  0.15 0.84 0.57 3.52 
99-45 H H T’ T’  0.47 0.99 1.42 8.07 (9.98)
99-46 H T’ Y Y  0.17 0.31 0.43 2.67 
99-47 H T’ Y H  0.10 0.37 0.50 2.30 
99-48 H T’ Y T’  0.52 1.07 1.39 6.74 (8.12)
99-49 H T’ H Y  0.20 0.37 0.55 3.29 
99-50 H T’ H H  0.16 0.42 0.51 3.61 
99-51 H T’ H T’  0.46 0.95 1.56 6.85 (6.98)
99-52 H T’ T’ Y  1.02 1.65 2.34 8.77 (10.4)
99-53 H T’ T’ H  0.33 1.02 1.34 7.32 (7.05)
99-54 H T’ T’ T’  0.84 1.61 2.11 7.63 (8.09)
99-55 T’ Y Y Y  0.15 0.34 0.38 2.04 
99-56 T’ Y Y H  0.23 0.50 0.73 3.30 
99-57 T’ Y Y T’  0.22 0.42 0.76 3.65 
99-58 T’ Y H Y  0.25 0.42 0.46 2.26 
99-59 T’ Y H H  0.23 0.48 0.72 3.31 
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peptide sequencea)  µmol of 3-methoxybenzaldehyde after: peptide–
ligand X1 X2 X3 X4  1.5 h 2.5 h 3.5 h 24 hb) 
99-60 T’ Y H T’  0.64 1.01 1.48 5.70 
99-61 T’ Y T’ Y  0.66 1.10 1.51 4.35 (3.23)
99-62 T’ Y T’ H  0.72 1.31 1.77 9.39 
99-63 T’ Y T’ T’  2.06 3.12 4.34 17.5 (19.6)
99-64 T’ H Y Y  0.39 0.62 0.84 4.19 
99-65 T’ H Y H  0.58 1.01 1.24 5.24 
99-66 T’ H Y T’  0.82 1.42 1.84 6.95 
99-67 T’ H H Y  0.38 0.59 0.97 4.88 
99-68 T’ H H H  0.24 1.12 0.59 3.65 
99-69 T’ H H T’  0.58 1.61 2.12 8.40 
99-70 T’ H T’ Y  0.62 1.52 1.92 11.1 (11.3)
99-71 T’ H T’ H  0.63 1.03 1.46 7.29 
99-72 T’ H T’ T’  1.72 3.03 3.85 14.7 (15.3)
99-73 T’ T’ Y Y  0.42 0.95 1.08 4.75 
99-74 T’ T’ Y H  0.88 1.09 1.74 6.74 
99-75 T’ T’ Y T’  1.19 2.85 3.42 15.6 (12.7)
99-76 T’ T’ H Y  1.01 0.92 1.18 5.85 
99-77 T’ T’ H H  0.30 0.55 0.74 4.12 
99-78 T’ T’ H T’  1.46 1.89 2.89 10.5 (11.6)
99-79 T’ T’ T’ Y  0.70 1.37 1.69 6.99 
99-80 T’ T’ T’ H  1.14 2.27 2.86 10.1 (9.67)
99-81 T’ T’ T’ T’  0.53 1.77 1.99 7.64 
a) Y = tyrosine, H = histidine, T’ = TOAC 
b) The values in bracket correspond to the results obtained by GC analysis.   
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8.8.2 Control experiments for the catalytic aerobic oxidation of 
3-methoxybenzyl alcohol 39 
8.8.2.1 Effect of copper on the catalytic aerobic oxidation of 3-methoxybenzyl 
alcohol 39 
V-MAG-10 
 
1.00 mol% peptide–ligand, air 
 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
 
A 5 mL vial was charged with 20.0 mg (4.00 µmol, 1.00 mol%) of solid-supported 
peptide–ligand from the TOAC library (99-75, 99-78 or 99-81). 2.00 mL of a 1:1 
mixture of acetonitrile and water was then added, followed by 50.0 µL (400 µmol, 
200 mM, 1.00 eq) of the test substrate 3-methoxybenzyl alcohol 39. The resulting 
mixture was shaken at room temperature with the vial open to air. The reaction was 
followed by UV. For this purpose, aliquots of 50.0 µL were withdrawn from the 
reaction mixture and added to 500 µL of acetonitrile / water (1:1). The resulting 
solution was filtered through cotton wool and 50.0 µL of the filtrate were transferred 
into a 384-well titerplate for analysis at λ = 310 nm. The quantity of 
3-methoxybenzaldehyde 40 formed after 1.5, 2.5 and 24 hours is summarised in 
Table  8-10. 
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Table  8-10: Comparison of 3 peptide–ligands with or without copper salt in the 
catalytic aerobic oxidation of 3-methoxybenzyl alcohol 39. 
µmol of 3-methoxybenzaldehyde after: 
peptide–ligand 
Cu(OAc)2 
[mol%] 1.5 h 2.5 h 24 h 
99-75 3.00 1.19 2.85 15.6 
99-75 - - - 0.60 
99-78 3.00 1.46 1.89 10.5 
99-78 - - - 0.50 
99-81 3.00 0.53 1.77 7.64 
99-81 - - - 0.50 
 
8.8.2.2 Catalytic effect of non-peptidic TOAC and L-tyrosine  
IV-MAG-16 
 
3.00 mol% Cu(OAc)2, 
1.00-4.00 mol% Fmoc-TOAC or L-tyrosine, 
air 
OH
OMe  
MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
 
In a 5 mL vial, 2.18 mg (12.0 µmol, 3.00 mol%) of copper(II) acetate were dissolved 
in 2.00 mL of a 1:1 mixture of acetonitrile and water. 1.00, 2.00, 3.00 or 4.00 mol% of 
Fmoc-TOAC-OH and/or 1.00, 2.00, 3.00 or 4.00 mol% of H2N-L-Tyr-OH were added 
as given in Table  8-11. 50.0 µL (400 µmol, 200 mM, 1.00 eq) of the test substrate 
3-methoxybenzyl alcohol 39 were added and the resulting mixture was shaken at 
room temperature with the vial open to air. The reaction was followed by UV. For this 
purpose, aliquots of 50.0 µL were withdrawn from the reaction mixture and added to 
500 µL of acetonitrile / water (1:1). The resulting solution was filtered through cotton 
wool and 50.0 µL of the filtrate were transferred into a 384-well titerplate for analysis 
at λ = 310 nm. 
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Table  8-11: Control experiments for the catalytic aerobic oxidation of 
3-methoxybenzyl alcohol 39: catalytic effect of non-peptidic TOAC 43 and 
L-tyrosine. 
Cu(OAc)2  Fmoc-TOAC, 43 L-tyrosine 
3-methoxybenzaldehyde 
[µmol] entry 
[mg] [mol%]  [mg] [mol%] [mg] [mol%] 2.5 h 3.5 h 24 h 
1 - -  - - - - 0.09 0.00 0.25 
2 2.18 3.00  - - - - 0.07 0.00 0.57 
3 - -  1.70 1.00 - - 0.00 0.00 0.43 
4 - -  3.50 2.00 - - 0.00 0.00 0.38 
5 - -  5.20 3.00 - - 0.00 0.00 0.42 
6 - -  7.00 4.00 - - 0.00 0.16 1.45 
7 2.18 3.00  1.70 1.00 - - 1.17 1.78 4.23 
8 2.18 3.00  3.50 2.00 - - 1.36 1.95 4.32 
9 2.18 3.00  5.20 3.00 - - 1.57 2.34 4.25 
10 2.18 3.00  7.00 4.00 - - 1.59 2.01 5.05 
11 - -  - - 0.70 1.00 0.08 0.18 0.94 
12 - -  - - 1.40 2.00 0.08 0.20 0.89 
13 - -  - - 2.20 3.00 0.07 0.36 1.05 
14 - -  - - 2.90 4.00 0.12 0.03 0.43 
15 2.18 3.00  - - 0.70 1.00 0.03 0.00 0.25 
16 2.18 3.00  - - 1.40 2.00 0.00 0.00 2.10 
17 2.18 3.00  - - 2.20 3.00 0.00 0.09 0.63 
18 2.18 3.00  - - 2.90 4.00 0.00 0.62 1.82 
19 2.18 3.00  3.50 2.00 1.40 2.00 0.37 0.00 0.25 
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8.8.2.3 Catalysis under inert atmosphere 
V-MAG-10 
 
1.00 mol% peptide–ligand 99-18, 
3.00 mol% Cu(OAc)2 
 
OH
OMe  abs. MeCN, r.t. 
H O
OMe  
39  40 
 
In a 5 mL Schlenk flask equipped with a septum and a gas inlet, 2.18 mg (12.0 µmol, 
3.00 mol%) of copper(II) acetate were dissolved in 2.00 mL of absolute acetonitrile. 
20.0 mg (4.00 mmol, 1.00 mol%) of the solid-supported peptide-ligand from the 
TOAC library (99-18) were added. The flask was evacuated and filled with argon. 
50.0 µL (400 µmol, 200 mM, 1.00 eq) of the test substrate 3-methoxybenzyl alcohol 
39 were added and the resulting mixture was shaken at room temperature under 
argon. The reaction was followed by UV. For this purpose, aliquots of 50.0 µL were 
withdrawn from the reaction mixture and added to 500 µL of acetonitrile / water (1:1). 
The resulting solution was filtered through cotton wool and 50.0 µL of the filtrate were 
transferred into a 384-well titerplate for analysis at λ = 310 nm. Only 0.25 µmol of 
3-methoxybenzaldehyde were formed after 24 hours. 
 
8.8.3 Recycling of the peptide–copper catalysts 
V-MAG-11 
 
1.00 mol% peptide–copper(II) complex, 
air 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
 
Three of the peptide–copper(II) complexes from the library 99 (99-63, 99-71 and 
99-78) used for the catalytic aerobic oxidation of 3-methoxybenzyl alcohol  39 were 
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washed with water and dried under reduced pressure. A 5 mL vial was charged with 
20.0 mg (4.00 µmol, 1.00 mol%) of solid-supported peptide–copper(II) complex 
99-63, 99-71 or 99-78, 2.00 mL of a 1:1 mixture of acetonitrile and water, followed by 
50.0 µL (400 µmol, 200 mM, 1.00 eq) of the test substrate 3-methoxybenzyl alcohol 
39. Eventually, 1.30 mg (7.33 µmol, 2.00 mol%) of copper(II) acetate were added 
(Table  8-12) and the resulting mixture was shaken at room temperature with the vial 
open to air. The reaction was followed by UV. For this purpose, aliquots of 50.0 µL 
were withdrawn from the reaction mixture and added to 500 µL of acetonitrile / water 
(1:1). The resulting solution was filtered through cotton wool and 50.0 µL of the 
filtrate were transferred into a 384-well titerplate for analysis at λ = 310 nm. The 
quantity of 3-methoxybenzaldehyde 40 formed after 1.5, 2.5 and 24 hours is 
summarised in Table  8-12. 
 
Table  8-12: Quantity of 3-methoxybenzaldehyde 40 formed after 1.5, 2.5 and 24 hours 
for the second use of the catalysts. 
Cu(OAc)2 µmol of 3-methoxybenzaldehyde 40 after:
peptide–copper(II) complex 
[mol %] 1.5 h 2.5 h 24 h 
99-63 - 0.1 0.3 1.3 
99-71 - 0.1 0.4 1.5 
99-78 - 0.1 0.2 1.3 
99-43 2.00 0.1 0.2 1.0 
99-44 2.00 0.4 0.3 1.6 
99-80 2.00 0.3 0.7 2.0 
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8.9 Synthesis of one of the members of the library on TentaGel Wang 
resin and catalysis with the soluble peptide–ligand 
8.9.1 Synthesis of the decapeptide 103 following the Fmoc strategy 
V-MAG-6 
 
OCOPheFmoc-HN
PEG OTentaGel with Wang linkerpre-loaded with Fmoc-L-Phe-OH: CH2O
O
NH-Fmoc
Ph
 
102 
 
Phe Gly Gly
D-Pro
Gly
TOAC His(Trt)
GlyHis(Trt)H2N
OCO
TOAC
 
103 
 
1) 20 % piperidine in DMF  
2) 2.50 eq Fmoc-Gly-OH, 2.50 eq PyBOP, 3 % NMM 
in DMF 
3) test for free amino functions 
4) 20 % piperidine in DMF 
 
 
102 
5) repetition of the steps 2) to 4) with the 
Fmoc-protected amino acids, Fmoc-TOAC-OH 43, 
Fmoc-L-His(Trt)-OH, Fmoc-Gly-OH or Fmoc-D-
Pro-OH, according to the given decapeptide 
sequence 
 
103 
 
A 100 mL Merrifield flask was charged with 1.50 g (theoretical loading = 0.23 mmol/g) 
of TentaGel Wang resin pre-loaded with Fmoc-L-Phe-OH. 15 mL of absolute DMF 
were added and the resin was allowed to swell by gentle shaking at room 
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temperature for 1 hour. The Fmoc protecting groups were cleaved according to the 
general procedure ( 8.2.6) and the loading of the resin was determined to be 
0.24 mmol/g. 15 mL of a 3 % NMM solution in absolute DMF were added to the resin, 
followed by 2.50 eq of Fmoc-protected amino acid (Fmoc-Gly-OH, Fmoc-TOAC-OH 
43, Fmoc-L-Tyr(Trt)-OH or Fmoc-D-Pro-OH) and 449 mg (0.86 mmol, 2.50 eq) of the 
coupling agent PyBOP. The resulting suspension was shaken at room temperature 
under argon for 12 hours. The solution was filtered and the resin washed 3 times with 
15 mL of DMF. The completion of the reaction was checked with the NF31 test. If 
necessary the coupling step was repeated. Table  8-13 summarises the number of 
times the coupling was repeated and the yield obtained for each step. Once the 
colour test was negative, the Fmoc protecting group was removed and the coupling 
was quantified by UV. 
 
Table  8-13: Synthesis of the decapeptide 103 on TentaGel Wang resin.  Quantities 
of amino acid used, number of coupling steps and yield for each coupling. 
amino acida) loading yield  
 [mg] [mmol]
Nr of 
couplings [mmol/g] [%] 
Phe - - - 0.239 100 
Gly 256 0.86 1 0.249 104 
TOAC 377 0.86 1 0.143 60 
His 534 0.86 3 0.234 98 
Gly 256 0.86 1 0.246 103 
D-Pro 291 0.86 1 0.246 103 
Gly 256 0.86 3 0.229 96 
TOAC 377 0.86 1 0.129 54 
Gly 256 0.86 3 0.170 71 
His 534 0.86 3 0.172 72 
a) All amino acids are in the L-configuration, except for proline which has the D-configuration. 
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8.9.2 Acetylation of the N-terminus of the decapeptide 103 
V-MAG-6 
 
Phe Gly Gly
D-Pro
Gly
TOAC His(Trt)
GlyHis(Trt)H2N
OCO
TOAC
Phe Gly Gly
D-Pro
Gly
TOAC His(Trt)
GlyHis(Trt)N
H
OCO
TOAC
O
H3C
103 104 
 
1) Ac2O, 3 % NMM in DMF 
103 
2) test for free amino functions
104 
 
15 mL of a 3 % NMM solution in absolute DMF were added to the resin. 82.0 µL 
(860 µmol, 2.50 eq) of acetic anhydride were added to the suspension and the 
reaction mixture was shaken at room temperature under argon for 12 hours. The 
solution was filtered and the resin washed 3 times with DMF. A few beads were 
taken and a NF31 test was performed in order to check the completion of the 
reaction. The colour test was negative, indicating that the reaction had been 
successful. By comparison, the test performed on the starting material 103 was 
positive. 
 
8.9.3 Deprotection of the side chains and cleavage from the TentaGel Wang 
resin 
V-MAG-6 
 
Phe Gly Gly
D-Pro
Gly
TOAC His(Trt)
GlyHis(Trt)AcHN
OCO
TOAC
Phe Gly Gly
D-Pro
Gly
TOAC His
GlyHisAcHN
HO2C
TOAC
 
104 101 
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90 % TFA, 5 % H2O, 5 % TIS 
104 
 
101 
 
The resin was washed 3 times with dichloromethane and 3 times with methanol in 
order to remove the DMF. It was shaken 5 hours in 15 mL of a mixture of 90 % of 
TFA, 5 % of water and 5 % of triisopropylsilane. The yellow solution was filtered and 
the filtrate was concentrated under reduced pressure. The product was precipitated 
by the addition of diethylether. The product was filtered, dissolved in 80 mL of a 
mixture of water and methanol (90 : 10) and lyophilised. 382 mg of crude product 
were obtained. 50 mg were purified by preparative HPLC (RP-18, 
water : acetonitrile : acetic acid = 90 : 10 : 0.5) to give 38 mg of pure peptide. The 
analysis by LC–MS showed that the obtained peptide had two hydroxyl amine 
moieties (105). 
 
HO
O
NH
O
HN
O
NH
O
HN
O
NH
O
O
H
N
O
N
H
H
N
O
O
N
H
N
N
N
H
N
OH
O
H3C
NHO
HN N H3C CH3
H3C
H3C CH3
H3C
H3C
H3C
105 
 
C56H82N16O14 
 
1203.35 g·mol–1 
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Yield 
 
290 mg, 0.24 mmol, 64 % 
HPLC 
 
τR = 9.6 mins (RP-18, water : acetonitrile : acetic acid = 
90 : 10 : 0.5) 
 
MS (positive ESI, H2O) m/z (%, formula) = 1203 ([M]+), 1204 ([M+H]+), 
1125 ([M+Na]+), 1226 ([M+Na+H]+). 
 
 
8.9.4 Catalysis with the soluble peptide-ligand 105 
V-MAG-12 
 
1.00 mol% soluble peptide–ligand 105, 
3.00 mol% Cu(OAc)2, air 
 
OH
OMe  MeCN / H2O (1:1), r.t. 
H O
OMe  
39  40 
 
In a 5 mL vial, 2.18 mg (12.0 mmol, 3.00 mol%) of copper(II) acetate were dissolved 
in 2.00 mL of a 1:1 mixture of acetonitrile and water. 4.8 mg (4.00 µmol, 1.00 mol%) 
of the soluble peptide–ligand 101 were added, followed by 50.0 µL (400 µmol, 
200 mM, 1.00 eq) of the test substrate 3-methoxybenzyl alcohol 39. The resulting 
mixture was shaken at room temperature with the vial open to air. The reaction was 
followed by UV. For this purpose, aliquots of 50.0 µL were withdrawn from the 
reaction mixture and added to 500 µL of acetonitrile / water (1:1). The resulting 
solution was filtered through cotton wool and 50.0 µL of the filtrate were transferred 
into a 384-well titerplate for analysis at λ = 310 nm. After 24 hours, 14.32 µmol of 
3-methoxybenzaldehyde 39 were formed, which corresponds to a yield in aldehyde 
of 3.6 %. 
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8.10 Synthesis of the resin-supported low molecular weight ligand 66 
8.10.1 Synthesis of the resin-supported tosylamide 67[117] 
I-MAG-32 
 
10 eq H2N-CH2-CH2-NH2 
 S
O
O
Cl
 CH2Cl2 
S N
H
O
O
NH2
 
69  67 
 = 1 % cross-linked polystyrene resin 
 
A 100 mL Merrifield flask was charged with 100 mg (144 µmol, 1.00 eq) of 
chlorosulfonated polystyrene resin PS-TsCl (loading = 1.44 mmol/g) 69 and 10 mL of 
dry dichloromethane. The resin was allowed to swell by gentle shaking at room 
temperature for 1 hour. The solvent was filtered and a solution of 87.0 mg 
(1.44 mmol, 10.0 eq) of ethylenediamine in 10 mL of dry dichloromethane was 
added. The suspension was shaken at room temperature under argon overnight. The 
solvent was filtered and the resin was washed 3 times with dichloromethane. To 
check the completion of the reaction, a NF31 test was performed on a few beads of 
product 67. The red colour of the beads indicated the presence of free amino 
functions. When the same colour test was performed on the starting material, the 
beads remained colourless. 
 
8.10.2 Synthesis of the resin-supported tosylamide ligand 66[118] 
II-MAG-33 
t-Bu
t-Bu
OH
O
H
68a[89] 
 
                                                 
a 2,4-di-tert-butyl-salicylaldehyde 68 was synthesised by Stephan Bulat.  
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10 eq 68 
 S NH
O
O
NH2
 CH2Cl2 
t-Bu
t-Bu
OH
N
S
O
O
HN
 
67  66 
 
10 mL of dichloromethane and 337 mg (1.44 mmol, 10.0 eq) of 
2,4-di-tert-butyl-salicylaldehyde 68 were added to 100 mg (144 µmol, 1.00 eq) of 
resin 67 (loading = 1.44 mmol/g). The solution was shaken at room temperature 
under argon for 24 hours. The solvent was removed by filtration, the resin was 
washed 3 times with dichloromethane and dried under reduced pressure to give 
ligand 66. 
 
OH
N
HN S
O
O
H3C
CH3
Hb
Ha
Hc Hd
Hc HdCH3H3C
H3C
H3C
1
23
4
5 6
66 
 
FT-IR (KBr disc) ν [cm–1] = 3298 [br, ν(O–H) + ν(N–H)], 1627 [s, ν(C=N)], 
1158 [s, ν(C–O)]. 
 
HR-MAS 
1H-NMR 
(300 MHz, CDCl3) δ = 1.40 (s, 9H, t-Bu), 1.55 (s, 9H, t-Bu), 3.25 (s, 
2H, CH2), 3.70 (s, 2H, CH2), 5.20-5.30 (s, 1H, NH), 6.61 (s, 1H, 
Ha), 6.73 (s, 1H, Hd), 7.19 (s, 1H, Hb), 7.55 (s, 1H, Hc), 8.39 (s, 1H, 
OH), 11.3-11.6 (m, 1H, N=CH). 
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HR-MAS 
13C-NMR 
(75 MHz, CDCl3) δ = 29.9 (q, CH3 / t-Bu), 31.2 (q, CH3 / t-Bu), 34.9 
(s, Cq / t-Bu), 36.1 (s, Cq / t-Bu), 40.8 (d, CH2–NHTos), 60.0 (d, 
CH2–N=), 119.9 (s, aryl–C), 128.5 (d, 4 aryl–C from Tos), 138.7 (s, 
aryl–C–S), 141.2 (s, aryl–C), 144.8 (s, aryl–C), 159.3 (s, aryl–C2), 
169.1 (s, C=N). 
 
 
8.10.3 Complexation of the resin-supported tosylamide ligand 66 with 
copper[90] 
I-MAG-36 
 
t-Bu
t-Bu
OH
N N S
O
O
 
t-Bu
t-Bu
O
N N S
O
OCu
O
H3C
H
II
 
66 65 
 
Cu(OAc)2, KOH 
66 
MeCN, MeOH 
65 
 
To 100 mg (144 µmol, 1.00 eq) of resin 66 (loading = 1.44 mmol/g), 10 mL of 
acetonitrile, 24.0 mg (430 µmol, 3.00 eq) of potassium hydroxide and 26.0 mg 
(144 µmol, 1.00 eq) of copper(II) acetate were added. The suspension was shaken at 
room temperature under argon. After 3 hours, 10 mL of methanol were added and 
the reaction mixture was shaken further overnight. The solution, green at the 
beginning, turned yellow overnight. The solvent was filtered and the resin was 
washed several times with methanol until a clean green resin was obtained. 
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8.11 Catalytic aerobic oxidation of primary alcohols with different low 
molecular weight ligands 
8.11.1 Comparison of the soluble sulfonamide ligand 31 and its 
resin-supported equivalent 66[89] 
 
t-Bu
t-Bu
OH
N
S
O
O
HN
 
t-Bu
t-Bu
OH
N
S
O
O
HN
CH3  
66 31[89] 
 
8.11.1.1 Aerobic oxidation of benzyl alcohol 33 to benzaldehyde 34 
III-MAG-17 
 
0.50 mol% ligand 66 or 31, 
0.50 mol% Cu salt, 5.00 mol% KOH, 
air 
 
OH
 
MeCN, r.t. 
OH
 
33  34 
 
In a 25 mL round-bottomed flask, 49.0 µmol (0.50 mol%) of ligand 66 or 31 and 
49.0 µmol (0.50 mol%) of copper(I) chloride or copper(II) acetate were added to 
10.0 mL of acetonitrile. To this reaction mixture, 100 µL of diphenylether were added 
as the internal standard, then 1.00 mL (9.70 mmol, 970 mM, 1.00 eq) of benzyl 
alcohol 33 was added, followed by 27.5 mg (490 µmol, 5.00 mol%) of potassium 
hydroxide. The reaction mixture was stirred at room temperature with the flask open 
to air for 3 hours. 100 µL of solution was taken, 1.00 mL of acetonitrile was added 
and the resulting solution was filtered over a short aluminium oxide (pH neutral) 
column. The filtrate was analysed by GC (GC program 1). 
 
EXPERIMENTAL PART 
 - 228 -
Table  8-14: Yield and turnover after 3 hours for the catalytic aerobic oxidation of 
benzyl alcohol 33 with ligands 66 and 31. 
ligand copper salt 
yield of 
benzaldehydea) 
TON
entry 
 [mg] [mol%]  [mg] [mol %] [%]  
1 66 34.0 0.50 Cu(II)(OAc)2 8.75 0.50 18 36 
2 31 21.1 0.50 Cu(II)(OAc)2 8.75 0.50 17 34 
3 66 34.0 0.50 Cu(I)Cl 4.90 0.50 18 36 
4 31 21.1 0.50 Cu(I)Cl 4.90 0.50 19 38 
5 66 34.0 0.50 - - - 2 4 
6 - - - Cu(II)(OAc)2 8.75 0.50 4 8 
7b) 66 34.0 0.50 Cu(II)(OAc)2 8.75 0.50 1 2 
8b) 66 34.0 0.50 - - - 1 2 
9b) - - - Cu(II)(OAc)2 8.75 0.50 1 2 
10 - - - - - - 1 2 
11b) - - - - - - 1 2 
a) Benzoic acid was not formed. 
b) The reaction was carried out without potassium hydroxide. 
 
8.11.1.2 Oxidation of 3-methoxybenzyl alcohol 39 to 3-methoxybenzaldehyde 40 
I-MAG-46 
 
0.50 mol% ligand 66 or 31 
0.50 mol% Cu(OAc)2, 5.00 mol% KOH, 
air 
OH
OMe  
MeCN, r.t. 
H O
OMe  
39  40 
In a 25 mL round-bottomed flask, 8.00 mg (140 µmol, 5.00 mol%) of potassium 
hydroxyde, 2.50 mg (14.0 µmol, 0.50 mol%) of copper(II) acetate and 14.0 µmol 
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(0.50 mol%) of ligand 66 or 31 were suspended in 25.0 mL of acetonitrile. 350 µL 
(2.80 mmol, 112 mM, 1.00 eq) of 3-methoxybenzyl alcohol 39 were added to the 
solution and the reaction mixture was shaken at room temperature with the flask 
open to air for 4 hours. In order to follow the reaction, aliquots of 50.0 µL were taken, 
added to 5.00 mL of acetonitrile and 50.0 µL of the resulting solution were transferred 
to a 384-well titerplate for analysis at λ = 310 nm. 
 
Table  8-15: Yield and turnover after 3.5 hours for the catalytic aerobic oxidation of 
3-methoxybenzyl alcohol 39 with ligands 66 and 31. 
ligand 3-methoxybenzaldehydea) TON 
entry 
 [mg] [mol%] [%]  
1 66 9.70 0.50 16 32 
2 31 6.00 0.50 13 26 
a) 3-Methoxybenzoic acid was not formed. 
 
Table  8-16: Formation of 3-methoxybenzaldehyde 40 by catalytic aerobic oxidation 
with ligands 66 and 31. 
yield [%] 
time [mins] 
ligand 66 ligand 31 
10 6.9 3.3 
20 8.0 7.4 
40 9.9 9.6 
70 12.2 11.2 
120 14.7 12.6 
165 14.7 14.1 
210 16.2 14.2 
260 16.3 14.2 
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10 Appendix 
10.1 List of abbreviations 
 
° C degree celcius 
µL microliter 
µmol micromol 
AA amino acid 
abs. absolute 
Ac acetyl 
Ac2O acetic anhydride 
bipy bipyridine 
Boc tert-butyloxycarbonyl 
BOP (benzotriazol-1-yloxy)-tris(dimethyl-amino)-phosphonium 
BuLi butyllithium 
conc. concentrated 
CDI 1,1’-carbonyl-diimidazole 
Cys cysteine 
DCC N,N’-dicyclohexylcarbodiimide 
DIC N,N’-diisopropycarbodiimide 
DCM dichloromethane 
DEAD diethylazodicarboxylate 
DIAD diisopropylazodicarboxylate 
DMAP 4-N,N’-dimethylaminopyridine 
DMF N,N’-dimethylformamide 
DMSO dimethyl sulfoxide 
eq equivalent 
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Fmoc 9-fluorenylmethyloxycarbonyl 
Fmoc-OSu o-(9-fluorenylmethyloxycarbonyl)-N-hydroxysuccinimide 
GC gas chromatography 
Gly glycine 
GO, GOase galactose oxidase 
h hour 
HBTU 2-(1H-benzotriazol-1-yl)-1’,1’,3’,3’-tetramethyluronium 
hexafluorophosphate 
His histidine 
HOBt 1-hydroxybenzotriazole 
HPLC high-performance liquid chromatography 
LC–MS liquid chromatography – mass spectrometry 
min. minute 
mod-Cys modified cysteine 
MOM methoxymethyl 
NHE normal hydrogen electrode 
NMM N-methylmorpholine 
NMR nuclear magnetic resonance 
PEG polyethyleneglycol 
PG protecting group 
Phe phenylalanine 
Phen phenanthroline 
Pro proline 
py pyridine 
PyBOP 1-benzotriatolyloxy-tripyrrolidinophosphonium 
hexafluorophosphate 
R residue 
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r.t. room temperature 
t-Bu tert-butyl 
TBTU 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
tetrafluoroborate 
TEMPO 2,2,6,6-tetramethylpiperidin-1-yloxy 
TES triethylsilane 
TFA trifluoroacetic acid 
THF tetrahydrofuran 
TOAC 2,2,6,6-tetramethylpiperidin-1-yloxy-4-amino-4-carboxylic 
acid 
TON turnover number 
TSTU O-(N-succinimidyl)-N,N,N’,N’-tetramethyluronium 
tetrafluoroborate 
Trt trityl 
Tyr tyrosine 
UV ultra-violet 
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10.2 Abstract 
Within this thesis, copper complexes have been synthesised as models for the 
enzyme galactose oxidase. A combinatorial library of 81 decapeptides containing the 
redox active TOAC amino acid was synthesised following the split-mix strategy. The 
peptide-ligands were complexed with copper(II) and screened for activity in the 
aerobic oxidation of 3-methoxybenzyl alcohol. The screening revealed active 
members. Moreover an unnatural amino acid derived from L-cysteine has been 
synthesised. This amino acid is a model for the Tyr-Cys cross-link found at the active 
site of galactose oxidase and was further included successfully in two different 
peptide sequences. In a third part, a low molecular weight tosylamide ligand was 
synthesised on solid support. The copper complex of this ligand showed activity in 
the aerobic oxidation of benzyl alcohols. 
 
10.3 Kurzzusammenfassung 
Im Rahmen dieser Arbeit wurden Kupferkomplexe als Modelle für Galactose-Oxidase 
entwickelt. Eine kombinatorische Bibliothek von 81 Decapeptiden, die die redoxaktive 
Aminosäure TOAC enthält,  wurde mit Hilfe der Split-Mix Methode synthetisiert. Die 
Peptidliganden wurden mit Kupfer(II) komplexiert und auf Aktivität in der aeroben 
Oxidation von 3-Methoxybenzylalkohol geprüft. Im Screening konnten aktive 
Katalysatoren identifiziert werden. Darüberhinaus wurde eine unnatürliche, vom 
L-Cystein abgeleitete Aminosäure dargestellt. Diese Aminosäure ist ein Modell für 
den Tyr-Cys Cross-link der Galactose-Oxidase und wurde erfolgreich in zwei 
verschiedene Peptidsequenzen eingebaut. Im dritten Teil dieser Arbeit wurde ein 
niedermolekularer Tosylamid-Ligand auf der Festphase synthetisiert. Der 
Kupferkomplex dieses Liganden zeigte ebenfalls katalytische Aktivität in der aeroben 
Oxidation von Benzylalkoholen. 
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10.4 Important molecular formulae 
N
O
CO2HH2N
H3C CH3
H3C CH3
 
S
OH
t-But-Bu
CO2HH2N  
S
OMOM
t-But-Bu
CO2HBoc-HN  
S
OMOM
t-But-Bu
CO2HCbz-HN
41 42 47 53 
    
t-Bu
t-Bu
OH
N
S
O
O
HN
 
t-Bu
t-Bu
O
N N S
O
OCu
O
H3C
H
II
 
66 65 
  
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
 
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
           82           83 
   
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu II
PEG
 
X1 = mod-Cys 
X2 = Tyr 
X3 = His 
X4 = His 
X1 = mod-Cys 
X2 = His 
X3 = His 
X4 = Tyr 
           84           85 
   
NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
PEG
 NH CO Phe Gly X1 X2 Gly
D-Pro
GlyX3GlyX4AcHN
Cu II
PEG
 
Xn = Tyr, His, TOAC Xn = Tyr, His, TOAC 
99 100 
 
